PNdex - กองควบคุมวัตถุเสพติด

Transcription

PNdex - กองควบคุมวัตถุเสพติด
PNdex ������������.indd 5
24/3/2553 18:13:05
4th Edition
ª×èÍ˹ѧÊ×Í
ÀÒÉÒä·Â
ÃٻẺàÀÊѪÀѳ±Çѵ¶ØÍÍ¡Ä·¸ÔìáÅÐÂÒàʾµÔ´ãËŒâ·É
»ÃÐà·Èä·Â 2553
ÀÒÉÒÍѧ¡ÄÉ
PNDEX THAILAND 2010
(Psychotropics & Narcotics Index 2010)
ISBN
974-244-092-1
¨Ñ´·íÒáÅÐ
ÃǺÃÇÁâ´Â
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êíҹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
¡ÃзÃǧÊÒ¸ÒóÊØ¢
â·Ã/â·ÃÊÒÃ 0 2590 7346
ÍÕàÁŏ : [email protected]
àÃÕºàÃÕ§
ºÃÔÉÑ· ·ÔÁʏ (»ÃÐà·Èä·Â) ¨íÒ¡Ñ´
áÅШѴ¾ÔÁ¾â´Â 58-60 ÊØ¢ØÁÇÔ· 62 ºÒ§¨Ò¡ ¾ÃÐ⢹§ ¡ÃØ§à·¾Ï 10260
â·Ã 0 2741 5354 â·ÃÊÒÃ 0 2741 5360
All rights reserved.
ʧǹÅÔ¢ÊÔ·¸ÔìµÒÁ¾ÃÐÃÒªºÑÞÞѵÔ
AW_PNdex front 20100402.indd 1
2/4/2553 13:57:04
OBJECTIVES
Çѵ¶Ø»ÃÐʧ¤
1. ÊíÒËÃѺ㪌໚¹¤Ù‹Á×ͧ͢਌Ò˹ŒÒ·ÕèÊÒ¸ÒóÊآ㹡ÒþÔÊÙ¨¹àÍ¡Åѡɳ áÅÐÃÙ»¾Ãó
(Identification) ¢Í§Çѵ¶ØÍÍ¡Ä·¸Ôì áÅÐÂÒàʾµÔ´ãËŒâ·É ¡Ã³Õ·Õèà¡Ô´ÍÒ¡ÒÃ
äÁ‹¾Ö§»ÃÐʧ¤¨Ò¡¡ÒÃ㪌ÂÒ ËÃ×Í¡ÒÃ㪌ÂÒà¡Ô¹¢¹Ò´
2. ÊíÒËÃѺ㪌໚¹¤ÙÁ‹ Í× ¢Í§à¨ŒÒ˹ŒÒ·Õ»è ͇ §¡Ñ¹áÅлÃÒº»ÃÒÁ´ŒÒ¹Çѵ¶ØàʾµÔ´ã¹¡ÒþÔʨ٠¹
àÍ¡Åѡɳ áÅÐÃÙ»¾Ãó (Identification) ¢Í§Çѵ¶ØÍÍ¡Ä·¸Ôì áÅÐÂÒàʾµÔ´ãËŒâ·É
¡Ã³Õ·ÕèÁÕ¡ÒáÃзíÒ½†Ò½„¹¡®ËÁÒÂ
3. 㪌໚¹¤Ù‹Á×Í͌ҧÍÔ§ËÃ×Í㪌»ÃÐ⪹Í×è¹æ ã¹·Ò§¡ÒÃᾷ
¤³Ð¼ÙŒ¨Ñ´·íÒ
·Õè»ÃÖ¡ÉÒ
¹¾.¾Ô¾Ñ²¹ ÂÔè§àÊÃÕ
¹¾.¾§È¾Ñ¹¸ ǧȏÁ³Õ
ÀÞ.¹ÔµÂÒ áÂŒÁ¾ÂѤ¦
À¡.ÇÔâ蹏 ÊØ‹ÁãËÞ‹
¤³Ð·íÒ§Ò¹
àÅ¢Ò¸Ô¡Òä³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
ÃͧàÅ¢Ò¸Ô¡Òä³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
àÀÊѪ¡ÃàªÕèÂǪÒÞ´ŒÒ¹ÃкҴÇÔ·ÂҢͧÇѵ¶ØàʾµÔ´
¼ÙŒª‹ÇÂàÅ¢Ò¸Ô¡Òä³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
¹Ò§¨Ñ¹·¹Ò »Ò¹»ÃÕªÒ
¹Ò¨ÔÃÇѲ¹ ÈÃÕÁ§¤Å¡ØÅ
¹Ò§¨Ñ¹·¹Ò ¸ÃÃÁÇÕÃо§É
¹Ò§ÊØÀÒÇ´Õ ÇѨ¹Ð¾ÃÊÔ·¸Ôì
¹Ò¸ÕÃÐ ªÑ¾ÔÃÔÂÐÈÑ¡´Ôì
¹Ò§¹ÑÂ¹Ò ¾ÑªÃä¾ÈÒÅ
¹ÒÂÊع·Ã ¾Ø·¸ÈÃÕ¨ÒÃØ
¹Ò§¢¹ÔÉ°Ò µÑ¹µÔÈÔÃÔ¹·Ã
¹Ò§ÊÒǸÕøà Á⹸ÃÃÁ
¹Ò§ÊÒÇ°»¹Õ à¨ÃÔÞÊÔ¹
¹Ò§ÊÒÇ¡ÁŪ¹¡ ÊØÃÔ¡ØÅ ³ ÍÂظÂÒ
AW_PNdex front 20100402.indd 2
¼ÙŒÍíҹǡÒáͧ¤Çº¤ØÁÇѵ¶ØàʾµÔ´
àÀÊѪ¡Ã ªíÒ¹ÒÞ¡ÒþÔàÈÉ
àÀÊѪ¡Ã ªíÒ¹ÒÞ¡ÒþÔàÈÉ
àÀÊѪ¡Ã ªíÒ¹ÒÞ¡ÒþÔàÈÉ
àÀÊѪ¡Ã ªíÒ¹ÒÞ¡ÒþÔàÈÉ
àÀÊѪ¡Ã ªíÒ¹ÒÞ¡ÒþÔàÈÉ
àÀÊѪ¡Ã ªíÒ¹ÒÞ¡ÒÃ
àÀÊѪ¡Ã ªíÒ¹ÒÞ¡ÒÃ
àÀÊѪ¡Ã ªíÒ¹ÒÞ¡ÒÃ
àÀÊѪ¡Ã »¯ÔºÑµÔ¡ÒÃ
àÀÊѪ¡Ã »¯ÔºÑµÔ¡ÒÃ
2/4/2553 13:57:04
CONTENTS
ÊÒúÑÞ
OBJECTIVES:วัตถุประสงค์
2
HOWTOUSE:วิธีการใช้หนังสือ
5
PRODUCT IDENTIFICATION SEQUENCE
ลำาดับการจัดภาพยาเม็ดด้วยสีรูปร่างและขนาด
9
PRODUCT IDENTIFICATION CHART
หมวดรูปภาพเภสัชภัณฑ์
สีขาว
สีเหลือง
สีส้ม
สีแดง
สีชมพู
สีมวง
สีฟา/น้ําเงิน
สีเขียว
สีน้ําตาล
สีเทา/ดํา
หลายสี
10
14
15
16
16
19
19
21
23
23
23
PINK PAGES
หมวดหน้าสีชมพู
10-39
40-61
CLASSIFICATION OF PSYCHOTROPICS AND NARCOTICS
การจัดประเภทของวัตถุออกฤทธิ์และยาเสพติดให้โทษที่ขึ้นทะเบียน
ในประเทศไทย
40
NATIONAL LIST OF ESSENTIAL MEDICINE (FOR PSYCHOTROPICS AND NARCOTICS)
วัตถุออกฤทธิ์และยาเสพติดให้โทษในบัญชียาหลักแห่งชาติ
42
IMPORTANT DRUG NOTES
ข้อมูลที่สำาคัญของตัวยาที่ขึ้นหรือเคยขึ้นทะเบียนในประเทศไทย 48
P2วัตถุออกฤทธิ์ในประเภท2
48
P3วัตถุออกฤทธิ์ในประเภท3
53
P4วัตถุออกฤทธิ์ในประเภท4
54
N2ยาเสพติดให้โทษประเภท2
58
N3ยาเสพติดให้โทษประเภท3
60
AW_PNdex front 20100402.indd 3
2/4/2553 13:57:04
4
INDEX
หมวดดัชนีต่างๆ
CONTROLLED SUBSTANCE CLASS
ดัชนีเภสัชภัณฑ์เรียงตามประเภทกลุ่มยา และชื่อตัวยาจาก A-Z
P2 วัตถุออกฤทธิ์ในประเภท 2
P3 วัตถุออกฤทธิ์ในประเภท 3
P4 วัตถุออกฤทธิ์ในประเภท 4
N2 ยาเสพติดให้โทษในประเภท 2
N3 ยาเสพติดให้โทษในประเภท 3
62-86
62
62
63
64
65
62-65
MANUFACTURER’S INDEX
ดัชนีเภสัชภัณฑ์เรียงตามชื่อผู้ผลิต
66-70
GENERIC AND BRAND NAME INDEX
ดัชนีรวมชือ่ สามัญและชื่อการค้า จัดเรียงตาม A-Z
71-86
แบบสำ�รวจ
87-88
AW_PNdex front 20100402.indd 4
5/4/2553 17:45:15
HOW TO USE5
1
ÇÔ¸Õ¡ÒÃ㪌˹ѧÊ×Í
·ÃÒºµÑÇÍ‹ҧ ÃÙ»¾Ãó àÍ¡Åѡɳ ËÃ×Í ÅѡɳТͧÂÒàÁç´
PRODUCT IDENTIFICATION SEQUENCE
การจัดลำาดับยาเม็ดด้วยสีรูปร่างขนาด...หน้า9
PRODUCT IDENTIFICATION CHART
ค้นหารูปภาพเภสัชภัณฑ์...หน้า10-39
ชื่อผู้ผลิต(Manufacturer’sname)
ชื่อการค้า(Tradename)
ชื่อสามัญ(Genericname)
ประเภทวัตถุออกฤทธิ์หรือยาเสพติดให้โทษ
น้ําหนักของเม็ด
ภาพเม็ดยาจะมีขนาดเทาของจริง
ภาพผลิตภัณฑที่ไมใชเม็ดยาจะเปนขนาดยอ
หมายเลขของภาพ
AW_PNdex front 20100402.indd 5
2/4/2553 13:57:05
6
2
·ÃÒºª×èÍ¡ÒäŒÒËÃ×ͪ×èÍÊÒÁÑޢͧÇѵ¶ØÍÍ¡Ä·¸ÔìËÃ×ÍÂÒàʾµÔ´ãËŒâ·É
GENERIC AND BRAND NAME INDEX
ดัชนีรวมชื่อสามัญและชื่อการค้า...หน้า71-86
PRODUCT IDENTIFICATION CHART
รูปภาพเภสัชภัณฑ์...หน้า10-39
ค้นตามหมายเลขภาพมุมลางซ้าย
3
·ÃÒºª×èÍÊÒÁÑޢͧÇѵ¶ØÍÍ¡Ä·¸ÔìËÃ×ÍÂÒàʾµÔ´ãËŒâ·É
NATIONAL LIST OF ESSENTIAL MEDICINE
ข้อกำาหนดบัญชียาหลักแห่งชาติ...หน้า42-47
(เฉพาะวัตถุออกฤทธิ์และยาเสพติดให้โทษ)
ค้นตามชื่อสามัญเรียงลําดับชื่อA-Z
AW_PNdex front 20100402.indd 6
2/4/2553 13:57:06
4
7
·ÃÒº»ÃÐàÀ·¢Í§·ÐàºÕ¹Çѵ¶ØÍÍ¡Ä·¸ÔìËÃ×ÍÂÒàʾµÔ´ãËŒâ·É
CONTENTS
สารบัญ...หน้า3-4
CLASSIFICATION OF
PSYCHOTROPICS & NARCOTICS
การจัดกลุ่มประเภทและสาระตามกฏหมาย...หน้า40-41
สาระสําคัญในการควบคุมตามกฎหมาย
รายชื่อตัวยา (ชื่อสามัญ) ของวัตถุออกฤทธิ์และยาเสพติดให้โทษจัดตาม
กลุม/ประเภทตามกฎหมาย
CONTROLLED SUBSTANCE CLASS INDEX
ดัชนีกลุ่ม/ประเภทของทะเบียน...หน้า62-65
ค้นตามชื่อสามัญเรียงลําดับชื่อA-Zในแตละกลุม
AW_PNdex front 20100402.indd 7
IMPORTANT DRUG NOTES
ข้อมูลสำาคัญของตัวยา...หน้า48-61
ค้นตามชื่อสามัญจากA-Zในแตละกลุม
2/4/2553 13:57:07
8
5
·ÃÒºª×èͺÃÔÉÑ·¼ÙŒ¼ÅÔµ
MANUFACTURE’S INDEX
ดัชนีรวมชื่อสามัญและชื่อการคา... หนา 66-70
PRODUCT IDENTIFICATION CHART
รูปภาพเภสัชภัณฑ ... หนา 10-39
คนตามหมายเลขภาพมุมลางซาย
6
¡ÒþÔÊÙ¨¹ÊÑÞÅѡɳ¨Ò¡ Ἃ¹«Õ´Õ PNdex
(powered by MIMS.com)
โปรแกรมรูปภาพเภสัชภัณฑ
ใหกดเลือกหรือพิมพคุณลักษณะที่สําคัญ
ควรเลือกคุณสมบัติที่เดนที่สุดเทานั้น ไมควรเลือกทั้งหมด
สีที่ 1
สีที่ 2 (เลือกกรณีมีมากกวาหนึ่งสี)
รูปราง
มีรอยบากกลาง
มีอักษรหรือเลข (ใหพิมพตัวเลขหรืออักษร)
มีโลโก
ชื่อการคา (ใหพิมพชื่อ)
ชื่อตัวยา (ใหพิมพชื่อสามัญ)
ประเภทของทะเบียนผลิตภัณฑ
ชื่อผูผลิต (ใหพิมพชื่อ)
กลุมการออกฤทธิ์หรือการรักษา
กดปุมคนหา หรือ ปุมลบเพื่อเลือกใหม
AW_PNdex front 20100402.indd 8
ENTER
กดปุมเขาสูโปรแกรม
7/4/2553 9:45:42
9
PRODUCT IDENTIFICATION SEQUENCE
ÅíҴѺ¡ÒèѴÀÒ¾ÂÒàÁç´
หมายเหตุ:
สีที่ปรากฏในหนังสืออาจคลาดเคลื่อนกับสีจริงของเม็ดยาแนะนําให้ตรวจด้วยคุณลักษณะอื่นรวมด้วยเชนขนาดสัญลักษณ
AW_PNdex front 20100402.indd 9
2/4/2553 13:57:09
10
PN DEX 2010
PRODUCT IDENTIFICATION CHART
WHITE
Tablet
DILOMIL† 
Diphenoxylate HCl 2.5 mg
XN3
PHENOBARBITAL ATLANTIC

⌫
Lorazepam 1 mg
Phenobarbital Na 32.5 mg
P4
[86 mg]
P4
[100 mg]
022
011
PHENOBARBITAL ATLANTIC

LIZAVAN 
Lorazepam 1 mg
Phenobarbital Na 65 mg
XP4
[100.4 mg]
P4
[95 mg]
023
P2
[50 mg]
012
KEMORA 
002
LORAZENE 
001
BUPRINE

Buprenorphine HCl 0.2 mg
LORAZEP ⌫
Lorazepam 1 mg
013
003
ZEDA
LORAMED 
Lorazepam 1 mg
☯  ⌫
XP4
Lorazepam 0.5 mg
Codeine Phosphate (Analgesic) 15 mg
P4
[90 mg]
N2
[73 mg]
014
025
DIANO
LORAPAM 

Lorazepam 1 mg
XP4
Diazepam 2 mg
004
PHENOBARBITONE
NEW LIFE PHARMA 
Phenobarbital Na 30 mg
XP4
P4
[80 mg]
026
015
LORA-P
⌫ ⌫ ⌫
Lorazepam 1 mg
005
XP4
[113.37 mg]
LOMOTIL† 
016
Diphenoxylate HCl 2.5 mg
N3
[63 mg]
DIAZEPAM T P DRUG
⌫ ⌫ 
006
017
P2
[59.98 mg]
Codeine Phosphate (Analgesic) 30 mg
CODEINE GPO 
N2
[113 mg]
007
018
XN3
Lorazepam 1 mg
LONZA ⌫
P4
[85 mg]
Diphenoxylate HCl 2.5 mg
N3
[79.97 mg]
 
Lorazepam 1 mg
P4
[100 mg]
020
009
DIAPINE
ANTA

Diazepam 2 mg
XP4
PHENOBARBITAL ACDHON
Phenobarbital Na 60 mg
MEILAX
XP4
ORA

Lorazepam 1 mg
P4
[100 mg]
VALAX
⌫   
Diazepam 2 mg
XP4
031

Ethyl Loflazepate 1 mg
RAZEPAM 
Lorazepam 1 mg
P4
[100 mg]
XP4
XP4
010
021
032
Indicates brands that contain more than 1 ingredient

030
019
⌫
Lorazepam 1 mg
029
DITROPINE† ⌫
SPASIL†
ATIVAN 
028
TEMGESIC  ⌫
008

Lorazepam 1 mg
P4
[100 mg]
XP4
Diphenoxylate HCl 2.5 mg
LORAVAN
027
Diazepam 2 mg
Buprenorphine HCl 0.2 mg
P4
[100 mg]
024
P4
[65 mg]
CODEINE GPO 
Lorazepam 1 mg
XP4
Lorazepam 1 mg
†
ANXIRA

PN DEX 2010
PRODUCT IDENTIFICATION CHART 11
LORAZEPAM ACDHON 
LORAZIN 
PRENARPIL 
XP4
P4
[103.02 mg]
P4
[148.76 mg]
Lorazepam 1 mg
033
Lorazepam 1 mg
Clonazepam 2 mg
044
TRANAVAN

Lorazepam 1 mg
P4
[100 mg]
054
PSEUDOEPHEDRINE MILANO

RIVOTRIL
P2
[130 mg]
P4
[170 mg]
034
LORAPINE ⌫
Lorazepam 1 mg
XP4
055
045
PHENOBARB
SIPAM
⌫ ⌫ ⌫
LORA 

Diazepam 2 mg
Phenobarbital Na 60 mg
035
P4
[164 mg]
XP4
[130 mg]
Lorazepam 1 mg
056
046
P4
[130 mg]
PSEUDOEPHEDRINE
ASIAN PHARM ⌫
036
FRISIUM ⌫
Clobazam 10 mg

Clonazepam 2 mg
Pseudoephedrine HCl 60 mg
Pseudoephedrine HCl 60 mg
ALPRAX

Alprazolam 1 mg
XP4
[190 mg]
P2
[155 mg]
XP4
057
TAZCINE
047
037
RUBIFEN
 
Methylphenidate HCl 10 mg
P2
[190 mg]
ZOPAM 
Diazepam 2 mg

XP3
[149 mg]
P4
[160 mg]
058
048
038
MED-ZEPAM 
Diazepam 2 mg
XP4
DIVOPAN 
VOMED ⌫ 
  
Diazepam 2 mg
XP4
Diazepam 2 mg
P4
[180 mg]
059
049
039
DIPAM 
Diazepam 2 mg
☯ ⌫
Pentazocine HCl 25 mg
DONNATAL† 
DIAZEPAM BJ BENJAOSOTH
Phenobarbital Na 16.2 mg
☯⌫ 
XP4
Diazepam 2 mg
XP4
P4
[158.25 mg]
040
050
RITALIN ⌫
GRANDAXIN
P2
[140 mg]
P4
[180 mg]
XP4
[180 mg]
051
061
DIAZEPAM GPO 
NITRADOS 
P4
[182 mg]
P2
042
052
062
FRISIUM ⌫⌫
MED-ZEPOXIDE
Chlordiazepoxide HCl 10 mg
Diazepam 2 mg
P4
[120 mg]
XP4
[198.8 mg]
XP4
043
053
Methylphenidate HCl 10 mg
041
ALPRALAN 
Alprazolam 0.25 mg
P4
[154.7 mg]
Clobazam 5 mg
060
DIAZ 
⌫⌫
Diazepam 2 mg
Tofisopam 50 mg
Nitrazepam 5 mg
Diazepam 2 mg

WINOPAM 

063
†
Indicates brands that contain more than 1 ingredient
12
PN DEX 2010
PRODUCT IDENTIFICATION CHART
⌫  
VORAPAM
PARADEINE†

Diazepam 2 mg
Codeine Phosphate (Analgesic) 15 mg
P4
[180 mg]
N3
[470 mg]
REINBAMATE 
Meprobamate 400 mg
XP3
[525 mg]
064
VALENIUM 
Diazepam 2 mg
074
XP4
TYLENOL WITH CODEINE†
082

Codeine Phosphate (Analgesic) 15 mg
N3
[432.5 mg]
065
DIAZEPAM LERD SINGH
Diazepam 2 mg

Codeine Phosphate (Analgesic) 8 mg
XN3

P4
[180 mg]
075
TYLENOL WITH CODEINE†
066
POVANIL
PARADYL

Codeine Phosphate (Analgesic) 30 mg
 
Clonazepam 2 mg
083
DIETIL RETARD 
Diethylpropion HCl 75 mg
N3
[478.72 mg]
P2
[755 mg]
P4
[150 mg]
067
076
DIMED 
PARCOD†
Diazepam 2 mg
Codeine Phosphate (Analgesic) 15 mg
XP4
XN3
[600 mg]
⌫  
084
ANAX

Alprazolam 0.25 mg
P4
[130 mg]
068
XANAX XR
085

Alprazolam 1 mg
077
P4
[347.19 mg]
ALODORM 
ANZION 
Alprazolam 0.25 mg
XP4
[132.25 mg]
Nitrazepam 5 mg
P2
[556 mg]
069
LEXOTAN
086

ALNAX
⌫
Bromazepam 1.5 mg
Alprazolam 0.25 mg
P4
[200 mg]
XP4
[130 mg]
078
PARCONO†

Codeine Phosphate (Analgesic) 8 mg
070
N3
[600 mg]
COCET† 
ANPRESS
P4
[131.2 mg]
XN3
088
079
†
NASA WITH CODEINE

Codeine Phosphate (Analgesic) 15 mg
CEMOL - CODEINE†
 
Codeine Phosphate (Analgesic) 15 mg
☯  
Alprazolam 0.25 mg
Codeine Phosphate (Analgesic) 15 mg
071
087
N3
[600 mg]
DIZOLAM 
Alprazolam 0.25 mg
P4
[130 mg]
089
XN3
MARZOLAM 
Alprazolam 0.25 mg
080
072
COTENOL†
⌫ ⌫ 
Codeine Phosphate (Analgesic) 15 mg
MOGADON 
Nitrazepam 5 mg
P2
XN3
P4
[129.75 mg]
090
XANACINE ⌫
Alprazolam 0.25 mg
P4
[110 mg]
073
†
081
Indicates brands that contain more than 1 ingredient
091

PN DEX 2010
PRODUCT IDENTIFICATION CHART 13
FARZOLAM 
ALLAM
Alprazolam 0.25 mg
Alprazolam 0.25 mg
Codeine Phosphate (Analgesic) 15 mg
XP4
P4
[130 mg]
XN3
[478.77 mg]
092
103
ZOLAM 
INZOLAM 
Alprazolam 0.25 mg
113
P4
[131.55 mg]
P4
[132 mg]
CONCERTA  
093
104
Alprazolam 0.25 mg
  
PARAGEN CO†

Methylphenidate HCl 36 mg
MOXINAX

Alprazolam 0.25 mg
P4
[130 mg]
P2
[515 mg]
ALPRAMED 
Alprazolam 0.5 mg
P4
[130 mg]
094
XALAM 
Alprazolam 0.25 mg
XP4
114
REGENON RETARD 
105
Diethylpropion HCl 75 mg
P2
[755 mg]
MITRANAX 
Alprazolam 0.25 mg
P4
[130 mg]
095
XANAX
106


Alprazolam 0.25 mg
SUNAX
P4
[128.25 mg]
Alprazolam 0.25 mg
115
XP4
[130.03 mg]
PARDEX
⌫
Dextropropoxyphene Napsylate 32.5 mg
096
XN3
ALCELAM
 
Alprazolam 0.25 mg
P4
[130 mg]
107
XIEMED
⌫
Alprazolam 0.25 mg
P4
[130.01 mg]
097

116
METHYLPHENIDATE HEXAL
108
 
P4
[125 mg]
ALPRAZOLAM FRX 
P2
[174.98 mg]
098
XP4
[130 mg]
SIAMPRAXOL
Alprazolam 0.25 mg
MANEX
Methylphenidate HCl 10 mg
Alprazolam 0.25 mg
⌫  
117
Alprazolam 0.25 mg
109
P4
[130 mg]
STILNOX ⌫
Capsule
ZEPOXIN
Zolpidem Tartrate 10 mg
Chlordiazepoxide HCl 10 mg
P2
[126 mg]
099
XP4
[100 mg]
ALPAZAM 
Alprazolam 0.25 mg
XP4
118
110
POPAM
KAPANOL 
 
Morphine Sulfate 20 mg
Diazepam 2 mg
100
N2
[142.8 mg]
XP4
PHARNAX

⌫  
Alprazolam 0.25 mg
P4
[131.65 mg]
111
101
Codeine Phosphate (Analgesic) 15 mg
LORAMET  
119
CODIGESIC† 
N3
[550 mg]
KAPANOL 
Morphine Sulfate 50 mg
N2
[323.3 mg]
Lormetazepam 1 mg
P2
102
112

120
†
Indicates brands that contain more than 1 ingredient
14
PN DEX 2010
PRODUCT IDENTIFICATION CHART
KAPANOL 
RAZEPAM 
DIAZEPAM SAMAKEEPHAESAJ
N2
[620.5 mg]
XP4
Diazepam 5 mg
Morphine Sulfate 100 mg
Lorazepam 2 mg
⌫
XP4
131
VALAX
⌫
142
Diazepam 5 mg
PSEUDOEPHEDRINE
ASIAN PHARM ⌫
XP4
121
Pseudoephedrine HCl 30 mg
132
YELLOW
Phenobarbital Na 30 mg
XP4

XP4
[153 mg]
143
133
Amobarbital 50 mg
AMA† 
DIAZEPAM VESCO 
P3
[208.7 mg]
P4
[109 mg]
144
134
ZOPAM 
Diazepam 5 mg
122
LORA-P
⌫ ⌫ ⌫
Lorazepam 2 mg
XP4
[113.43 mg]
PSEUDOEPHEDRINE
BJ BENJAOSOTH ☯⌫ 
123
BELLOID†
⌫⌫ 
Butobarbital 30 mg
Diazepam 5 mg
P4
[160 mg]
P2
[158.22 mg]
145
DIVOPAN
124
 
Lorazepam 2 mg
P4
[100 mg]
125
METHADONE GPO

Methadone HCl 5 mg
Diazepam 5 mg
PSEUDOEPHEDRINE MILANO
P4
[209 mg]

Pseudoephedrine HCl 30 mg
P2
[110 mg]
146
136
Diazepam 5 mg
VOMED
DIPAM 
XP4
XP4
147
126
COZEP
LORAZENE 
Chlordiazepoxide HCl 10 mg
 
P4
[179.55 mg]
DIAZEPAM GENERAL DRUGS
HOUSE 
Diazepam 5 mg
P4
[160 mg]
148
138
⌫
127
PORA
LORAPAM 
Lorazepam 1 mg
Lorazepam 2 mg
⌫ 
Diazepam 5 mg
137
XP4
   
135
N2
[110 mg]
Lorazepam 2 mg

Pseudoephedrine HCl 60 mg
XP4
ANTA
P2
[145 mg]
Clorazepate Dipotassium 5 mg
Tablet
PHENOBARBITAL ACDHON
 ⌫  ⌫
DOPAM
XP4
DIAZEPAM GPO 
Diazepam 5 mg
P4
[182 mg]
XP4
139
149

128
DIANO
ATIVAN 
Diazepam 5 mg
Lorazepam 2 mg
P4
[110.2 mg]
VALENIUM 
Diazepam 5 mg
XP4
XP4
140
129
TRANOLAN 
Diazepam 2 mg
P4
[150.62 mg]
130
†
PHENYLPROPANOLAMINE
PHARMASANT  
150
DIZEPAM 
Phenylpropanolamine HCl 25 mg
Diazepam 5 mg
XP2
P4
[170 mg]
141
151
Indicates brands that contain more than 1 ingredient

PN DEX 2010
VALIUM
PRODUCT IDENTIFICATION CHART 15

DIAZEPAM POND’S CHEMICAL
⌫
Diazepam 5 mg
XP4
Capsule

Diazepam 5 mg
POSENE
XP4
Clorazepate Dipotassium 5 mg
XP4
[140 mg]
152
DIAZA 
162
Diazepam 5 mg
DIAZEPAM T MAN
XP4
[172 mg]
Diazepam 5 mg
⌫  
172
XP4
TRANCAP
⌫ ⌫ 
Clorazepate Dipotassium 10 mg
153
XP4
SIPAM
163

DIMED 
Diazepam 5 mg
Diazepam 5 mg
P4
[164 mg]
173
XP4
PREFAMONE

Diethylpropion HCl 75 mg
154
DIAZEPAM T P DRUG
Diazepam 5 mg
⌫ ⌫ 
P2
164
CO-COF† 
Codeine Phosphate (Antitussive) 10 mg
XP4
N3
[294.9 mg]
155
ALPRAX
174
165

Alprazolam 0.25 mg
DIAPINE
P4
[189.74 mg]
POZAPAM

 
Prazepam 10 mg
Diazepam 5 mg
P4
[336.5 mg]
P4
[280 mg]
156
DIAZ 
166
Diazepam 5 mg
MILA-TERCON† 
XP4
[180 mg]
Codeine Phosphate (Antitussive) 8 mg
175
N3
[410.05 mg]
ORANGE
157
ROPAM
 ⌫  ⌫
Tablet
Diazepam 5 mg
167
XP4
[170 mg]
TRIALAM 
MEILAX

Ethyl Loflazepate 2 mg
XP4
Triazolam 0.25 mg
P2
[100 mg]
158
VORAPAM
⌫  
176
Diazepam 5 mg
168
P4
[183 mg]
CONCERTA  
TRANOLAN 
Diazepam 5 mg
Methylphenidate HCl 18 mg
P4
[150.85 mg]
P2
[268 mg]
159
DIAZEPAM H K PHARM
177
  
169
Diazepam 5 mg
POPAM
P4
[160 mg]
Diazepam 5 mg
DILIUM 
 
Diazepam 2 mg
XP4
XP4
160
DIAZEPAM LERD SINGH
Diazepam 5 mg

178
170
DIZEP
ZORA 

P4
[175 mg]
Diazepam 2 mg
161
171
Lorazepam 2 mg
P4
[130 mg]
P4
[115.05 mg]

179
†
Indicates brands that contain more than 1 ingredient
16
PN DEX 2010
PRODUCT IDENTIFICATION CHART
PHENOBARBITONE
NEW LIFE PHARMA 
Phenobarbital Na 60 mg
XP4
DIZEP

Capsule
Diazepam 5 mg
P4
[115.05 mg]
CORYNIL†

Codeine Phosphate (Antitussive) 10 mg
XN3
[430 mg]
190
180
COZEP
 
Chlordiazepoxide HCl 25 mg
P4
[206.23 mg]
Capsule
DIAZEPION 
Diazepam 10 mg
191
Ethyl Loflazepate 2 mg
201
XP4
RED
Tablet
MST CONTINUS 
Morphine Sulfate 60 mg
N2
[154 mg]
PONDNEBIUM ⌫
XP4
[74.82 mg]
EPOXIDE
XP4
[205.49 mg]
P2
[144.7 mg]
193
BENPINE
Codeine Phosphate (Antitussive) 10 mg
⌫ ⌫ ⌫
Phenobarbital Na 60 mg
XP4
[120 mg]
ROTUSS†

P4
[165.2 mg]
194
CHLORDIXIDE 
185
Chlordiazepoxide HCl 10 mg
POVANIL
P4
[237 mg]
 
N3
[456.5 mg]
204
ZEPOXIN

Chlordiazepoxide HCl 5 mg
195
CLINOPECT† 
205
Codeine Phosphate (Antitussive) 10 mg
186
EPOXIDE
  ⌫
Codeine Phosphate (Antitussive) 10 mg
XP4
[100 mg]
Clonazepam 0.5 mg
P4
[150 mg]
N3
[430 mg]
203
Chlordiazepoxide HCl 25 mg

N3
[430 mg]
ROLAR†  
Chlordiazepoxide HCl 25 mg
Pseudoephedrine HCl 60 mg
MENOBARB
 
Codeine Phosphate (Antitussive) 10 mg
202
192
184
CODEPECT†
Chlordiazepoxide HCl 10 mg
183
PSEUDOEPHEDRINE MEDICINE
PRODUCTS ⌫
  ⌫
N3
[558.5 mg]
181
182
ROPECT†
Codeine Phosphate (Antitussive) 10 mg
XP4
[100 mg]
VICTAN ⌫
200
⌫ ⌫ ⌫
Chlordiazepoxide HCl 10 mg
XP4
[284.17 mg]
PINK
XN3
[217 mg]
Tablet
196
PAM-5
ZORITUSS   
Diazepam 5 mg
Codeine Phosphate (Antitussive) 10 mg
⌫ ⌫ 
XP4
XN3
187
NEOCOF† 
206
Codeine Phosphate (Antitussive) 10 mg
197
XN3
NEO-COPHEN
⌫
Codeine Phosphate (Antitussive) 10 mg
BELLERGAL† ⌫
Phenobarbital Na 20 mg
XP4
XN3
188
198
XN3
[580 mg]
Codeine Phosphate (Antitussive) 10 mg
Codeine Phosphate (Analgesic) 8 mg
189
†
207
PACOGESIC† 
NEOPECT†

PHENOBARBITAL ATLANTIC

Phenobarbital Na 16.25 mg
N3
[399.73 mg]
XP4
[84.99 mg]
199
208
Indicates brands that contain more than 1 ingredient

PN DEX 2010
PHENOBARB
⌫ ⌫ ⌫
PRODUCT IDENTIFICATION CHART 17
S.CO ZEPAM
Phenobarbital Na 30 mg
Diazepam 5 mg
XP4
[90 mg]
XP4
  
ANAX
P4
[130 mg]
209
LORAMED 
Lorazepam 2 mg
P4
[100 mg]
230
220
BELLADONNA ALKALOIDS WITH
PHENOBARBITAL† ⌫
Phenobarbital Na 16.2 mg
XP4
[160 mg]
210

Alprazolam 0.5 mg
ANZION 
Alprazolam 0.5 mg
XP4
[132.5 mg]
231
DIAZEPAM T MAN
Diazepam 5 mg
⌫  
ALNAX
221
DIAZEPAM BJ BENJAOSOTH
211
Diazepam 10 mg
ORA
XP4
[130 mg]
☯⌫ 

⌫
Alprazolam 0.5 mg
P4
[62.46 mg]
232
P4
[233 mg]
DIZOLAM 
Lorazepam 2 mg
Alprazolam 0.5 mg
XP4
222
212
P4
[130 mg]

KENSPA†
Chlordiazepoxide HCl 5 mg
VISPAM ⌫
Diazepam 5 mg
233
P4
[246 mg]
PRAZOL 
Alprazolam 0.5 mg
XP4
[70.02 mg]
P4
[216.36 mg]
223
DIZEPAM 
213
ALPRALAN 
Alprazolam 0.5 mg
Diazepam 2 mg
234
P4
[170 mg]
MARZOLAM 
P4
[157.28 mg]
Alprazolam 0.5 mg
P4
[130 mg]
224
214
PORA
⌫
Lorazepam 2 mg
XP4
CENTRODINE CD†
 
Codeine Phosphate (Antitussive) 10 mg
235
N3
[205.2 mg]
XANACINE
P4
[110 mg]
225
215
DIAZEPAM POND’S CHEMICAL
⌫
Diazepam 5 mg
TAZCINE
☯ ⌫
236
Pentazocine HCl 50 mg
ZOLAM 
XP3
Alprazolam 0.5 mg
P4
[145.6 mg]
P4
[133.8 mg]
226
216
LORA 
Lorazepam 2 mg
P4
[200 mg]
⌫ 
Alprazolam 0.5 mg
LORAZIN 
237
Lorazepam 2 mg
MOXINAX
P4
[200 mg]

Alprazolam 0.5 mg
P4
[130 mg]
227
217
DIAZEPAM H K PHARM
  
Diazepam 2 mg
LEXOTAN

238
Bromazepam 3 mg
XALAM 
P4
[200 mg]
Alprazolam 0.5 mg
XP4
P4
[130 mg]
228
218
AZEPAM

Diazepam 2 mg
PHENOCON
239

Phenobarbital Na 60 mg
XANAX
XP4
219

Alprazolam 0.5 mg
XP4
[100 mg]
P4
[128.56 mg]
229

240
†
Indicates brands that contain more than 1 ingredient
18
PN DEX 2010
PRODUCT IDENTIFICATION CHART
ALPRAMED 
ANXENE
Alprazolam 0.25 mg
Clorazepate Dipotassium 10 mg
P4
[130 mg]
P4
[130 mg]
XP4
241
252
FARZOLAM ⌫
MITRANAX 
XP4
P4
[130 mg]
ALCELAM
 
Alprazolam 0.5 mg
Alprazolam 0.5 mg
242
⌫ 
262
MANOTRAN 
Alprazolam 0.5 mg
Clorazepate Dipotassium 10 mg
XP4
[150 mg]
253
SIAMPRAXOL

SUNAX

Alprazolam 0.5 mg
Alprazolam 0.5 mg
263
P4
[125.75 mg]
XP4
[129.95 mg]
CLORAMED 
243
254
Clorazepate Dipotassium 10 mg
XP4
⌫  
MANEX
CODICET PINK†
⌫  
Alprazolam 0.5 mg
Codeine Phosphate (Analgesic) 15 mg
P4
[130 mg]
XN3
264
DEDA
  
Clorazepate Dipotassium 10 mg
244
P4
[130 mg]
255
ALPAZAM 
Alprazolam 0.5 mg
XP4
245
ALPAZAM 
Alprazolam 1 mg
XP4
ALPRAZOLAM FRX 
Alprazolam 0.5 mg
P4
[130 mg]
265
256
CLORAZE 
TRANSPON FORTE 
XP4
[120 mg]
Clorazepate Dipotassium 10 mg
Clorazepate Dipotassium 10 mg
XP4
[190 mg]
246
266
257
PHARNAX
⌫  
P4
[131.9 mg]
UPTRAN
Capsule
Alprazolam 0.5 mg

Clorazepate Dipotassium 10 mg
SANOR 
XP4
Clorazepate Dipotassium 10 mg
XP4
247
ANPRESS
⌫
267
POLIZEP 
Alprazolam 0.5 mg
258
P4
[130 mg]
SERENE MASA LAB
Clorazepate Dipotassium

10 mg
XP4
[234 mg]
XP4
[173.5 mg]
248
XIEMED
☯  
Alprazolam 0.5 mg
P4
[130.25 mg]
268
259
DIPOSEF
249
ALLAM
Clorazepate Dipotassium 10 mg
⌫
Clorazepate Dipotassium 10 mg
  
Alprazolam 0.5 mg
XP4
[140 mg]
TENMED 
Clorazepate Dipotassium 10 mg
P4
[234 mg]
P4
[130 mg]
250
INZOLAM 
Alprazolam 0.5 mg
P4
[132.81 mg]
251
†
260
269
TRANMED 
POLYDINE CD†
Clorazepate Dipotassium 10 mg
XP4
[163.13 mg]
261
Indicates brands that contain more than 1 ingredient
 
Codeine Phosphate (Antitussive) 10 mg
XN3
270

PN DEX 2010
PRODUCT IDENTIFICATION CHART 19
TRANXENE ⌫
ANZION 
MANEX
Alprazolam 1 mg
Alprazolam 1 mg
XP4
XP4
[133.12 mg]
P4
[130 mg]
280
291
Clorazepate Dipotassium 10 mg
271
TRANCLOR 
Clorazepate Dipotassium 10 mg
XP4
ALNAX
⌫
PHARNAX
⌫  
Alprazolam 1 mg
Alprazolam 1 mg
XP4
[100 mg]
P4
[132.41 mg]
281
272
⌫  
292
ANPRESS
☯  
ALLAM
  
Alprazolam 1 mg
Alprazolam 1 mg
P4
[131.2 mg]
P4
[130 mg]
282
293
273
MARZOLAM 
INZOLAM 
FLULIUM  
P4
[130 mg]
P4
[134.39 mg]
CEXENE
⌫   
Clorazepate Dipotassium 10 mg
XP4
Alprazolam 1 mg
Clorazepate Dipotassium 10 mg
Alprazolam 1 mg
XP4
283
294
XANACINE
⌫
MITRANAX 
Alprazolam 1 mg
274
†
DAVOL
☯⌫ 
Dextropropoxyphene HCl 32.5 mg
XN3
[377.5 mg]
Alprazolam 1 mg
P4
[110 mg]
P4
[130 mg]
284
295
ZOLAM 
XIEMED
Alprazolam 1 mg
Alprazolam 1 mg
P4
[136.67 mg]
P4
[130 mg]
285
296
XALAM 
275
DIZOLAM 
Alprazolam 1 mg
PURPLE
Tablet
CALMIPAM 
Diazepam 5 mg
XP4
⌫
Alprazolam 1 mg
XP4
P4
[130 mg]
286
XANAX
297


Alprazolam 1 mg
BRONPECT†
P4
[129.12 mg]
Codeine Phosphate (Antitussive) 10 mg
N3
[573.5 mg]
276
287
PHENOBARBITAL ATLANTIC

ALCELAM  
P4
[128.97 mg]
P4
[130.2 mg]
277
288
MST CONTINUS 
FARZOLAM ⌫
N2
[154 mg]
XP4
278
289
ZEPOXIDE
SIAMPRAXOL 
ANXIRA
Alprazolam 1 mg
Lorazepam 0.5 mg
P4
[91.2 mg]
XP4
P4
[50 mg]
279
290
Phenobarbital Na 100 mg
298
Alprazolam 1 mg
AZEPAM

Diazepam 5 mg
XP4
Morphine Sulfate 30 mg
299
Alprazolam 1 mg
BLUE
⌫ ⌫ 
Chlordiazepoxide HCl 10 mg

Tablet
⌫
300
†
Indicates brands that contain more than 1 ingredient
20
PN DEX 2010
PRODUCT IDENTIFICATION CHART
LORAZENE 
Lorazepam 0.5 mg
PHENOBARBITAL
CHEW BROTHERS
XP4
Phenobarbital Na 30 mg

XP4
[70 mg]
VISPAM ⌫
Diazepam 10 mg
P4
[102.26 mg]
323
301
LORAVAN

Lorazepam 0.5 mg
312
LONZA ⌫
P4
[50 mg]
Lorazepam 0.5 mg
302
313
LOZEPAM 
LORAPINE
P4
[50 mg]
LORAZIN 
Lorazepam 0.5 mg
P4
[103.03 mg]
324
Lorazepam 0.5 mg
XP4
⌫   
Lorazepam 0.5 mg
XP4
ANTA
 
Lorazepam 0.5 mg
RAZEPAM 
Lorazepam 0.5 mg
XP4
P4
[49.6 mg]
LIZAVAN 
Lorazepam 0.5 mg
XP4
[50.22 mg]
305
LORAMED 
Lorazepam 0.5 mg
XP4
306
TRANAVAN

⌫
VEMED
Lorazepam 0.5 mg
Lorazepam 0.5 mg
P4
[50 mg]
⌫  
ZORA 
Lorazepam 0.5 mg
Lorazepam 0.5 mg
XP4
[50 mg]
P4
[130 mg]
317
328
DIAZEPAM GENERAL DRUGS
HOUSE 
DIAPAM  
Diazepam 5 mg
P4
[152 mg]
329
LORA-P
⌫ ⌫ ⌫
Lorazepam 0.5 mg
XP4
[105.2 mg]
DIPAM 
Diazepam 10 mg
XP4
330
319
LORAZEP ⌫
Diazepam 10 mg
327
318
308
DIAZEPAM T MAN
LORAZEPAM ACDHON 
P4
[50 mg]
XP4
XP4
316
P4
[139.83 mg]
Lorazepam 0.5 mg
Diazepam 5 mg
XP4
Diazepam 2 mg
ATIVAN 
DILIUM 
XP4
Lorazepam 0.5 mg
307
P4
[110 mg]
326
315
304
Diazepam 2 mg
325
314
303
DIAZEPAM VESCO 
DIAZEPAM SOMMAI BHAESAJ
ZOPAM 
Diazepam 5 mg
P4
[180 mg]

Diazepam 10 mg

XP4
331
309
ORA
BLUCON†
320

Lorazepam 0.5 mg
P4
[50.02 mg]
HAWKCOPAX
 ⌫  ⌫
Lorazepam 0.5 mg
P4
[100 mg]
⌫  
Codeine Phosphate (Antitussive) 10 mg
XN3
[175.2 mg]
332
†
310
321
LORAPAM 
VALAX
Lorazepam 0.5 mg
Diazepam 10 mg
XP4
[43.67 mg]
XP4
XP4
311
322
333
Indicates brands that contain more than 1 ingredient
⌫   
DIAZEPAM CHAROEN BHAESAJ

Diazepam 2 mg

PN DEX 2010
DIAZEPAM GPO
Diazepam 10 mg

PRODUCT IDENTIFICATION CHART 21
XANAX XR

Capsule
Alprazolam 0.5 mg
ZEPAM 
P4
[182 mg]
P4
[346.11 mg]
334
344
MANODIAZO 
NEOCOD†
Diazepam 5 mg
XP4
Diazepam 10 mg
P4
[160 mg]
354

   
Codeine Phosphate (Antitussive) 10 mg
BLUCO†
XN3
[497.3 mg]
Codeine Phosphate (Antitussive) 10 mg
N3
[249.7 mg]
335
345
MED-ZEPAM 
NEO-CODEIN† ⌫
Diazepam 5 mg
Codeine Phosphate (Antitussive) 10 mg
XP4
355
XN3
[503 mg]
GREEN
Tablet
336
PRENARPIL 
346
PHENOBARBITAL ACDHON
Phenobarbital Na 15 mg
P4
[147.79 mg]
PARA-CO 
Codeine Phosphate (Analgesic) 15 mg
Clonazepam 1 mg
N3
[390.09 mg]
XP4
356
337
LORAZEP ⌫
DIAZA 
Lorazepam 2 mg
Diazepam 2 mg
P4
[65 mg]
347
XP4
[172 mg]
TRYCAM 
Triazolam 0.25 mg
357
P2
CHLORDIXIDE 
338
SIPAM

Chlordiazepoxide HCl 5 mg

P4
[232 mg]
348
Diazepam 10 mg
DIADON
P4
[160 mg]

Diazepam 5 mg
358
XP4
CHLORZEP ⌫
339
Chlordiazepoxide HCl 5 mg
DIAZEPAM T P DRUG
Diazepam 10 mg
⌫ ⌫ 
XP4
349
XP4
HALCION ⌫
Triazolam 0.25 mg
359
P2
[97.408 mg]
ZEDA
☯  ⌫
Lorazepam 1 mg
340
350
DIAZ 
DORMICUM 
Midazolam 15 mg
360
XP4
[180 mg]
P2
[208 mg]
CALMIPAM 
341
351
Diazepam 10 mg
P4
[90 mg]
Diazepam 2 mg
XP4
CLONARIL ⌫ 
CODICET BLUE
P4
[150 mg]
Clonazepam 1 mg
†
   
361
Codeine Phosphate (Analgesic) 15 mg
COMOBEN
N3
[365 mg]
Chlordiazepoxide HCl 5 mg
   
P4
[125.82 mg]
342
DIAZEPAM H K PHARM
362
352

  
XANAX XR
Diazepam 10 mg
Alprazolam 2 mg
P4
[166.62 mg]
P4
[345.69 mg]
343
353

DIAZEPAM SAMAKEEPHAESAJ
⌫
Diazepam 2 mg
XP4
363
†
Indicates brands that contain more than 1 ingredient
22
PN DEX 2010
PRODUCT IDENTIFICATION CHART
DIAZEPAM T MAN
Diazepam 2 mg
⌫  
P4
[115 mg]
WINOPAM 
DIRAX† 
XP4
P4
[200 mg]
Diazepam 5 mg
Chlordiazepoxide HCl 5 mg
364
HAWKCOPAX
 ⌫  ⌫
375
385
 
Lorazepam 1 mg
POBRAX†
XP4
Chlordiazepoxide HCl 5 mg
XP4
Diazepam 2 mg
376
386
MODURAX† ⌫
XP4
[140 mg]
Chlordiazepoxide HCl 5 mg
P4
[250 mg]
366

Diazepam 10 mg
P4
[320 mg]
365
VISPAM ⌫
DIAPINE
⌫  
TERCO-C†
Codeine Phosphate (Antitussive) 10 mg
N3
[591.1 mg]
DIAZEPAM POND’S CHEMICAL
⌫
377
Diazepam 2 mg
CLINOPRONT† 
P4
[122 mg]
Codeine Phosphate (Antitussive) 10 mg
CODEE-C† 
Codeine Phosphate (Antitussive) 10 mg
N3
[283.31 mg]
367
387
N3
[345.02 mg]
LORA 
Lorazepam 0.5 mg
378
P4
[100 mg]
LICON†  
388
Chlordiazepoxide HCl 5 mg
SECO†
XP4
Codeine Phosphate (Antitussive) 10 mg
368
DIAPAM  
Diazepam 2 mg
P4
[142 mg]
379
CEBARAX†
369
PORA
⌫
N3
[331.56 mg]

Chlordiazepoxide HCl 5 mg
⌫
Lorazepam 0.5 mg
P4
[250 mg]
389
TOCODYL†
⌫  ⌫
Codeine Phosphate (Antitussive) 10 mg
XN3
[325.82 mg]
XP4
380
370
PONDNEBIUM
LIBRAX†
⌫
Chlordiazepoxide HCl 5 mg
P4
[200 mg]

Chlordiazepoxide HCl 5 mg
P4
[299 mg]
CODESIA† ⌫
Codeine Phosphate (Antitussive) 10 mg
N3
[350 mg]
371
381
LORAZEPAM MACROPHAR
CHLORDIBRAX† ⌫
391
XP4
RADIBRAX†

Lorazepam 1 mg
Chlordiazepoxide HCl 5 mg
XP4
372
382
CHLORDIAZEPOXIDE T MAN
UTORAX† ⌫
⌫  
Chlordiazepoxide HCl 10 mg
 
Chlordiazepoxide HCl 5 mg
XP4
[120 mg]
Chlordiazepoxide HCl 5 mg
XP4
392
ALPRAMED 
Alprazolam 1 mg
P4
[168.8 mg]
P4
[259 mg]
373
383
ZEPOBRAX† 
393
DIAZEPAM BJ BENJAOSOTH
Chlordiazepoxide HCl 5 mg
ROHYPNOL
XP4
Flunitrazepam 1 mg
☯⌫ 
Diazepam 5 mg
374

P2
[175 mg]
P4
[190.2 mg]
†
390
384
Indicates brands that contain more than 1 ingredient
394

PN DEX 2010
PRODUCT IDENTIFICATION CHART 23
PARAMED-CO† 
BENERA†
Codeine Phosphate (Analgesic) 15 mg
Phenobarbital Na 20 mg
⌫  ⌫
XN3
[601.1 mg]
XP4
[135.5 mg]
MIXED COLORS
Tablet
CODICET
404
⌫  
Codeine Phosphate (Analgesic) 15 mg
LOZEPAM 
N3
[565 mg]
Lorazepam 1 mg
395
†
XP4
VASON

Diazepam 2 mg
405
P4
[110 mg]
414
MST CONTINUS 
Morphine Sulfate 10 mg
396
CELIUM ⌫
Capsule
N2
[154 mg]
FREXENE
Clorazepate Dipotassium 5 mg
Medazepam 5 mg
XP4
406
P4
[110 mg]
 
PRENARPIL 
397
Clonazepam 0.5 mg
415
P4
[147.22 mg]
TRANPATE
Capsule
EUHYPNOS 20
 ⌫ 
Temazepam 20 mg
P2
[868.96 mg]
⌫  
Clorazepate Dipotassium 5 mg
P4
[146 mg]
407
RIVOTRIL

Clonazepam 0.5 mg
416
P4
[150 mg]
DIZAN 
Diazepam 5 mg
XP4
[175 mg]
408
398
ZEPAM

Diazepam 2 mg
ALPRAX

Alprazolam 0.5 mg
XP4
XP4
[189.98 mg]
399
409
TUMAX† ⌫
MASAPARA WITH CODEINE† 
P4
[180 mg]
N3
[500 mg]
417
DITRAN
Chlordiazepoxide HCl 5 mg
 
Diazepam 2 mg
P4
[163 mg]
Codeine Phosphate (Analgesic) 15 mg
418
FREXENE
 
Clorazepate Dipotassium 10 mg
400
XP4
STESOLID 
410
Diazepam 2 mg
419
BLACK
XP4
CONZEP
Tablet
401
POSENE

Clorazepate Dipotassium 10 mg
XP4
KEMORA 
XP4
P4
[50 mg]
420
Lorazepam 0.5 mg
CLOZENE
411
BENPINE
402
Tablet
NEURAMIZONE† ⌫
XP4
[165 mg]
P4
[136.82 mg]
421
412
ZEPOXIDE
TRANCON ⌫
⌫ ⌫ 
Phenobarbital Na 20 mg
Chlordiazepoxide HCl 5 mg
P4
[30.3 mg]
XP4
403
413


Clorazepate Dipotassium 5 mg

Chlordiazepoxide HCl 5 mg
BROWN

Clorazepate Dipotassium 10 mg
Clorazepate Dipotassium 10 mg
XP4
[140 mg]
422
†
Indicates brands that contain more than 1 ingredient
24
PN DEX 2010
PRODUCT IDENTIFICATION CHART
POMADOM  
DIPOT ⌫
TRANPON 
P4
[140 mg]
P4
[145 mg]
XP4
[173 mg]
423
432
441
PHENTERMINE TRENKER
CLORAZE 
CLOZEPATE 
P4
[120 mg]
XP4
Clorazepate Dipotassium 10 mg

Clorazepate Dipotassium 5 mg
Clorazepate Dipotassium 5 mg
Phentermine Resinate 30 mg
P2
[180 mg]
TRANZEP 
Clorazepate Dipotassium 5 mg
PANBESY
Clorazepate Dipotassium 5 mg
442
433
424
Clorazepate Dipotassium 5 mg
FLULIUM  
Clorazepate Dipotassium 5 mg
XP4
XP4
[160 mg]
434
443
MANOTRAN 
POLIZEP 
XP4
[150 mg]
P4
[234 mg]

Phentermine HCl 15 mg
P2
[310 mg]
Clorazepate Dipotassium 5 mg
425
SANOR
Clorazepate Dipotassium 5 mg

Clorazepate Dipotassium 5 mg
XP4
[149.55 mg]
435
444
CLORAXENE 5
⌫  ⌫
Clorazepate Dipotassium 5 mg
P4
[121.8 mg]
426
DIPOSEF
TAMYLAB-S ⌫
Clorazepate Dipotassium 5 mg
XP4
[220 mg]
⌫
Clorazepate Dipotassium 5 mg
XP4
[140 mg]
436
DEDA
445
  
Clorazepate Dipotassium 5 mg
P4
[160 mg]
427
T-FIVE
⌫  
Clorazepate Dipotassium 5 mg
XP4
TRANMED 
Clorazepate Dipotassium 5 mg
P4
[163.1 mg]
437
TRANXENE
446

Clorazepate Dipotassium 5 mg
P4
[145 mg]
428
CLORAMED 
TRANADON-S 
Clorazepate Dipotassium 5 mg
XP4
[220 mg]
Clorazepate Dipotassium 5 mg
XP4
438
TRANCLOR 
429
ANXENE
Clorazepate Dipotassium 5 mg
⌫ 
XP4
447
GAXENE
⌫  
Clorazepate Dipotassium 5 mg
XP4
Clorazepate Dipotassium 5 mg
XP4
430
SERENE V S PHARMA
⌫  
Clorazepate Dipotassium 5 mg
XP4
[163.1 mg]
431
†
439
448
TENMED 
ZETRAN 
P4
[234 mg]
XP4
[166 mg]
440
449
Clorazepate Dipotassium 5 mg
Indicates brands that contain more than 1 ingredient
Clorazepate Dipotassium 5 mg

PN DEX 2010
CEXENE
⌫   
PRODUCT IDENTIFICATION CHART 25
ANXIELAX

Clorazepate Dipotassium 5 mg
Clorazepate Dipotassium 5 mg
XP4
XP4
[248 mg]
MED-ZEPOXIDE 
Chlordiazepoxide HCl 5 mg
XP4
468
450
MANODIAZO 
PHENTERMINE OSMOPHARM
460
Phentermine HCl 15 mg
PANBESY
P2
[130.01 mg]
Phentermine HCl 30 mg

Diazepam 2 mg

P4
[165 mg]
P2
[320 mg]
469
TRANCAP
⌫ ⌫ 
Clorazepate Dipotassium 5 mg
451
CLOZENE

P4
[160 mg]
461
Clorazepate Dipotassium 10 mg
ZEPAXID
XP4
[165 mg]
P4
☯ ⌫
Diazepam 5 mg
470
DZP2
452
A-ZERAX ⌫
Diazepam 2 mg
P4
[145 mg]
 
Diazepam 2 mg
462
XP4
A-ZERAX ⌫
Diazepam 5 mg
471
P4
[145 mg]
DIAZEPAM ACDHON
Diazepam 2 mg
453

XP4
CONZEP

Clorazepate Dipotassium 5 mg
XP4
463
DOMAR

472
Pinazepam 5 mg
P4
[101 mg]
454
DIAPINE
P4
[146 mg]
POMADOM  
Clorazepate Dipotassium 5 mg
XP4
464
V DAY ZEPAM
Diazepam 5 mg
455
TRANCON ⌫
⌫ ⌫ ⌫
473
DIAZEPION 
P4
[200 mg]
Diazepam 5 mg
Clorazepate Dipotassium 5 mg
P4
[140 mg]

Diazepam 2 mg
XP4
[100 mg]
465
474
PHENTERMINE TRENKER
V DAY ZEPAM

456
DIZAN 
Diazepam 2 mg
XP4
[175 mg]
Diazepam 2 mg
Phentermine Resinate 15 mg
⌫ ⌫ ⌫
P4
[200 mg]
P2
[160 mg]
475
457
DITRAN
PRASEPINE

Prazepam 5 mg
XP4
CHLORDIAZEPOXIDE
MARCH PHARMA 
Chlordiazepoxide HCl 25 mg
458
POZAPAM
 
P4
[165 mg]
476
P4
[346 mg]
MINOXIDE ☯⌫ 
Chlordiazepoxide HCl 10 mg
Prazepam 5 mg
P4
[149.5 mg]
P4
[170 mg]
459
 
Diazepam 5 mg
466
477
467

†
Indicates brands that contain more than 1 ingredient
26
PN DEX 2010
PRODUCT IDENTIFICATION CHART
DALMADORM 
DUROMINE
Flurazepam 15 mg
Phentermine Resinate 30 mg
Chlordiazepoxide HCl 10 mg
P2
P2
[291 mg]
  
P4
[130 mg]
BENPINE

478
STESOLID 
488
Diazepam 10 mg
EXAN
XP4
Clorazepate Dipotassium 5 mg
498
⌫
XP4
489

Diazepam 2 mg
UPZENE
XP4
[100 mg]
Clorazepate Dipotassium 5 mg
XP4
☯ ⌫
499
CHLORDIAZEPOXIDE
CHAROEN BHAESAJ 
480
METAXIDE
  
Phentermine Resinate 15 mg
P2
[291.03 mg]
479
DIAZEPION 
DUROMINE
490
Chlordiazepoxide HCl 10 mg
   
Chlordiazepoxide HCl 10 mg
COMOBEN
P4
[120 mg]
Chlordiazepoxide HCl 10 mg
P4
[211.36 mg]
XP4
500
CHLORDIAZEPOXIDE ACDHON
481
DIAMED 

491
Chlordiazepoxide HCl 10 mg
⌫
Diazepam 5 mg
EXAN
P4
[168.5 mg]
Clorazepate Dipotassium 10 mg
XP4
XP4
501
492
482
MEDAZINE 
Medazepam 10 mg
P4
[165 mg]
 ⌫ 
Codeine Resinate 30 mg
XN3
[234 mg]

Diazepam 5 mg
P4
[147 mg]
484
STESOLID 
Diazepam 5 mg
XP4
MANODIAZO 
Diazepam 5 mg
P4
[165 mg]
502
493
483
DIAPINE
CODIPRONT†
CODIPRONT†

Codeine Resinate 30 mg
N3
[298.6 mg]
DIAMED 
Diazepam 2 mg
P4
[165.53 mg]
503
494
CLINEPECT† 
Codeine Phosphate (Antitussive) 10 mg
XN3
[270 mg]
MIRAPRONT N 
D-norpseudoephedrine HCl 20 mg
P2
504
485
REGENON RETARD 
495
Diethylpropion HCl 75 mg
MONOZIDE
P2
[480 mg]
Diazepam 2 mg
 ⌫ ⌫ ⌫
XP4
D-NORPSEUDOEPHEDRINE SR
OSMOPHARM 
D-norpseudoephedrine Resinate 20 mg
P2
[173.28 mg]
496
486
MEDAZINE 
Medazepam 5 mg
ATRACTIL 
Diethylpropion Resinate 75 mg
505
P2
[402.64 mg]
ZEPAXID
487
†
☯ ⌫
Diazepam 2 mg
P4
[165 mg]
P4
497
Indicates brands that contain more than 1 ingredient
506

PN DEX 2010
*COMODINE COUGH
†
   
PRODUCT IDENTIFICATION CHART 27
*PHENOBARBITAL ELIXIR
ACDHON 
Codeine Phosphate (Antitussive) 60 mL
Phenobarbital Na 20 mg/5 mL x 240 mL
XN3
XP4
*BROMTUSSIA DC† ⌫
Codeine Phosphate (Antitussive) 60 mL
XN3
507
511
515
*PHENOBARBITAL ELIXIR
ACDHON 
*PHENOBARBITAL ELIXIR
ACDHON 
*CODESIA†
Phenobarbital Na 20 mg/5 mL x 30 mL
XP4
⌫
Phenobarbital Na 20 mg/5 mL x 450 mL
Codeine Phosphate (Antitussive)
10 mg/5 mL x 60 mL
XP4
N3
508
512
516
*PHENOBARBITAL ELIXIR
ACDHON 
*PHENOBARBITAL ELIXIR
ACDHON 
*PHENOTAL ELIXIR ⌫
Phenobarbital Na 20 mg/5 mL x 60 mL
Phenobarbital Na 20 mg/5 mL x 500 mL
XP4
Phenobarbital Na 20 mg/5 mL x 60 mL
P4
XP4
509
513
517
*PHENOBARBITAL ELIXIR
ACDHON 
*PHENOBARBITAL ELIXIR
ACDHON 
*PSEUDOEPHEDRINE SYRUP
ASIAN PHARM ⌫
Phenobarbital Na 20 mg/5 mL x 120 mL
Phenobarbital Na 20 mg/5 mL x 1000 mL
XP4
510
XP4
514

Pseudoephedrine HCl 30 mg/5 mL x 60 mL
P2
518
*Shown smaller than actual size
28
PN DEX 2010
PRODUCT IDENTIFICATION CHART
*TENADRIN-C†
⌫  
Codeine Phosphate (Antitussive) 60 mL
XN3
*PSEUDOEPHEDRINE SYRUP
BJ BENJAOSOTH ⌫ 
Pseudoephedrine HCl 30 mg/5 mL x 60 mL
P2
*BROWN MIXTURE GPO†

Camphorated Opium Tinct
0.6 mL/5 mL x 180 mL
N3
519
*TERADENE†
527
523
⌫  
*PHENSODI†

Codeine Phosphate (Antitussive) 60 mL
Codeine Phosphate (Antitussive) 60 mL
XN3
XN3
*BROWN MIXTURE GPO†

Camphorated Opium Tinct
0.6 mL/5 mL x 450 mL
N3
520
*COFCODYL COUGH
528
524
†

Codeine Phosphate (Antitussive) 60 mL
†
*PHENSODI

Codeine Phosphate (Antitussive) 120 mL
XN3
Opium Tinct 5 mL/100 mL x 1000 mL
XN3
N3
521
525
*COFCODYL COUGH†
*PHENSODI†

Codeine Phosphate (Antitussive) 100 mL
*CAMPHORATED OPIUM
TINCTURE BP 1980† 
529

Codeine Phosphate (Antitussive) 1000 mL
XN3
XN3
*COUGH SYRUP GPO†

Camphorated Opium Tinct
0.6 mL/5 mL x 60 mL
XN3
522
†
526
Indicates brands that contain more than 1 ingredient
530

PN DEX 2010
PRODUCT IDENTIFICATION CHART 29
†
*MIST. SCILL AMMON. GPO

*MASADYL COUGH
Camphorated Opium Tinct
0.6 mL/5 mL x 180 mL
†

*NEO COUGH†

Codeine Phosphate (Antitussive) 100 mL
Codeine Phosphate (Antitussive) 240 mL
XN3
XN3
N3
531
535
*TERADYL SYRUP
†
   
539
*MASADYL COUGH
†

Codeine Phosphate (Antitussive) 240 mL
XN3
Codeine Phosphate (Antitussive) 60 mL
*CODYL COUGH† 
Codeine Phosphate (Antitussive)
9 mg/5 mL x 60 mL
N3
XN3
540
532
536
*TERADYL SYRUP†
*NEO COUGH†
   

Codeine Phosphate (Antitussive) 60 mL
XN3
Codeine Phosphate (Antitussive) 1000 mL
*CODYL COUGH† 
Codeine Phosphate (Antitussive)
9 mg/5 mL x 100 mL
N3
XN3
537
533
*MASADYL COUGH
†

541
†
*NEO COUGH

Codeine Phosphate (Antitussive) 60 mL
Codeine Phosphate (Antitussive) 100 mL
XN3
XN3
*CODYL COUGH† 
Codeine Phosphate (Antitussive)
9 mg/5 mL x 1000 mL
XN3
534
538

542
*Shown smaller than actual size
30
PN DEX 2010
PRODUCT IDENTIFICATION CHART
*CODYL COUGH† 
Codeine Phosphate (Antitussive)
9 mg/5 mL x 4500 mL
XN3
Pseudoephedrine HCl 30 mg/5 mL x 60 mL
*BENADRYL CD†

Codeine Phosphate (Antitussive) 1000 mL
XN3
P2
543
*MENOBARB ELIXIR
*PSEUDOEPHEDRINE SYRUP
MILANO 
551
547

Phenobarbital Na 15 mg/5 mL x 60 mL
XP4
*POLY-COF SYRUP†

Codeine Phosphate (Antitussive)
9 mg/5 mL x 60 mL
*BENYLIN CD†

Codeine Phosphate (Antitussive) 60 mL
XN3
N3
544
*MENOBARB-20 ELIXIR
552
548

Phenobarbital Na 20 mg/5 mL x 60 mL
XP4
*POLY-COF SYRUP
†

*PHENSEDYL†

Codeine Phosphate (Antitussive)
9 mg/5 mL x 100 mL
Codeine Phosphate (Antitussive)
9 mg/5 mL x 100 mL
N3
N3
545
549
*MILA-CONO† 
*BENADRYL CD†
553

Codeine Phosphate (Antitussive) 60 mL
Codeine Phosphate (Antitussive) 60 mL
XN3
XN3
*BROWN MIXTURE
OSOTH INTERLAB† 
Camphorated Opium Tinct
0.6 mL/5 mL x 180 mL
N3
546
†
550
Indicates brands that contain more than 1 ingredient
554

PN DEX 2010
†
*HISEDYL

PRODUCT IDENTIFICATION CHART 31
†
*P-CODYL
Codeine Phosphate (Antitussive) 60 mL
XN3
555
†
*HISEDYL


XN3
N3
563
*PHENOBARB ELIXIR
*PONDNADYL†
⌫ ⌫ ⌫
XN3
⌫
Phenobarbital Na 20 mg/5 mL x 60 mL
Codeine Phosphate (Antitussive)
9 mg/5 mL x 100 mL
XP4
N3
556
560
*MIXTURE SCILLAE AMMON†
*BONADINE CD†
564
 
Codeine Phosphate (Antitussive) 60 mL
XN3
Camphorated Opium Tinct
2 mL/15 mL x 180 mL
⌫
Codeine Phosphate (Antitussive)
9 mg/5 mL x 60 mL
559
Codeine Phosphate (Antitussive) 120 mL

*PONDNADYL†
Codeine Phosphate (Antitussive)
9 mg/5 mL x 120 mL
*PONDNADYL†
⌫
Codeine Phosphate (Antitussive)
9 mg/5 mL x 1000 mL
XN3
XN3
557
561
*P-CODYL
†

*PERCIDYL COUGH†
Codeine Phosphate (Antitussive)
9 mg/5 mL x 60 mL
Codeine Phosphate (Antitussive) 100 mL
XN3
XN3
558
565
⌫
*NORDYL LINCTUS†
 
Codeine Phosphate (Antitussive)
9 mg/5 mL x 100 mL
N3
562

566
*Shown smaller than actual size
32
PN DEX 2010
PRODUCT IDENTIFICATION CHART
*NORDYL LINCTUS†
 
Codeine Phosphate (Antitussive)
9 mg/5 mL x 500 mL
*PHENOSIL ELIXIR ⌫
Phenobarbital Na 20 mg/5 mL x 450 mL
XP4
XN3

Camphorated Opium Tinct
0.45 mL/5 mL x 60 mL
N3
571
567
*NORTUSS LINCTUS†
 
Codeine Phosphate (Antitussive) 100 mL
XN3
568
*NORTUSS LINCTUS
*MIXTURE TUSSIS†
†
 
*DECOS†
575
⌫
*MIXTURE TUSSIS†

Codeine Phosphate (Antitussive)
9 mg/5 mL x 100 mL
Camphorated Opium Tinct
0.45 mL/5 mL x 120 mL
N3
N3
572
576
*ELIXIR PHENOBARB
Codeine Phosphate (Antitussive) 500 mL
Phenobarbital Na 60 mL
XN3
XP4

*MIXTURE TUSSIS†

Camphorated Opium Tinct
0.45 mL/5 mL x 240 mL
N3
569
573
*PHENOSIL ELIXIR ⌫
*MIXTURE TUSSIS†
Phenobarbital Na 20 mg/5 mL x 60 mL
XP4
570
†
577

*MIXTURE TUSSIS†

Camphorated Opium Tinct
0.45 mL/5 mL x 30 mL
Camphorated Opium Tinct
0.45 mL/5 mL x 450 mL
N3
N3
574
578
Indicates brands that contain more than 1 ingredient

PN DEX 2010
*MIXTURE TUSSIS
†
PRODUCT IDENTIFICATION CHART 33

†
*CONADYL
Camphorated Opium Tinct
0.45 mL/5 mL x 1800 mL
⌫  ⌫
Codeine Phosphate (Antitussive) 60 mL
XN3
XN3
*PHENCODIN†
⌫  
Codeine Phosphate (Antitussive)
9 mg/5 mL x 500 mL
XN3
579
583
*MIXTURE TUSSIS†

587
*PHENOCO ELIXIR
Camphorated Opium Tinct
0.45 mL/5 mL x 3600 mL
⌫  ⌫
Phenobarbital Na 20 mg/5 mL x 450 mL
P4
XN3
*PHENCODIN†
⌫  
Codeine Phosphate (Antitussive)
9 mg/5 mL x 1000 mL
XN3
580
584
*MANTADYL COUGH†
⌫  
588
*PHENOCO ELIXIR
⌫  ⌫
Codeine Phosphate (Antitussive) 60 mL
Phenobarbital Na 20 mg/5 mL x 3800 mL
XN3
XP4
*TUSSIDYL†
⌫  
Codeine Phosphate (Antitussive)
9 mg/5 mL x 60 mL
N3
581
585
*COSEDYL COUGH LINCTUS†
*PHENCODIN†
⌫ ⌫ 
589
⌫  
*MIST TUSSIS†

Codeine Phosphate (Antitussive) 60 mL
Codeine Phosphate (Antitussive)
9 mg/5 mL x 60 mL
Camphorated Opium Tinct
0.6 mL/5 mL x 450 mL
XN3
N3
N3
586
590
582

*Shown smaller than actual size
34
PN DEX 2010
PRODUCT IDENTIFICATION CHART
*SQUILL AND AMMONIA MIXTURE† *ORAMORPH  

Morphine Sulfate 20 mg/mL x 30 mL
*FENTANYL ANTIGEN 
Fentanyl Citrate 0.05 mg/mL x 10 mL
N2
N2
591
595
599
*DIMETANE EXPECTORANT DC†
*METHADONE GPO
*DIAPINE
Camphorated Opium Tinct
1.3 mL/10 mL x 450 mL
N3

Codeine Phosphate (Antitussive) 2.5 L
XN3

Methadone HCl 10 mg/mL x 1000 mL

Diazepam 5 mg/mL x 1 mL
P4
N2
592
†
*CODIPRONT
 
Codeine Resinate 60 mL
XN3
596
600
*PENTAZOCINE ALL PLANTS
*DIAPINE

Pentazocine 30 mg/mL x 1 mL

Diazepam 10 mg/2 mL x 2 mL
P4
XP3
593
597
601
*ORAMORPH  
*FENTANYL ANTIGEN 
*PETHIDINE BIOLAB 
Morphine Sulfate 10 mg/5 mL x 250 mL
†
Fentanyl Citrate 0.05 mg/mL x 2 mL
Pethidine HCl 100 mg/2 mL x 2 mL
N2
N2
N2
594
598
602
Indicates brands that contain more than 1 ingredient

PN DEX 2010
*DIAZEPAM GPO

PRODUCT IDENTIFICATION CHART 35
*PANGON
 ⌫  ⌫
Diazepam 10 mg/2 mL x 2 mL
Pentazocine 30 mg/mL x 1 mL
P4
P3
*PETHIDINE
M & H MANUFACTURING
   
Pethidine HCl 50 mg/mL x 1 mL
N2
603
607
*EPHEDRINE GPO

*ROPAM
611
 ⌫  ⌫
Ephedrine HCl 30 mg/mL x 1 mL
Diazepam 10 mg/2 mL x 2 mL
P2
P4
*PETHIDINE
M & H MANUFACTURING
   
Pethidine HCl 100 mg/2 mL x 2 mL
N2
604
608
612
*FENTANYL JANSSEN-CILAG
*MORPHINE SULFATE INJ BLUE
*MANOLIUM 
⌫
   
Diazepam 10 mg/2 mL x 2 mL
P4
Fentanyl Citrate 0.05 mg/mL x 2 mL
Morphine Sulfate 10 mg/mL x 1 mL
N2
N2
605
609
613
*FENTANYL JANSSEN-CILAG
*MORPHINE SULFATE INJ PURPLE
*ZEPAM
⌫
   
Fentanyl Citrate 0.05 mg/mL x 10 mL
Morphine Sulfate 10 mg/mL x 1 mL
N2
N2
606
610


Diazepam 10 mg/2 mL x 2 mL
XP4
614
*Shown smaller than actual size
36
PN DEX 2010
PRODUCT IDENTIFICATION CHART
*TRANOLAN 
Diazepam 10 mg/2 mL x 2 mL
P4
*TEMGESIC  ⌫
Buprenorphine HCl 0.3 mg/mL x 1 mL
P2
*FENTANYL SANDOZ
 
Fentanyl Citrate 0.05 mg/mL x 2 mL
N2
615
*V DAY ZEPAM
619
⌫ ⌫ ⌫
623

Diazepam 10 mg/2 mL x 2 mL
Diazepam 10 mg/2 mL x 2 mL
P4
XP4
616
*V DAY ZEPAM NL
⌫ ⌫ ⌫
Diazepam 10 mg/2 mL x 2 mL
*SOSEGON ⌫
Pentazocine 30 mg/mL x 1 mL
P3
620
624
*DORMICUM 
*DIAZA 
Midazolam 5 mg/mL x 1 mL
Diazepam 10 mg/2 mL x 2 mL
P4
P2
617
621
625
*FORTWIN ⌫
*DORMICUM 
*SIPAM
Pentazocine 30 mg/mL x 1 mL
XP3
618
†
*VALIUM
XP4

Midazolam 15 mg/3 mL x 3 mL
Diazepam 10 mg/2 mL x 2 mL
P2
P4
622
626
Indicates brands that contain more than 1 ingredient

PN DEX 2010
*DIAZEPAM T P DRUG
PRODUCT IDENTIFICATION CHART 37
⌫ ⌫ 
*PETHIDINE T.P. DRUG
⌫ ⌫ 
Diazepam 10 mg/2 mL x 2 mL
Pethidine HCl 50 mg/mL x 1 mL
P4
N2
627
631
*MORPHINE T.P. DRUG
⌫ ⌫ 
635
*MONOZIDE-10
 ⌫ ⌫ ⌫
Morphine Sulfate 10 mg/mL x 1 mL
Diazepam 10 mg/2 mL x 2 mL
P4
⌫ ⌫ 
*TAZCINE
*VESCOPAM 
Diazepam 10 mg/2 mL x 2 mL
P4
632
*MORPHINE T.P. DRUG
Diazepam 10 mg/2 mL x 2 mL
XP4
N2
628
*LAYLIUM-10 
636
☯ ⌫
*RIVOTRIL

Morphine Sulfate 10 mg/mL x 1 mL
Pentazocine 30 mg/mL x 1 mL
Clonazepam 1 mg/mL x 1 mL
N2
XP3
XP4
629
633
*MORPHINE T.P. DRUG
⌫ ⌫ 
*ZEPAXID
637
☯ ⌫
*GARDENAL ⌫⌫
Morphine Sulfate 10 mg/mL x 1 mL
Diazepam 10 mg/2 mL x 2 mL
N2
P4
P4
634
638
630

Phenobarbital Na 200 mg/4 mL
*Shown smaller than actual size
38
PN DEX 2010
PRODUCT IDENTIFICATION CHART
*NEMBUTAL
⌫  
Pentobarbital Na 50 mg/mL x 20 mL
P3
*KETALAR 
Ketamine HCl 50 mg/mL x 10 mL
P2
*FENTANYL SANDOZ
 
Fentanyl Citrate 0.05 mg/mL x 10 mL
N2
639
*AMYTAL
643
⌫ ⌫
Amobarbital Na 0.5 g
XP3
645
⌫⌫ 
Ketamine HCl 50 mg/mL x 10 mL
*FENTANYL GPO  ⌫⌫
Fentanyl 25 mcg/hr
P2
N2
641
646
*KETA-HAMELN 
*FENTANYL GPO  ⌫⌫
Ketamine HCl 50 mg/mL x 10 mL
†
Fentanyl 12 mcg/hr
N2
640
*CALYPSOL
644
*FENTANYL GPO  ⌫⌫
Fentanyl 50 mcg/hr
P2
N2
642
647
Indicates brands that contain more than 1 ingredient

PN DEX 2010
*FENTANYL HEXAL  ⌫
Fentanyl 12 mcg/hr
PRODUCT IDENTIFICATION CHART 39
*DUROGESIC ⌫
Fentanyl 50 mcg/hr x 5 mg
N2
N2
648
652
*FENTANYL HEXAL  ⌫
*DUROGESIC ⌫
Fentanyl 25 mcg/hr
Fentanyl 100 mcg/hr x 10 mg
N2
N2
649
653
*FENTANYL HEXAL  ⌫
Fentanyl 50 mcg/hr
N2
650
*DUROGESIC ⌫
Fentanyl 25 mcg/hr x 2.5 mg
N2
651

*Shown smaller than actual size
CLASSIFICATION OF PSYCHOTROPICS & NARCOTICS
 ⌫ ⌫ ⌫

  
      ⌦    ⌦
 ⌫ ⌫ ⌫ 
⌫ ⌦⌫⌫  
    
     
      ⌦     
 ⌫ ⌫ ⌫⌫
 ⌦⌫⌫  
        
  
       ⌫ 
⌫ ⌫
  
   ⌫⌦  
 ⌫ ⌫ ⌦
   ⌦  ⌫ 
  
 ⌫  ⌦  ⌫  ⌫⌫ ⌦ 
   
   
1. AMFEPRAMONE
(DIETHYLPROPION)
2. AMINEPTINE
3. AMINOREX
4. BROTIZOLAM
5. BUPRENORPHINE
6. BUTORPHANOL
7. CATHINE
(D-NORPSEUDOEPHEDRINE)
8. EPHEDRINE
9. ESTAZOLAM
10. FENCAMFAMIN
11. FENETHYLLINE
12. FLUNITRAZEPAM
13. FLURAZEPAM
14. HALOXAZOLAM
15. KETAMINE
16. LOPRAZOLAM
17. LORMETAZEPAM
18. MAZINDOL
19. MESOCARB
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
METHYLPHENIDATE
MIDAZOLAM
N-ETHYLAMPHETAMINE
NIMETAZEPAM
NITRAZEPAM
PEMOLINE
PHENCYCLIDINE
PHENDIMETRAZINE
PHENMETRAZINE
PHENTERMINE
PHENYLPROPANOLAMINE
PIPRADROL
PSEUDOEPHEDRINE
QUAZEPAM
SECOBARBITAL
TEMAZEPAM
TRIAZOLAM
ZALEPLON
ZIPEPROL
ZOLPIDEM
ZOPICLONE
   
1.
2.
3.
4.
AMOBARBITAL
BUTALBITAL
CYCLOBARBITAL
GLUTETHIMIDE
Pink Pages_2010_Tip.pmd
5. MEPROBAMATE
6. PENTAZOCINE
7. PENTOBARBITAL
40
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
ALLOBARBITAL
ALPRAZOLAM
BARBITAL
BENZPHETAMINE
BROMAZEPAM
BUTOBARBITAL
CAMAZEPAM
CHLORAL HYDRATE AND
ITS ADDUCTS
CHLORDIAZEPOXIDE
CHLORPHENTERMINE
CLOBAZAM
CLONAZEPAM
CLORAZEPATE
CLORTERMINE
CLOTIAZEPAM
CLOXAZOLAM
DIAZEPAM
DELORAZEPAM
ETHCHLORVYNOL
ETHINAMATE
ETHYL LOFLAZEPATE
FENPROPORAX
FLUDIAZEPAM
HALAZEPAM
INORGANIC BROMIDES
KETAZOLAM
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
7/4/2553, 09:28
LORAZEPAM
MEDAZEPAM
MEFENOREX
METHYPHENOBARBITAL
METHYPRYLON
NORDAZEPAM
OXAZEPAM
OXAZOLAM
PERLAPINE
PHENOBARBITAL
PINAZEPAM
PRAZEPAM
PROPYLHEXEDRINE
PYROVALERONE
SECBUTABARBITAL
SPA
TETRAZEPAM
TOFISOPAM
VINYLBITAL
PN DEX 2010
41

 ⌫  ⌦ ⌫  ⌫⌫ ⌦ 
  
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
101.
ACETYLDIHYDROCODEINE
ACETYLMETHADOL
ALFENTANIL
ALLYLPRODINE
ALPHACETYLMETHADOL
ALPHAMEPRODINE
ALPHAMETHADOL
ALPHAPRODINE
ANILERIDINE
BENZETHIDINE
BENZYLMORPHINE
BETACETYLMETHADOL
BETAMEPRODINE
BETAMETHADOL
BETAPRODINE
BEZITRAMIDE
CLONITAZENE
COCA BUSH
COCAINE
CODEINE
CODOXIME
CONCENTRATE OF POPPY STRAW
DEXTROMORAMIDE
DEXTROPROPOXYPHENE
DIAMPROMIDE
DIETHYLTHIAMBUTENE
DIFENOXIN
DIHYDROCODEINE
DIHYDROMORPHINE
DIMENOXADOL
DIMEPHEPTANOL
DIMETHYLTHIAMBUTENE
DIOXAPHETYLBUTYRATE
DIPHENOXYLATE
DIPIPANONE
DROTEBANOL
ECGONINE
ETHYLMETHYLTHIAMBUTENE
ETHYLMORPHINE
ETONITAZENE
ETOXERIDINE
FENTANYL
FURETHIDINE
HYDROCODONE
HYDROMORPHINOL
HYDROMORPHONE
HYDROXYPETHIDINE
ISOMETHADONE
LEVOMETHORPHAN
LEVOMORAMIDE
LEVOPHENACYLMORPHAN
Pink Pages_2010_Tip.pmd
41
LEVORPHANOL
MEDICINAL OPIUM
METAZOCINE
METHADONE
METHADONE INTERMEDIATE
METHYLDESORPHINE
METHYLDIHYDROMORPHINE
METOPON
MORAMIDE-INTERMEDIATE
MORPHERIDINE
MORPHINE
MORPHINE METHOBROMIDE
MORPHINE N-OXIDE
MYROPHINE
NICOCODINE
NICODICODINE
NICOMORPHINE
NORACYMETHADOL
NORCODEINE
NORLEVORPHANOL
NORMETHADONE
NORMORPHINE
NORPIPANONE
OPIUM
OXYCODONE
OXYMORPHONE
PETHIDINE
PETHIDINE-INTERMEDIATE-A
PETHIDINE-INTERMEDIATE-B
PETHIDINE-INTERMEDIATE-C
PHENADOXONE
PHENAMPROMIDE
PHENAZOCINE
PHENOMORPHAN
PHENOPERIDINE
PHOLCODINE
PIMINODINE
PIRITRAMIDE
PROHEPTAZINE
PROPERIDINE
PROPIRAM
RACEMETHORPHAN
RACEMORAMIDE
RACEMORPHAN
REMIFENTANIL
SUFENTANIL
THEBACON
THEBAINE
TILIDINE
TRIMEPRIDINE
  
1. CODEINE
2. DIPHENOXYLATE
3. OPIUM TINCTURE/CAMPORATED
OPIUM TINCTURE
7/4/2553, 09:28
NATIONAL LIST OF ESSENTIAL MEDICINES (NLEM)
⌫
 
 ⌫   
  
  ⌧  ⌫ ⌫  
 ⌫ 
   ⌫
⌫  ⌫
  ⌫ ⌫  
⌫   ⌫ ⌫   
       ⌫⌫
⌦    ⌫   
   ⌫        
 ⌦⌦⌫      
   ⌫    
    
 ⌦⌦  ⌫ ⌦   
 
 ⌫  ⌫ ⌫ ⌦ ⌫ ⌫  
  ⌦   ⌫ ⌫ 
 ⌦⌦⌫ ⌫     ⌫ ⌫
Pink Pages_2010_Tip.pmd
42
7/4/2553, 09:28
PN DEX 2010
43
 ⌫   ⌫ ⌫  ⌫ ⌫ ⌫⌫
⌫    ⌫ ⌫ ⌫⌫ 
     
 ⌫⌫ ⌫⌫⌫  
       ⌫
   ⌫  ⌦ ⌫        ⌫
⌫ 
⌦ ⌫
⌫ ⌫⌫
⌫⌫⌫

⌫ 
⌦ ⌫ ⌫ ⌫   
 ⌫  
⌫ 
⌦ ⌫     ⌫  
  ⌫ ⌦ ⌫ 
⌫  ⌦   ⌫
⌫       
  ⌫ ⌫ ⌫  ⌫
⌫  ⌫⌫  ⌫
 ⌫  ⌫
⌫ 
⌦ ⌫ ⌫  ⌫ ⌫ ⌫ ⌫
⌫   ⌫ ⌫  ⌦ ⌫ ⌫ 
⌫     ⌫
             
⌦
 ⌫ ⌫       
⌫ ⌦ 
   ⌫ 
Pink Pages_2010_Tip.pmd
43
7/4/2553, 09:28
PN DEX 2010
44
⌫ 
⌫  
⌫  
⌫ ⌫⌫⌫
  
⌫  
  ⌫ 

   
⌫⌫⌫ ⌫

  ⌫ ⌫  ⌦ ⌫
⌦    ⌦  ⌫
  
 
 
  ⌫   ⌫ ⌫⌫ ⌫
⌫
 ⌫    
 ⌦  

⌫    ⌫⌫ ⌫ ⌫⌫ 
 ⌫    ⌫  ⌫ ⌫  
    ⌦⌫      ⌫ 
⌫    ⌫     ⌦
  ⌫ ⌫  

Pink Pages_2010_Tip.pmd
44
7/4/2553, 09:28
PN DEX 2010
45
   ⌫  
    ⌫   ⌦ 
⌫   
 


⌫
(Generic Name)
Alprazolam
P4
tab

4.1. Hypnotics and
anxiolytics
Buprenorphine
hydrochloride
P2
sublingual tab,
sterile sol

4.7.1. Opioid
analgesics
Chloral hydrate
P4
oral sol (hosp)

4.1. Hypnotics
and anxiolytics
Chlordiazepoxide P4
cap, tab

4.1. Hypnotics
and anxiolytics
Clonazepam
tab

4.1. Hypnotics and
anxiolytics
P4
 
  
⌫

4.8.1. Drugs used
in the control of
epilepsy
4.9. Drugs used in
movement disorders
Codeine
phosphate
N2
tab

3.6.1. Cough
suppressants
4.7.1. Opioid
analgesics
Diazepam
P4
cap, tab, sterile sol

4.1. Hypnotics
and anxiolytics
Dipotassium
clorazepate
P4
cap, tab

4.1. Hypnotics
and anxiolytics
Ephedrine
hydrochloride
P2
nasal drop (hosp)
( 0.5-3%)

12.2.2. Topical nasal
decongestants
sterile sol

2.7.2. Vasoconstrictor
sympathomimetics
   ⌫  ⌫     
Pink Pages_2010_Tip.pmd
45
7/4/2553, 09:28
PN DEX 2010
46


⌫
Fentanyl
N2
transdermal
therapeutic system
(as base)

4.7.1. Opioid
analgesics
Fentanyl citrate
N2
sterile sol

15.1.4. Sedative
and analgesic
peri-operative drugs
Ketamine
hydrochloride
P2
sterile sol

15.1.1. Intravenous
anaesthetics
Lorazepam
P4
tab

4.1. Hypnotics
and anxiolytics
Methadone
N2
oral sol

 
(Generic Name)
hydrochloride
 
  
⌫
4.10. Drugs used
   ⌫ ⌫

  ⌫ 

⌫  ⌫

  ⌫
in substance
dependence
tab, oral sol
4.7.1. Opioid
analgesics
Methylphenidate
P2
tab (10 mg)

4.4. Central
nervous system
stimulants
 AttentionDeficit Hyperactivity
Disorder (ADHD)
Midazolam
hydrochloride
P2
sterile sol

15.1.4. Sedative
and analgesic
peri-operative
drugs
      
 ⌦    
⌫⌫
 
 ⌦
4.8.2. Drugs used in
epilepticus status

15.1.4. Sedative
and analgesic
peri-operative
drugs
⌫  
 ⌦
Midazolam
maleate
P2
tab

refractory
status epilepticus
(premedication)

  
⌦ 
   ⌫  ⌫     
Pink Pages_2010_Tip.pmd
46
7/4/2553, 09:28
PN DEX 2010
 
47


⌫
(Generic Name)
Morphine
sulfate
Nitrazepam
N2
P2
 
  
⌫
cap, tab, SR cap,
SR tab, sterile sol

4.7.1. Opioid
analgesics
sterile sol

15.1.4. Sedative
and analgesic
peri-operative drugs
tab

4.8.1. Drugs used
in the control of
epilepsy
⌫
 
 infantile
spasms
Opium and
Glycyrrhiza
Mixture
Compound
(Mist. Tussis;
Brown Mixture)
N2
mixt (hosp)

3.6.1. Cough
suppressants
Pethidine
hydrochloride
N2
sterile sol

15.1.4. Sedative
and analgesic
peri-operative drugs
4.7.1. Opioid
analgesics
Phenobarbital
P4
tab (as base or
sodium)

4.8.1. Drugs used
in the control of
epilepsy
Phenobarbital
sodium
P4
sterile pwdr

4.8.2. Drugs used in
status epilepticus

16. Antidotes
(Phenobarbitone
sodium)
Pseudoephedrine P2
hydrochloride
tab, syr

3.7. Systemic nasal
decongestants
Squill and
Ammonia Mixture
mixt (hosp)

3.6.1. Cough
suppressants
N3
     ⌫

   ⌫  ⌫     
Pink Pages_2010_Tip.pmd
47
7/4/2553, 09:28
IMPORTANT DRUG NOTES
⌫ ⌫ ⌫
Provides useful information on significant contraindications, precautions, adverse reactions and
interactions of drugs, presented according to the Psychotropic & Narcotic Drugs List of Thailand.
Note: I: Indications; CI: Contraindications; SP: Precautions; AR: Adverse Reactions;
DI: Drug Interactions.
P2 - Psychotropic Substance
Schedule 2
AMFEPRAMONE
(DIETHYLPROPION)
     ⌫ ⌫ 
I: Obesity.
CI: Advanced arteriosclerosis. Hyperthyroidism.
Hypersensitivity. Glaucoma. Agitated states.
History of drug abuse. Pulmonary HTN or severe
hypertension. Heart murmur or valvular disorders.
Emotional instability. History of psychiatric illness.
Concomitant use w/ other anorectic agents. MAOI
therapy or w/in 2 wk of discontinuation. Pregnancy
& lactation. Child & elderly.
SP: Increased risk of developing primary pulmonary
HTN (PPH). HTN & severe CV disease. Prolonged
use may induce dependence w/ withdrawal
symptoms on cessation of therapy; do not use for
more than 3 months. May increase convulsions in
some epileptic patients. Toxic psychosis. Peptic
ulceration. Prostatic hyperplasia.
AR: CV & CNS disturbances; GI effects; allergic
reactions; impotence; changes in libido,
gynecomastia, menstrual upset; hematopoietic
effects; dyspnea, hair loss, muscle pain, dysuria,
increased sweating, polyuria.
DI: Hypertensive risk w/ MAOIs. b-blockers,
guanethidine, tricyclic antidepressants, urinary
alkalinisers or acidifiers. Alters antidiabetic drug
requirements.
⊗
BUPRENORPHINE
⌦
I: As a perioperative analgesic supplement.
Moderate to severe pain. Premedication before
anaesthesia.
⊗
CI: Acute alcoholism; convulsive disorders; head
injuries; increased intracranial pressure; comatose
patients; resp depression & obstructive airway
disease; patients on established opioid agonists.
SP: Hepatic or renal disease; pregnancy, lactation;
hypothyroidism; adrenocortical insufficiency;
asthma; prostatic hyperplasia; shock; hypotension;
inflammatory or obstructive bowel disorders;
myasthaenia gravis; infants/neonates. Reduce dose
in elderly & debilitated patients. May precipitate
withdrawal symptoms in narcotic addicts.
AR: Sedation, nausea, dizziness, vertigo,
hypotension, miosis, headache, hypoventilation,
resp or CNS depression; tachycardia, bradycardia,
urinary retention, coma, vomiting, drowsiness,
sweating, confusion, dry mouth, diaphoresis,
withdrawal syndrome.
DI: Plasma-buprenorphine concentrations may be
affected when co-administered w/ drugs that
induce or inhibit cytochrome P450 isoenzyme
CYP3A4. Enhanced depressant effects w/ other
CNS depressants e.g. alcohol, anaesthetics,
anxiolytics, hypnotics, TCAs & antipsychotics.
Diazepam may produce resp & cardiac collapse.
CATHINE
(D-NORPSEUDOEPHEDRINE)

I: Obesity.
CI: Patients treated w/ MAOI or stopped MAOI w/in
the last 2 wk; moderate or severe hypertension;
pulmonary hypertension; structural cardiac
abnormalities or advanced arteriosclerosis; adrenal
tumour; hyperthyroidism or hyperexcitability; coronary
thrombosis; closed-angle glaucoma; pregnancy.
SP: Heart disease, mild hypertension, CHF or angina
of effort; prostate hyperplasia; patients w/ history
of drug or alcohol abuse; DM; psychotic patients; renal
disease. Growth retardation may occur in children.
AR: Headache, tachycardia, precordial pain,
Registration expired
Pink Pages_2010_Tip.pmd
48
7/4/2553, 09:28
PN DEX 2010
IMPORTANT DRUG NOTES 49
giddiness, restlessness or insomnia; dry mouth &
thrist, nausea, vomiting, sweating; difficulty in
micturition; muscular weakness & tremors;
tolerance & /or dependence may occur.
DI: Reduced effect of guanethidine. Increased risk
of arrhythmia in patients treated w/ digitalis due to
its sympathomimetic effects. Increased risk of
arrhythmia w/ chloroform, cyclopropane, halothane
or other halogenated anesthetics. The effect of
cathine may be reduced/enhanced by tricyclic antidepressants. Cathine should not be used in patients
treated w/ a MAOI or w/in 14 days of stopping MAOI
as hypertensive crisis may occur if used.
EPHEDRINE
 
I: Relief of moderate to severe acute asthma, relief
of broncoconstiction.
CI: Hypersensitivity. Hypertension, thyrotoxicosis,
BPH. Lactation.
SP: Ischaemic heart disease, hyperthyroidism,
diabetes mellitus, hypertension, angle-closure
glaucoma, renal impairment; prostatic
enlargement; pregnancy, elderly.
AR: Anxiety, tachycardia, tremor, dry mouth,
hypertension, cardiac arrhythmias, impaired
circulation to the extremities, nervousness, insomnia,
palpitations. Difficulty in micturition in patients w/
prostatic enlargement. Nasal drops: Local irritation,
rebound nasal congestion & drug-induced rhinitis on
prolonged use. Delusions, hallucinations. Seen w/
hypersensitivity & overdosage. Acute CNS & CVS
stimulation presenting as vomiting, fever,
hypertension, psychosis. Cardiac arrhythmias.
DI: Reduces antihypertensive effect of bethanidine
& guanethidine. May increase clearance of
dexamethasone. Increased incidence of adverse
effects when used w/ theophylline. Severe HTN when
combined w/ MAOIs or within 2 wk of discontinuance
of MAOI treatment. Increased risk of arrhythmias w/
cardiac glycosides, quinidine or tricyclic
antidepressants. Increased vaso-constriction or
pressor effects w/ ergot alkaloids or oxytocin.
FLUNITRAZEPAM

I: Induction of anaesthesia. Premedication in
surgery. Short-term management of insomnia.
CI: Preexisting CNS depression or coma, resp
depression, acute pulmonary insufficiency or sleep
apnoea; severe hepatic impairment; chronic
psychosis, phobic or obsessional states; may
precipitate suicide or aggressive behavior; not to
be used alone to treat depression or anxiety
associated w/ depression; glaucoma. Pregnancy,
lactation. Neonates.
SP: Chronic pulmonary insufficiency; elderly or
debilitated patients; muscle weakness, impaired
liver or kidney function; drowsiness may affect
skilled tasks; monitor cardio-respiratory function
when used for deep sedation; personality disorders
or organic brain changes; history of alcohol or drug
addiction; resp depression & hypotension w/
parenteral admin; this route should only be used
when facilities for reversing resp depression are
available.
AR: Drowsiness & lightheadedness, sedation,
muscle weakness & ataxia; less frequently vertigo,
headache, confusion, depression, slurred
speech, changes in libido, tremor, visual
disturbances, urinary retention, GI disturbances,
changes in salivation & amnesia.
DI: Enhanced sedation or resp & CV depression
w/ drugs w/ CNS depressant properties eg,
antidepressants, antihistamines, antipsychotics,
general anaesthetics, other hypnotics or sedatives,
opioid analgesics & cisapride. Alcohol. Calciumchannel blockers; clonidine; diaxozide; disulfiram;
clozapine; diuretics; moxonidine; nabitone; nitrates;
cimetidine, esomeprazole & omeprazole; muscle
relaxants; dopaminergics; lofexidine; hydralazine,
minoxidil & nitroprusside; antifungals; angiotensin
II receptor antagonist; antiepileptics; β-blockers;
antibacterials. Drugs which alter the hepatic
microsomal enzymes.
⊗
FLURAZEPAM

I: Short-term management of insomnia.
CI: Hypersensitivity; porphyria. Pregnancy (3 rd
trimester); neonates.
SP: Chronic pulmonary insufficiency; elderly or
debilitated patients; muscle weakness, impaired
liver or kidney function; drowsiness may affect
skilled tasks; monitor cardio-respiratory function
when used for deep sedation; personality disorders
or organic brain changes; history of alcohol or drug
addiction. Respiratory depression & hypotension
w/ parenteral admin. Dependence; lactation. Safety
& efficacy are not proven in child <15 yr.
⊗
Pink Pages_2010_Tip.pmd
49
7/4/2553, 09:28
Registration expired
50
KETAMINE
 ⌫

   
I: Induction of anaesthesia.
CI: Hypertension, history of cerebrovascular
accident. Eye injury, raised ocular & intracranial
pressure. Psychotic disorders.
SP: Minimise verbal & tactile stimulation during
recovery period. Chronic alcoholic & alcoholintoxicated patients. Preanaesthetic elevated
CSF pressure. Dependence & tolerance may
develop. May impair ability to drive or operate
machinery. Monitor cardiac function in patients
w/ HTN or cardiac decompensation. Pregnancy
& lactation.
AR: Emergence reactions e.g. vivid dreams,
hallucinations, confusion, irrational behaviour.
Increased muscle tone sometimes resembling
seizures. Temporary HTN & tachycardia.
Hypotension, bradycardia, arrhythmias.
Respiratory depression, apnoea, laryngospasm,
diplopia, nystagmus, nausea, vomiting,
lachrymation, hypersalivation, raised intraocular
& CSF pressure, skin rash & pain at inj site.
DI: May increase effects of nondepolarising
muscle relaxants. May reduce hypnotic effect of
thiopental. Prolonged recovery time w/
barbiturates/narcotics. Reduced cardiac output,
BP & pulse rate w/ halothane. Increased risk of
HTN & tachycardia w/ thyroid hormones.
Seizures & tachycardia may occur when used
w/ theophyllines.
⊗
PN DEX 2010
IMPORTANT DRUG NOTES
AR: Drowsiness & lightheadedness, sedation,
muscle weakness & ataxia; less frequently vertigo,
headache, confusion, depression, slurred
speech, changes in libido, tremor, visual
disturbances, urinary retention, GI disturbances,
changes in salivation & amnesia.
DI: Antidepressants, antihistamines, antipsychotics, general anesthetics, other hypnotics
or sedatives, opioid analgesics & cisapride.
Increased toxicity by amprenavir, cimetidine,
ciprofloxacin, clarithromycin, clozapine, CNS
depressants, diltiazem, disulfiram, digoxin,
erythromycin, ethanol, levodopa, loxapine,
metoprolol, metronidazole, miconazole,
nefazodone, nelfinavir, omeprazole, phenytoin,
rifabutin, rifampicin, ritonavir, troleandromycin,
valproic acid & verapamil. Effect is decreased by
carbamazepine, rifampicin & rifabutin. Alcohol.
⊗
LORMETAZEPAM
 
I: Short-term management of insomnia.
CI: CNS depression; resp depression, acute
pulmonary insufficiency or sleep apnoea; severe
hepatic impairment; chronic psychosis, phobic or
obsessional states; not to be used alone to treat
depression or associated anxiety; unstable
myasthenia gravis; glaucoma. Pregnancy &
lactation, children
SP: Chronic pulmonary insufficiency; elderly or
debilitated patients; muscle weakness, impaired
liver or kidney function; personality disorders or
organic brain changes; history of alcohol or drug
addiction.
AR: Drowsiness & lightheadedness, muscle
weakness & ataxia, vertigo, headache, confusion,
depression, slurred speech, changes in libido,
tremor, visual disturbances, urinary retention, GI
disturbances, changes in salivation & amnesia.
DI: Enhanced sedation or resp & CV depression
w/ drugs w/ CNS depressant properties eg,
antidepressants, antihistamines, antipsychotics,
general anaesthetics, other hypnotics or
sedatives, opioid analgesics & alcohol.
METHYLPHENIDATE
    
I: Hyperactivity disorders. Narcolepsy.
CI: Marked anxiety, tension, agitation; glaucoma;
Tourette’s syndrome or tics. Known severe
structural cardiac abnormalities, cardiomyopathy,
serious heart rhythm abnormalities, or other
serious cardiac disorders that could increase the
risk of sudden death. Extended-release form:
Severe hypertension, heart failure, arrhythmia,
hyperthyroidism, recent MI or angina.
SP: Pregnancy & lactation. History of alcohol or
drug abuse. Hypertension & other CV disorders
that might be exacerbated by increases in BP or
heart rate. Pre-existing psychosis or bipolar
disorder; monitor for symptoms of aggression or
hostility. History of seizure disorder. Children <6
yr (growth suppression); monitor growth during
therapy. May impair ability to drive or operate
machinery. Transdermal: Avoid exposure of
application site to any direct external heat source.
AR: Angina, arrhythmia, cerebral arteritis, cerebral
Registration expired
Pink Pages_2010_Tip.pmd
50
7/4/2553, 09:28
PN DEX 2010
IMPORTANT DRUG NOTES 51
occlusion, changes in BP, MI, necrotising vasculitis,
palpitation, pulse changes, tachycardia;
depression, dizziness, drowsiness, fever,
headache, insomnia, nervousness, neuroleptic
malignant syndrome (NMS), Tourette’s syndrome,
toxic psychosis; erythema multiforme, exfoliative
dermatitis, hair loss, rash, urticaria; growth
retardation; abdominal pain, anorexia, diarrhoea,
nausea, vomiting, wt loss; anaemia, leukopenia,
thrombocytopenic purpura, thrombocytopenia;
abnormal LFTs, hepatic coma, increased
transaminases; arthralgia, dyskinesia; blurred
vision, visual accommodation disturbance; cough,
pharyngitis, sinusitis, upper resp tract infection;
accidental injury, hypersensitivity. Transdermal:
Insomnia, decreased appetite; nausea; tic,
emotional instability; vomiting, anorexia; nasal
congestion, nasopharyngitis; wt loss.
DI: May reduce effects of antihypertensive agents.
Reduced serum level w/ carbamazepine. Increased
serum levels or effects w/ CYP2D6 inhibitors e.g.
chlorpromazine, delavirdine, fluoxetine,
miconazole, paroxetine, pergolide, quinidine,
quinine, ritonavir, ropinirole. May increase serum
levels of phenytoin, TCAs. Possible severe HTN &
tachycardia w/ sibutramine. CNS depression w/
alcohol. Severe toxic reactions w/ clonidine.
Increased risk of hypertensive crisis w/ MAOIs.
respiration rate; apnoea; headache; hiccup;
nausea, increased appetite, vomiting; cough;
oversedation; seizure-like activity (paediatrics);
paradoxical reactions; kernicterus; nystagmus;
skin rash, pruritus; reduced alertness, confusion,
euphoria, hallucinations, fatigue, dizziness, ataxia,
post-op sedation, anterograde amnesia; jaundice;
cardiac arrest, heart rate changes, thrombosis;
anaphylaxis; laryngospasm, bronchospasm. Resp
depression, resp arrest; hypotension.
DI: Increased CNS depression w/ alcohol, opioids,
barbiturates, other sedatives & anaesthetics.
Increased resp depression w/ opiates,
phenobarbital, other benzodiazepines. Plasma
concentrations increased by CYP3A4 inhibitors
e.g. cimetidine, erythromycin, clarithromycin,
diltiazem, verapamil, ketoconazole & itraconazole,
antiretroviral agents, quinupristin w/ dalfopristin.
Midazolam conc decreased by phenytoin,
carbamazepine, phenobarbital, rifampicin.
Halothane, thiopental requirements may be
reduced during concurrent use.
NITRAZEPAM
 
MIDAZOLAM
 
I: Induction of anaesthesia. Premedication in
surgery. Sedation for dental & minor surgical
procedures. Sedation in critical care. Short-term
management of insomnia.
CI: Acute narrow-angle glaucoma; coma or patients
in shock; acute alcohol intoxication; intrathecal &
epidural admin. Acute pulmonary insufficiency or
marked neuromuscular resp weakness including
unstable myasthenia gravis; severe resp
depression.
SP: Paediatric patients w/ CV instability; chronic
renal failure; open-angle glaucoma; cardiac
disease; resp disease; myasthenia gravis;
neonates; history of drug or alcohol abuse; elderly
& debilitated (reduce dose); avoid prolonged use
or abrupt withdrawal; hepatic impairment; severe
fluid or electrolyte disturbances. May impair ability
to drive or operate machinery; titrate dose carefully;
monitor for early signs of hypoventilation, airway
obstruction, or apnea. Pregnancy, lactation.
AR: Physical & psychological dependence w/
withdrawal symptoms; decreased tidal vol &
I: Infantile spasms. Short-term management of
insomnia.
CI: Myasthenia gravis, narrow-angle glaucoma,
severe resp insufficiency, sleep apnoea
syndrome, severe hepatic impairment, porphyria.
SP: May induce anterograde amnesia; caution
patients to have uninterrupted sleep of 7-8 hr
after ingestion of dose. May impair ability to drive
or operate machinery. Depression, esp if suicidal
risk may be present. History of drug abuse or
acute alcoholism. Hepatic & renal impairment.
Respiratory disease. Debilitated patients. Patients
who are at risk of falls. Children, elderly. Pregnancy
& lactation.
AR: Hypotension, palpitation; agitation,
aggressiveness, amnesia, ataxia, confusion,
delusions, disorientation, dizziness, fatigue,
hallucination, hangover, headache, irritability,
nightmares, psychoses, rage, restlessness,
sedation; rash; changes in libido; constipation,
diarrhoea, excessive salivation, heartburn,
nausea, vomiting; granulocytopenia, leukopenia;
falling, muscle weakness; blurred or double vision;
tinnitus (associated w/ withdrawal); aspiration,
increased bronchial secretion, dyspnoea.
DI: CNS depressant effect increased w/ alcohol,
barbiturates, TCAs, phenothiazines, morphine
⊗
Pink Pages_2010_Tip.pmd
51
7/4/2553, 09:28
Registration expired
52
PHENTERMINE

I: Anorectic in short-term treatment of moderate
to severe obesity.
CI: Pulmonary hypertension, advanced
arteriosclerosis, moderate to severe hypertension,
hyperthyroidism, CV disease, glaucoma, history
of alcohol/drug abuse, agitated states, use during
or w/in 14 days following MAOI therapy. Lactation.
SP: Hypertension, DM, seizure disorder, Tourette’
s syndrome, patients who have used other
anorexigens w/in the past year, children. May
impair ability to drive & operate machinery. Potential
for drug dependency. Discontinue if results are
not satisfactory w/in 4 wk or tolerance develops.
History of epilepsy. Renal or hepatic disease.
Pregnancy.
AR: Urticaria, GI upsets, palpitations, tachycardia,
elevated blood pressure, overstimulation,
restlessness, insomnia, tremor, headache, dry
mouth, dizziness, dysphoria, euphoria, psychosis,
changes in libido & impotence. Primary pulmonary
HTN & valvular heart disease.
DI: Decreased excretion by antacids, carbonic
anhydrase inhibitors (e.g. acetazolamide,
dichlorphenamide, methazolamide). Excretion is
increased by urinary acidifiers. Increased risk of
adverse effects w/ other sympathomimetic agents.
There is a risk of arrhythmias when used w/ TCA.
May reduce serum concentrations of phenytoin,
phenobarbital and ethosuximide. Severe
hypertensive episodes w/ MAOI. Primary
pulmonary HTN or valvular heart disease may
occur when phentermine is used concurrently w/
fenfluramine or dexfenfluramine. Avoid concurrent
use w/ sibutramine.
PSEUDOEPHEDRINE

I: Nasal congestion.
CI: Severe hypertension, phaeochromocytoma.
SP: Hyperthyroidism; ischaemic heart disease,
arrhythmia or tachycardia; occlusive vascular
⊗
PN DEX 2010
IMPORTANT DRUG NOTES
derivatives. Effects may be antagonised by
theophylline. Increased levels/effects w/
probenecid. Reduced levels/effects w/ rifampicin.
May reduce effects of levodopa.
disorders e.g. arteriosclerosis, HTN or aneurysms;
DM & closed-angle glaucoma; renal impairment,
prostatic enlargement. Pregnancy; lactation.
AR: Anginal pain; rebound congestion &
rhinorrhoea; fear, anxiety, restlessness, tremor,
insomnia, confusion, irritability & psychotic states;
reduced appetite, nausea, vomiting; gangrene;
cerebral haemorrhage & pulmonary oedema; reflex
bradycardia, tachycardia & cardiac arrhythmias,
palpitations & cardiac arrest, hypotension &
dizziness, fainting & flushing. Tissue necrosis &
sloughing; myocardial & arterial necrosis.
DI: Increased risk of HTN & arrhythmias if given
w/ cardiac glycosides, quinidine or TCAs.
Increased risk of vasoconstrictor effects if given
w/ ergot alkaloids or oxytocin. Co-admin w/ MAOIs
may cause hypertensive crisis. Anaesthetics e.g.
cyclopropane, halothane & other halogenated
anaesthestics; antihypertensive agents.
TEMAZEPAM

I: Short-term management of insomnia.
CI: Severe hepatic impairment. Pregnancy.
SP: Chronic pulmonary insufficiency, elderly or
debilitated patients, impaired liver or kidney
function, personality disorders or organic brain
changes, history of alcohol or drug addiction,
lactation.
AR: Confusion, dizziness, drowsiness, fatigue,
headache, lethargy, hangover, euphoria, difficulty
w/ coordination, ataxia, anorexia, tremor, vomiting
& backache.
DI: Enhanced sedation, resp & CV depression w/
drugs w/ CNS depressant properties.
TRIAZOLAM

I: Short-term management of insomnia.
CI: Preexisting CNS depression or coma; resp
depression; acute pulmonary insufficiency or sleep
apnoea; myasthenia gravis; chronic psychosis,
phobic or obsessional states; may precipitate
suicide or aggressive behaviour so it should not
to be used alone to treat depression or anxiety
associated w/ depression. Porphyria. Pregnancy
& lactation. Child.
Registration expired
Pink Pages_2010_Tip.pmd
52
7/4/2553, 09:28
PN DEX 2010
IMPORTANT DRUG NOTES 53
SP: Chronic pulmonary insufficiency; elderly or
debilitated patients; sleep apnoea; muscle
weakness; impaired liver or kidney function;
drowsiness may affect skilled tasks; personality
disorders or organic brain changes; history of
alcohol or drug addiction.
AR: Drowsiness, lightheadedness, dizziness,
sedation, agitation, hallucinations, abnormal
behaviour, muscle weakness, ataxia, confusion,
slurred speech, changes in libido, urinary retention,
anterograde amnesia.
DI: Increased plasma triazolam concentrations w/
oral contraceptives, ergotamine, ciclosporin,
isoniazid, ranitidine & CYP3A inhibitors e. g. some
macrolide antibiotics, cimetidine, isoniazid,
fluvoxamine, sertraline, paroxetine, diltiazem,
verapamil, amiodarone. Additive CNS depression
w/ other CNS depressants eg, antipsychotics,
other hypnotics or sedatives, opioid analgesics &
alcohol. Increased risk of prolonged sedation w/
potent CYP3A inhibitors e.g. azole antifungal
agents, nefazodone, HIV protease inhibitors, nonnucleoside reverse transcriptase inhibitors.
ZOLPIDEM

I: Short-term management of insomnia.
CI: Severe hepatic insufficiency.
SP: Obstructive sleep apnoea, myasthenia gravis,
compromised resp function, hepatic impairment.
Caution in patients exhibiting symptoms of
depression. Patients should be warned from doing
any work involving mental alertness or motor
coordination after ingestion of the drug. Pregnancy
& lactation. Re-evaulate if insomnia fail to remit
after 7-10 days. Max duration of treatment: 4 wk
including tapering.
AR: Amnesia, drowsiness, dizziness, diarrhoea,
nausea, vomiting, abnormal thinking &
behaviour, drugged feelings, back pain, ataxia,
hiccups, confusion, euphoria, insomnia, vertigo,
diplopia, abnormal vision. Hepatitis, anaphylactic
reactions, sleep-driving (driving while not fully
awake after drug ingestion, w/ no recollection
of the event).
DI: Increased sedation & incoordination w/ TCA.
Increased sedation w/ haloperidol & alcohol. Small
increase in zolpidem conc w/ ketoconazole.
Reduced effect of hypnotic effects w/ rifampicin.
Increased risk of prolonged sedation & resp
depression w/ ritonavir.
P3 - Psychotropic substance
Schedule 3
AMOBARBITAL
           ⌫ ⌫     

I: Severe intractable insomnia.
CI: Depression; pulmonary insufficiency; sleep
apnoea; preexisting CNS depression or coma;
severe hepatic impairment. Porphyria. Pregnancy
& lactation. Elderly & debilitated patients; young
adults & child.
SP: Renal insufficiency; given to patients in pain
may provoke a paradoxical excitatory reaction,
unless an analgesic is given concomitantly; may
impair ability to drive or operate machinery.
AR: Dependence; drowsiness, sedation, ataxia;
resp depression; headache; GI disturbances; skin
reactions; confusion & memory defects;
paradoxical excitement, irritability; hypersensitivity
reactions; haematologic disorders.
DI: Sedation or resp depression may be enhanced
by drugs w/ CNS depressants; MAOIs may prolong
the CNS depressant effects & also reduce the
convulsive threshold, thereby antagonise the
anitconvulsant action of barbiturates. Others:
Fenoprofen, methadone, pethidine & opioid
analgesics; disopyramide, lidocaine & quinidine;
chloramphenicol, doxycycline; warfarin & coumarin;
antidepressants eg, bupropion, fluoxetine, lithium
& mianserin; valproate & progabide; vigabatrin,
oxcarbazepine, carbamazepine, clonazepam,
ethosuximide, lamotrigine, tiagabine & zonisamide,
griseofulvin; teniposide; metronidazole;
chlorpromazine; HIV-protease inhibitors; βblockers; calcium-channel blockers eg, nifedipine
& verapamil; digitoxin; ciclosporin; corticosteroids;
furosemide; montelukast; oral contraceptives;
theophylline; levothyroxine; flu vaccination &
vitamins. Alcohol. St. John’s wort.
PENTAZOCINE
⌦
I: Moderate to severe pain.
CI: Head injury; narcotic dependence; resp
depression; raised intracranial pressure; MI; heart
failure; arterial or pulmonary hypertension;
porphyria; pregnancy (prolonged use or high doses
at term).
⊗
Pink Pages_2010_Tip.pmd
53
7/4/2553, 09:28
Registration expired
54
IMPORTANT DRUG NOTES
SP: May precipitate withdrawal in narcotic addicts.
Impaired respiratory, renal & hepatic function;
morbidly obese patients; thyroid dysfunction;
prostatic hyperplasia or urinary stricture; biliary
tract impairment; adrenal insufficiency (including
Addison’s disease); abdominal conditions. Elderly
or debilitated patients; seizure-prone patients; child
& infants (safety & efficacy not established in <1
yr); lactation. May impair ability to drive or operate
machinery. Administer IM rather than SC (when
frequent inj are needed) & inj sites should be
varied.
AR: Physical dependence; sedation, dizziness,
euphoria, lightheadedness, alterations of mood;
resp depression; visual hallucinations,
disorientation, confusion; hypertension,
tachycardia, circulatory depression; shock;
hypotension; nausea, vomiting, constipation;
seizures, diaphoresis; rash; blood dyscrasias;
local tissue damages (SC), muscle fibrosis (IM).
Respiratory depression, hypotension, circulatory
failure, deepening coma, convulsions.
DI: Depressant affects potentiated by alcohol, CNS
depressants; concurrent use w/ fluoxetine may
lead to diaphoresis, ataxia flushing & tremor
associated w/ serotonin syndrome.
P4 - Psychotropic Substance
Schedule 4
ALPRAZOLAM
 
I: Panic attacks. Short-term management of anxiety.
CI: Acute narrow-angle glaucoma, preexisting
CNS depression or coma, resp depression, acute
pulmonary insufficiency or sleep apnoea; severe
hepatic impairment; pregnancy, lactation.
SP: Dosage reduction or gradual withdrawal.
Dependence. Geriatric or debilitated patients.
Muscle weakness, impaired hepatic or renal
function; arteriosclerosis; obesity; depression
particularly suicidal tendency; chronic pulmonary
insufficiency. May impair ability to drive or operate
machinery. Children <18 yr.
AR: Psychological & physical dependence,
withdrawal syndrome; drowsiness, sedation, vertigo,
headache, visual disturbances, GI disturbances,
jaundice; fatigue, muscle weakness, ataxia,
dizziness, confusion & depression. Blood dyscrasias.
⊗
PN DEX 2010
DI: Potentiates action of alcohol & CNS
depressants. Reduced conc w/ cigarette smoking
by 50%. Cimetidine & fluoxetine reduce the
clearance of alprazolam. Alprazolam enhances
activity of imipramine & desipramine.
BROMAZEPAM

I: Anxiety.
CI: Preexisting CNS depression or coma, resp
depression, acute pulmonary insufficiency or sleep
apnea; severe hepatic impairment; not indicated
for chronic psychosis, phobic or obsessional
states; may precipitate suicide or aggressive
behavior, not used alone to treat depression or
anxiety associated w/ depression; glaucoma.
SP: Chronic pulmonary insufficiency; elderly or
debilitated patients; muscle weakness, impaired
liver or kidney function; drowsiness may affect
skilled tasks; monitor cardio-respiratory function
when used for deep sedation; patients w/
personality disorders or organic brain changes;
pregnancy & lactation; history of alcohol or drug
addiction due to risk of dependence; resp
depression & hypotension w/ parenteral
administration, therefore this route should only be
used when facilities for reversing resp depression
are available.
AR: Drowsiness, sedation, muscle weakness &
ataxia; less frequently vertigo, headache,
confusion, depression, slurred speech, changes
in libido, tremor, visual disturbances, urinary
retention, GI disturbances, changes in salivation
& amnesia; rarely, jaundice, blood disorders &
hypersensitivity reactions; pain & thrombophlebitis;
raised liver enzyme values; paradoxical excitation.
DI: Enhanced sedation or resp & CV depression
w/ drugs w/ CNS depressant properties eg,
antidepressants, antihistamines, antipsychotics,
general anesthetics, other hypnotics or sedatives,
opioid analgesics & cisapride. Alcohol. Drugs which
alter the hepatic microsomal enzymes.
CHLORDIAZEPOXIDE

I: Acute anxiety. Acute symptoms of alcohol
withdrawal. Anxiety. Insomnia. Muscle spasms.
Premedication before anaesthesia. Severe
Registration expired
Pink Pages_2010_Tip.pmd
54
7/4/2553, 09:28
PN DEX 2010
IMPORTANT DRUG NOTES 55
symptoms of alcohol withdrawal.
CI: Acute pulmonary insufficiency, resp depression,
patients w/ marked neuromuscular resp weakness;
hypersensitivity to benzodiazepines; chronic
psychosis; porphyria; pregnancy & lactation.
SP: Alcohol; sedation, dependence. Elderly &
debilitated patients. Liver or kidney dysfunction.
Avoid prolonged usage.
AR: Physical & psychological dependence;
withdrawal syndrome; impairs psychomotor
performance, aggression (in predisposed individuals
esp in combination w/ alcohol); sedation; blood
dyscrasias, jaundice, hepatic dysfunction. May rarely
cause hypoplastic or haemolytic anaemia.
DI: Cimetidine increases serum conc of
chlordiazepoxide. Potentiates action of major
neuroleptics. Alcohol potentiates CNS-depressant
effect of chlordiazepoxide.
CLOBAZAM
 
I: Adjunct in epilepsy. Short-term management of
anxiety.
CI: Hypersensitivity; history of drug dependence;
myasthaenia gravis; pregnancy (1 st trimester),
lactation; serious liver damage; sleep apnoea
syndrome; impaired resp function.
SP: May impair ability to perform skilled tasks &
hazardous activities; elderly; renal or hepatic
impairment; alcoholics; obesity; withdrawal should
be gradual.
AR: Constipation, anorexia, nausea; dizziness,
fine tremors; worsening of resp symptoms in
predisposed individuals; ataxia, drowsiness,
headache, confusion; loss of libido, motor
dysfunction; dependence; visual disturbances &
wt gain. Respiratory depression.
DI: Increased hepatic clearance of clobazam
when administered w/ phenytoin, phenobarbital
or carbamazepine. Cimetidine may increase levels
of clobazam. Concurrent alcohol, hypnotics &
sedative antidepressants can potentiate CNS side
effects of clobazam.
CLONAZEPAM
 
I: Emergency management of status epilepticus.
Epilepsy. Panic disorder.
CI: Hypersensitivity to benzodiazepines, acute
pulmonary insufficiency, acute narrow angle
glaucoma.
SP: Neonates, chronic pulmonary insufficiency,
hepatic/renal dysfunction, porphyria, elderly;
pregnancy & lactation.
AR: Drowsiness, fatigue, muscular hypotonia,
coordination disturbances, dizziness, vertigo,
anorexia, visual disturbances, libido changes.
Salivary or bronchial hypersecretion leading to resp
problems (children). May produce diminished
reflexes or coma. Rarely, blood dyscrasias.
DI: Carbamazepine, phenobarbitone or phenytoin
may accelerate clonazepam metabolism.
Increased sedative effect w/ alcohol, general
anaesthetics & TCAs.
CLORAZEPATE

I: Alcohol withdrawal syndrome. Anxiety. Epilepsy.
CI: Hypersensitivity (cross-sensitivity w/ other
benzodiazepines may occur); narrow-angle
glaucoma. Patients w/ depressive or psychotic
disorders. child <9 yr. Pregnancy; lactation.
SP: Elderly, debilitated patients; hepatic disease,
alcoholics; renal impairment; resp disease;
impaired gag reflex; patients experiencing apnoea
during sleep; operating machines or driving;
patients on CNS depressant or psychoactive drug
therapy; depression, esp those w/ suicidal
tendencies; history of drug-dependence.
AR: Jaundice, hepatic necrosis; extrapyramidal
disorders; acute attacks of porphyria in porphyric
patients, hypotension; drowsiness, fatigue, ataxia,
lightheadedness, memory impairment, insomnia,
anxiety, headache, depression, slurred speech,
confusion, nervousness, dizziness, irritability; rash;
decreased libido; xerostomia, constipation,
diarrhoea, decreased salivation, nausea, vomiting,
increased or decreased appetite; dysarthria,
tremor; blurred vision, diplopia.
DI: Potentiates CNS effects of narcotic analgesics,
barbiturates,
phenothiazines,
ethanol,
antihistamines, MAO Inhibitors, sedativehypnotics, cyclic antidepressants. CYP3A4
inhibitors eg, amprenavir, cimetidine, ciprofloxacin,
clarithromycin may increase serum conc & toxicity
of clorazepate. Carbamazepine, rifampin & rifabutin
may decrease clorazepate therapeutic effects by
enhancement of clorazepate metabolism.
⊗
Pink Pages_2010_Tip.pmd
55
7/4/2553, 09:28
Registration expired
56
PN DEX 2010
IMPORTANT DRUG NOTES
⊗
DIAZEPAM
ETHYL LOFLAZEPATE
 

I: Adjunct in the management of seizures. Alcohol
withdrawal syndrome. Insomnia associated w/
anxiety. Muscle spasms. Premedication before
anaesthesia. Sedation in minor surgical & medical
procedures. Severe anxiety.
CI: Hypersensitivity; myasthenia gravis,
preexisting CNS depression or coma, resp
depression; acute pulmonary insufficiency or sleep
apnoea syndrome; severe hepatic impairment;
acute narrow angle glaucoma; child <6 mth (oral);
pregnancy & lactation.
I: Short-term management of anxiety.
SP: Impaired renal & hepatic function, resp
disease, organic cerebral changes, elderly,
psychotic patients, epileptics, history of alcohol
or drug addiction, impaired gag reflex, obese
patients. May cause CNS depression. Discontinue
treatment if patient develops psychiatric &
paradoxical reactions. Caution when used in
patients w/ depression or anxiety associated w/
depression, esp if patient has suicidal risk. May
increase risk of falls. Safety & efficacy of the inj
have not been established in child <1 mth of age.
Safety & efficacy of oral use have not been
established in child <6 mth of age. Safety &
efficacy of rectal gel have not been established
in child <2 yr of age. Abrupt withdrawal or large
dose reduction may cause rebound or withdrawal
symptoms.
AR: Psychological & physical dependence w/
withdrawal syndrome, fatigue, drowsiness,
sedation, ataxia, vertigo, confusion, depression,
GI disturbances, changes in salivation, amnesia,
jaundice, paradoxical excitation, elevated liver
enzyme values; muscle weakness, visual
disturbances, headache, slurring of speech &
dysarthria, mental changes, incontinence,
constipation, hypotension, tachycardia, changes
in libido, pain & thrombophlebitis at inj site (IV).
Respiratory & CNS depression, coma.
DI: Increased clearance of diazepam when used
w/ phenytoin, carbamazepine & phenobarbital.
Reversible deterioration of parkinsonism may occur
when given together w/ levodopa. Combination
w/ lithium may produce hypothermia. May need to
reduce dose of narcotics when used concurrently.
Phenothiazines, barbiturates, MAOIs potentiate
action of diazepam. Additive CNS depressant
effects w/ alcohol & CNS depressants or
psychoactive medications. Mutual potentiation of
action w/ analgesics, anaesthetics & some
anticonvulsants.
⊗
CI: Preexisting CNS depression or coma, resp
depression, acute pulmonary insufficiency or sleep
apnoea; severe hepatic impairment; not indicated
for chronic psychosis, phobic or obsessional states;
may precipitate suicide or aggressive behaviour,
not used alone to treat depression or anxiety
associated w/ depression; glaucoma.
SP: Chronic pulmonary insufficiency; elderly or
debilitated patients; muscle weakness, impaired
liver or kidney function; drowsiness may affect
skilled tasks; monitor cardio-respiratory function
when used for deep sedation; patients w/
personality disorders or organic brain changes;
pregnancy, lactation; history of alcohol or drug
addiction due to risk of dependence. Resp
depression & hypotension may occur w/ parenteral
admin.
AR: Drowsiness, sedation, muscle weakness &
ataxia; less frequently vertigo, headache,
confusion, depression, slurred speech, changes
in libido, tremor, visual disturbances, urinary
retention, GI disturbances, changes in salivation
& amnesia; rarely, jaundice, blood disorders &
hypersensitivity reactions; pain & thrombophlebitis;
raised liver enzyme values; paradoxical excitation.
DI: Enhanced sedation or resp & CV depression
w/ drugs that have CNS depressant properties e.g.
antidepressants, antihistamines, antipsychotics,
general anesthetics, other hypnotics or sedatives,
opioid analgesics & cisapride. Drugs which alter
the hepatic microsomal enzymes.
LORAZEPAM

I: Acute anxiety. Anxiety. Insomnia associated w/
anxiety. Premedication in surgery. Prophylaxis of
nausea & vomiting associated w/ cytotoxic therapy.
Sedation in critical care. Status epilepticus.
CI: Severe hepatic impairment; resp depression;
acute narrow-angle glaucoma; pregnancy & lactation.
SP: Hepatic & renal dysfunction; pulmonary
insufficiency; myasthenia gravis; may impair ability
to drive or operate machinery; elderly or debilitated
patients.
Registration expired
Pink Pages_2010_Tip.pmd
56
7/4/2553, 09:28
PN DEX 2010
IMPORTANT DRUG NOTES 57
AR: Drowsiness, headache, dizziness, confusion;
blurred vision; nausea; weakness; unsteadiness.
Resp depression.
DI: Potentiation of CNS depression produced by
alcohol; general anaesthetics; narcotic analgesics;
TCAs; MAOIs; phenothiazines; antipsychotics;
barbiturates; scopolamine.
MEDAZEPAM

I: Short-term management of anxiety.
CI: Glaucoma.
SP: Severe hepatic impairment. Elderly or
debilitated patients; muscle weakness or
myasthenia gravis; impaired liver or kidney function;
predisposition to seizures; depression; severe resp
dysfunction; sleep apnoea; movement disorders;
drowsiness may affect skilled tasks; history of
alcohol or drug addiction. Treatment withdrawal
should be gradual. Avoid long-term use. Pregnancy
& lactation.
AR: Fatigue, drowsiness, dizziness, prolonged
reaction time, headache, coordination disorders
(ataxia), confusion, anterograde amnesia. Rarely,
GI symptoms, laryngeal spasm, chest pain,
hypotension, bradycardia, depression, decreased
libido, increased appetite, dry mouth, muscle
weakness, resp failure.
DI: Additive CNS depression or sedative effects
w/ drugs that have CNS depressant properties e.g.
alcohol, antidepressants, sedating antihistamines,
antipsychotics, general anaesthetics, other
hypnotics or sedatives, opioid analgesics,
cisapride. Increased risk of toxicity w/ hepatic
microsomal enzyme inhibitors.
function. Patients w/ acute pain & depressive
disorders. May impair ability to drive or operate
machinery. Lactation.
AR: Bradycardia, hypotension, syncope;
drowsiness, lethargy, CNS excitation or
depression, impaired judgment, hangover effect,
confusion, somnolence, agitation, hyperkinesia,
ataxia, nervousness, headache, insomnia,
nightmares, hallucinations, anxiety, dizziness;
rash, exfoliative dermatitis; nausea, vomiting,
constipation; agranulocytosis, thrombocytopenia,
megaloblastic anaemia; pain at inj site,
thrombophlebitis (IV); oliguria: laryngospasm, resp
depression, apnoea (especially w/ rapid IV admin),
hypoventilation. Stevens-Johnson syndrome.
DI: May enhance the hepatotoxic potential of
paracetemaol overdoses. May decrease levels/
effects of various CYP isoenzyme substrates e.g.
teniposide, methotrexate, antipsychotics,
b-blockers, calcium-channel blockers, other
anticonvulsants, chloramphenicol, cimetidine,
corticosteroids, ciclosporin, doxycycline,
oestrogens, felbamate, griseofulvin, tacrolimus,
furosemide, methadone, oral contraceptives,
theophylline, TCAs, warfarin. May reduce effects
of guanfacine. Reduced metabolism & or increased
toxicity w/ chloramphenicol, felbamate, MAOIs,
valproic acid. May enhance the nephrotoxic effects
of methoxyflurane. Additive sedation and/or resp
depression w/ ethanol, sedatives, antidepressants,
opioid analgesics, benzodiazepines & other CNS
depressants. May decrease levels/effects of
antiarrhythmic drugs e.g. disopyramide,
propafenone, quinidine.
PINAZEPAM
 
PHENOBARBITAL
   
 
I: Emergency management of acute seizures.
Generalised tonic-clonic seizures. Hypnotic. Partial
seizures. Preoperative sedation. Sedation. Status
epilepticus.
CI: Severe renal & hepatic disorders. Severe resp
depression, dyspnoea or airway obstruction;
porphyria. Pregnancy.
SP: Elderly or debilitated patients, children.
Withdraw gradually. Impaired renal, hepatic & resp
I: Insomnia associated w/ anxiety. Short-term
management of anxiety.
CI: Preexisting CNS depression or coma, resp
depression, acute pulmonary insufficiency,
myasthenia gravis, sleep apnoea, severe hepatic
impairment; not indicated for chronic psychosis,
phobic or obsessional states; glaucoma.
SP: Chronic pulmonary insufficiency; elderly or
debilitated patients; muscle weakness, impaired
liver or kidney function; drowsiness may affect
skilled tasks; monitor cardio-respiratory function
when used for deep sedation; patients w/
personality disorders or organic brain changes;
pregnancy, lactation; history of alcohol or drug
addiction, hypotension & apnoea w/ IV admin,
therefore this route should only be used when
⊗
Pink Pages_2010_Tip.pmd
57
7/4/2553, 09:28
Registration expired
58
IMPORTANT DRUG NOTES
facilities for reversing resp depression are available.
Monitor for signs of suicidal tendency or aggressive
behavior; not to be used alone to treat depression
or anxiety associated w/ depression.
AR: Drowsiness, sedation, muscle weakness &
ataxia; less frequently vertigo, headache,
confusion, depression, slurred speech, changes
in libido, tremor, visual disturbances, urinary
retention, GI disturbances, changes in salivation
& amnesia; rarely, jaundice, blood disorders &
hypersensitivity
reactions;
pain
&
thrombophloebitis; raised liver enzyme values;
paradoxical excitation.
DI: Enhanced sedation or resp & CV depression
w/ drugs w/ CNS depressant properties e.g.
alcohol, antidepressants, antihistamines,
antipsychotics, general anaesthetics, other
hypnotics or sedatives, opioid analgesics &
cisapride.
PN DEX 2010
general anaesthetics, other hypnotics or sedatives,
opioid analgesics & cisapride. Decreased serum
levels when used w/ phenytoin. May increase the
plasma levels of bupivacaine. Serum levels may be
increased by valproate & modafinil.
TOFISOPAM

I: Alcohol withdrawal syndrome. Short-term
management of anxiety.
CI: Aggressive-impulsive psychopathy. Pregnancy.
SP: Discontinue if sleep disturbances occur. Avoid
sleep disturbances by taking last dose earlier (e.g.
before 5 pm).
AR: Nausea, rash, epigastric pain, itching, extreme
liveliness, hyperactivity, aggressiveness.
PRAZEPAM

N2 - Narcotic Drug Schedule 2
I: Short-term management of anxiety.
CI: Preexisting CNS depression or coma, resp
depression, acute pulmonary insufficiency or sleep
apnoea; severe hepatic impairment; chronic
psychosis, phobic or obsessional states; glaucoma;
porphyria. Myasthenia gravis.
SP: Chronic pulmonary insufficiency; elderly or
debilitated patients; muscle weakness, impaired liver
or kidney function; drowsiness may affect skilled
tasks; monitor cardio-respiratory function when used
for deep sedation; patients w/ personality disorders
or organic brain changes; pregnancy & lactation;
history of alcohol or drug addiction due to risk of
depression. resp depression & hypotension w/
parenteral admin, therefore this route should only
be used when facilities for reversing resp depression
are available. May precipitate suicide or aggressive
behavior, not used alone to treat depression or
anxiety associated w/ depression.
AR: Drowsiness, sedation, muscle weakness &
ataxia; less frequently vertigo, headache, confusion,
depression, slurred speech, changes in libido,
tremor, visual disturbances, urinary retention, GI
disturbances, changes in salivation & amnesia;
rarely, jaundice, blood disorders & hypersensitivity
reactions; pain & thrombophloebitis; raised liver
enzyme values; paradoxical excitation.
DI: Enhanced sedation or resp & CV depression w/
alcohol, drugs w/ CNS depressant properties eg,
antidepressants, antihistamines, antipsychotics,
⊗
CODEINE (ANALGESIC)
⌦
I: Mild to moderate pain.
CI: Resp depression, obstructive airway disease,
asthma. Acute alcoholism, convulsive disorders,
head injuries, comatose patients, raised
intracranial pressure. Pregnancy (prolonged use
or high doses at term).
SP: Hypothyroidism, adrenocortical insufficiency;
asthma, impaired hepatic or renal function,
prostatic hyperplasia, hypotension, shock,
inflammatory or obstructive bowel disorders,
myasthenia gravis. Infants, neonates; Reduce dose
in elderly or debilitated patients. May impair ability
to drive or operate machinery. Lactation.
AR: Dependence, withdrawal symptoms; nausea,
vomiting, constipation; drowsiness, confusion;
difficulty in micturition, ureteric or biliary spasms,
urinary retention; dry mouth, dizziness, sweating,
facial flushing, headache, vertigo, bradycardia,
tachycardia, palpitations, orthostatic hypotension,
hypothermia, restlessness, mood changes,
decreased libido or potency, hallucination, miosis;
raised intracranial pressure, muscle rigidity. Resp
depression & hypotension, w/ circulatory failure
& deepening coma (larger doses). Convulsions
(especially in child & infants). Rhabdomyolysis.
Registration expired
Pink Pages_2010_Tip.pmd
58
7/4/2553, 09:28
PN DEX 2010
IMPORTANT DRUG NOTES 59
DI: Enhanced depressant effects w/ alcohol,
anaesthetics, anxiolytics, hypnotics, TCAs,
antipsychotics. Possible CNS depression or
excitation w/ MAOIs. May alter effects of other
compounds e.g. cyclizine, mexiletine, cisapride,
metoclopramide & domperidone.
METHADONE
⌫ 
⌫ ⌫  
I: Analgesia. Intractable cough associated w/ lung
cancer. Neonatal abstinence syndrome. Opioid
dependence.
FENTANYL
⌫ 
 
I: Adjunct to general anaesthesia. Breakthrough
cancer pain. Intractable chronic pain. Premedication
before anaesthesia.
CI: Hypersensitivity.
SP: Myasthaenia gravis. Head injury; increased
intracranial pressure; intracranial lesions; renal or
hepatic impairment; neonates; opioid-nontolerant
patients. Increased risk of resp depression in
elderly, debilitated patients, patient w/ hypoxia or
hypercapnia.
Hypothyroidism,
prostatic
hyperplasia, inflammatory bowel disorders,
bradycardia or bradyarrhythmias. Rapid IV infusion
may cause skeletal muscle & chest wall rigidity,
impaired ventilation or resp distress/arrest.
Prolonged use may cause tolerance, psychological
& physical dependence. Abrupt withdrawal after
prolonged admin may lead to withdrawal
symptoms. Lactation. Pregnancy (avoid high doses
or prolonged usage).
AR: Nausea, vomiting; bradycardia, oedema, CNS
depression, confusion, dizziness,drowsiness,
headache, sedation, transient hypotension,
peripheral vasodilation; increased intracranial
pressure. High IV dose may cause chest wall
rigidity. Transdermal: Rash, erythema & itching.
Respiratory depression, trunk rigidity,
laryngospasm, bronchoconstriction.
DI: Depressant effects may be enhanced by other
CNS depressants e.g. alcohol, anaesthetics,
anxiolytics, hypnotics, TCAs & antipsychotics.
Ammonium Cl may increase excretion of fentanyl.
Phenothiazines may increase hypotensive effect
of opioid analgesics. Serum levels may be
increased by CYP3A4 inhibitors (e.g. azole
antifungals, clarithromycin, diclofenac, doxycycline,
erythromycin, imatinib, isoniazid, nefazodone,
nicardipine, propofol, protease inhibitors, quinidine,
telithromycin & verapamil). May reduce the efficacy
of pegvisomant. Serum levels may be reduced by
rifamycin derivatives. May increase serotonergic
effect of SSRIs & sibutramine.
CI: Acute resp depression; acute bronchial asthma;
acute alcoholism; risk of paralytic ileus; raised
intracranial pressure or head injury.
SP: Dose should be individualised. Prolonged QT
interval; CV disease; hepatic impairment;
electrolyte abnormalities; concommitant use of QT
prolonging drug; resp disease; elderly. May impair
ability to drive or operate machinery.
AR: Nausea; vomiting; constipation; anorexia;
abdominal pain; drowsiness; resp depression;
hypotension; bradycardia; euphoria; headache;
dysphoria; urinary retention; miosis; visual
disturbances; impotence; dizziness; sweating;
pruritis; asthenia; arrythmias; QT prolongation.
Cardiac arrest; resp arrest; shock.
DI: Withdrawal symptoms may be experienced w/
naloxone, naltrexone, pentazocine, nalbuphine,
butorphanol, & buprenorphine. Increased
clearance & possible reduced efficacy w/ some
antiretrovirals (abacavir, amprenavir, efavirenz,
nelfinavir, nevirapine, ritonavir, lopinavir); rifampin;
phenytoin; phenobarbital; carbamazepine.
Decreased clearance & possibly increased toxicity
w/ CYP3A4 inhibitors (e.g. ketoconazole,
voriconazole, sertraline, fluvoxamine). Increased
chance of cardiac toxicity w/ other QT prolonging
drugs. Increased CNS depression w/ alcohol, other
opioids or CNS depressants. Methadone may
increase plasma levels of desipramine, zidovudine.
MORPHINE
⌦
I: Acute pain. Acute pulmonary oedema. Analgesia
during labour. Chronic pain. Intractable cough
associated w/ lung cancer. Moderate to severe
pain. Pain associated w/ myocardial infarction. Pain
relief. Premedication in surgery. Unstable angina
not responsive to anti-ischaemic therapy.
CI: Respiratory depression, acute or severe
asthma; paralytic ileus; obstructive airway disease;
acute liver disease; comatose patients; increased
intracranial pressure; acute alcoholism. Pulmonary
⊗
Pink Pages_2010_Tip.pmd
59
7/4/2553, 09:28
Registration expired
60
IMPORTANT DRUG NOTES
PN DEX 2010
oedema resulting from a chemical resp irritant.
SP: Elderly; hypothyroidism; renal & liver disease;
head injury, intracranial lesions; hypotension,
circulatory shock; adrenocortical insufficiency;
asthma; prostatic hyperplasia; inflammatory or
obstructive bowel disease; myasthaenia gravis;
infants <3 mth; pregnancy, lactation; hypovolaemia,
biliary tract disorders.
AR: Convulsions; nausea, vomiting, dry mouth,
constipation; urinary retention; headache, vertigo;
palpitations; hypothermia; pruritus, urticaria;
tachycardia, bradycardia; blurred vision; miosis;
dependency; drowsiness; lightheadedness;
dizziness; sweating; dysphoria; euphoria.
Respiratory depression; circulatory failure;
hypotension; deepening coma; anaphylactic
reactions.
DI: May potentiate effects of TCAs; increased risk
of serotonin syndrome w/ serotonergic drugs; risk
of cardiac arrythmias w/ QT prolonging drugs;
sedative effects may be increased by
metoclopramide; antagonises efficacy of diuretics;
morphine levels decreased by rifampicin.
Increased CNS depression w/ other CNS
depressants (e.g. other opioids, general
anaesthetics, benzodiazepines, barbiturates),
alcohol. Risk of severe hypotension w/ MAOIs.
nausea, vomiting, constipation, anorexia, stomach
cramps, xerostomia, biliary spasm, paralytic ileus,
sphincter of Oddi spasm; ureteral spasms,
decreased urination; pain at inj site; weakness;
dyspnoea; histamine release, physical &
psychological dependence.
DI: Increased pethidine metabolite levels w/
aciclovir, cimetidine, ritonavir. Reduced analgesic
effects w/ phenytoin, barbiturates. Additive sedative
and/or resp depressive effects w/ alcohol,
barbiturates, benzodiazepines, phenothiazines,
TCAs, other CNS depressants. Increased risk of
serotonin syndrome w/ MAOIs (not be given
concurrently or w/in 14 days of their
discontinuation), serotonin agonists, serotonin
reuptake inhibitors, sibutramine, TCAs.
PETHIDINE
I: Cough suppressant. Mild to moderate pain.
CI: Resp depression, obstructive airway disease,
asthma. Acute alcoholism, convulsive disorders,
head injuries, comatose patients, raised
intracranial pressure. Pregnancy (prolonged use
or high doses at term).
SP: Hypothyroidism, adrenocortical insufficiency;
asthma, impaired hepatic or renal function,
prostatic hyperplasia, hypotension, shock,
inflammatory or obstructive bowel disorders,
myasthenia gravis. Infants, neonates; Reduce dose
in elderly or debilitated patients. May impair ability
to drive or operate machinery. Lactation.
AR: Dependence, withdrawal symptoms; nausea,
vomiting, constipation; drowsiness, confusion;
difficulty in micturition, ureteric or biliary spasms,
urinary retention; dry mouth, dizziness, sweating,
facial flushing, headache, vertigo, bradycardia,
tachycardia, palpitations, orthostatic hypotension,
hypothermia, restlessness, mood changes,
decreased libido or potency, hallucination, miosis;
raised intracranial pressure, muscle rigidity. Resp
depression & hypotension, w/ circulatory failure &
deepening coma (larger doses). Convulsions
(especially in child & infants). Rhabdomyolysis.
DI: Enhanced depressant effects w/ alcohol,
anaesthetics, anxiolytics, hypnotics, TCAs,
⌦

I: Adjunct to anaesthesia. Moderate to severe acute
pain. Obstetric analgesia. Postoperative pain.
Preoperative medication.
SP: May impair ability to drive or operate
machinery. Hypovolaemia, CV disease; adrenal
insufficiency; biliary tract disorder; CNS depression
or coma; history of drug abuse or acute alcoholism;
head injury, intracranial lesions, elevated
intracranial pressure; hepatic or renal impairment;
morbidly obese; prostatic hyperplasia; toxic
psychoses; pre-existing resp compromise (hypoxia
and/or hypercapnia), COPD or other obstructive
airway disease; sickle-cell disease; supraventricular
tachycardia; thyroid dysfunction. Elderly & debilitated
patients. Withdraw gradually. Pregnancy (avoid
prolonged use or high doses at term) & lactation.
AR: Hypotension; fatigue, drowsiness, dizziness,
nervousness, headache, restlessness, malaise,
confusion, depression, hallucinations, tremors,
muscle twitches, increased intracranial pressure,
seizure, serotonin syndrome; rash, urticaria;
⊗
N3 - Narcotic Drug Schedule 3
CODEINE
(ANTITUSSIVE/ANALGESIC)

⌦
Registration expired
Pink Pages_2010_Tip.pmd
60
7/4/2553, 09:28
PN DEX 2010
IMPORTANT DRUG NOTES 61
antipsychotics. Possible CNS depression or
excitation w/ MAOIs. May alter effects of other
compounds e.g. cyclizine, mexiletine, cisapride,
metoclopramide & domperidone.
⊗
DEXTROPROPOXYPHENE
⌦
I: Mild to moderate pain.
CI: Hypersensitivity, chronic resp diseases,
porphyria, pregnancy. Patients on MAOI treatment
or w/in 2 wk of stopping treatment.
SP: Suicidal patients, hepatic or renal disease;
lactation, elderly.
AR: Dizziness, sedation, weakness; nausea,
vomiting, constipation; rash, urticaria; visual
disturbances; physiological dependence.
Convulsions in long-term therapy. Cardiac
conduction abnormalities & arrhythmias; liver
impairment.
DI: Inhibits hepatic metabolism of benzodiazepines, b-blockers, carbamazepine, phenytoin
& warfarin. Increased risk of toxicity when coadministered w/ ritonavir. Potentiation of
depressant effects when used w/ alcohol or CNS
depressants. Accidental or intentional overdosage
fatal (especially if combined w/ alcohol, &
analgesics e.g. paracetamol & aspirin).
OPIUM TINCTURE /
CAMPORATED OPIUM TINCTURE

I: Cough suppressant.
CI: Severe hepatic & renal diseases; raised
intracranial pressure; acute resp depression or
obstructive airways disease; comatose patients;
prolonged use or high dosages near term.
SP: Hepatic or renal diseases; head injury, CNS
depression, history of opioid agonist dependence;
biliary tract or acute abdominal disorders; Addison’
s disease; obesity; urinary difficulties; resp
disease; thyroid disease; infants<3 mths,
debilitated patients & elderly; pregnancy.
AR: CNS depression, hypotension, drowsiness &
palpitation, bradycardia; sweating, flushing,
pruritis; malaise; urinary tract spasm & reduction
in urination; constipation; miosis. Severe resp
depression; increased intracranial pressure.
DI: Increased CNS depression w/ alcohol, other
opiate agonists, general anesthetics, tranquillizers,
sedatives & hypnotics. However, some
tranquillizers e.g. phenothiazines may antagonize
the effect of opiate analgesia; opium prep may
increase the effect of TCA & MAOIs. Reduced
effectiveness of diuretics in patients w/ CHF.
Should not be given to patients bitten by
Centruroides sculpturatus, Ewing & C. gertschi
Stahnke scorpions as opiate agonist may potentiate
the effect of the venoms. May cause serotonin
syndrome if used w/ MAOIs.
DIPHENOXYLATE
⌫⌫
 ⌫
I: Acute diarrhoea. Chronic diarrhoea.
CI: Infants & child <4 yr. Jaundice, intestinal
obstruction.
Diarrhoea
associated
w/
pseudomembranous colitis or enterotoxinproducing bacteria.
SP: Hepatic dysfunction, inflammatory bowel
disease. Pregnancy, lactation; young children.
AR: GI effects; headache, drowsiness, dizziness,
restlessness, euphoria, depression, numbness of
the extremities; hypersensitivity reactions,
swelling of the gums.
DI: Potentiates effects of other CNS depressants
(alcohol, barbiturates) & some anxiolytics.
Theoretical hypertensive crisis w/ MAOIs.
⊗
Pink Pages_2010_Tip.pmd
61
7/4/2553, 13:01
Registration expired
Color profile: Disabled
Composite 150 lpi at 45 degrees
CONTROLLED SUBSTANCE CLASS
´Ñª¹ÕàÀÊѪÀѳ±ì¨Ñ´àÃÕ§µÒÁ¡ÅØèÁ/»ÃÐàÀ·¢Í§·ÐàºÕ¹
Ketamine HCl
P2
Calypsol 50 mg/mL x 10 mL
Keta-Hameln
50 mg/mL x 10 mL
Ketalar 50 mg/mL x 10 mL
Buprenorphine HCl
002
007
Buprine 0.2 mg
Temgesic 0.2 mg
Temgesic
0.3 mg/mL x 1 mL
619
D-Norpseudoephedrine
HCl
Lormetazepam
Loramet 1 mg
Methylphenidate HCl
Concerta 18 mg
504 Concerta 36 mg
Methylphenidate
Hexal 10 mg
Ritalin 10 mg
D-Norpseudoephedrine Rubifen 10 mg
Mirapront N 20 mg
Resinate
D-Norpseudoephedrine SR
Osmopharm 20 mg
Diethylpropion HCl
Dietil Retard 75 mg
Prefamone 75 mg
Regenon Retard 75 mg
Regenon Retard 75 mg
505
Atractil 75 mg
Dormicum
5 mg/mL x 1 mL
Dormicum 15 mg
084 Dormicum
15 mg/3 mL x 3 mL
174
115
486
Alodorm 5 mg
Resinate Mogadon 5 mg
497 Nitrados 5 mg
Ephedrine GPO
30 mg/mL x 1 mL
Panbesy 15 mg
604 Panbesy 30 mg
Phentermine
Osmopharm 15 mg
Flunitrazepam
Rohypnol 1 mg
Flurazepam
Dalmadorm 15 mg
†
621 Temazepam
351 Euhypnos 20 20 mg
394
047
135
184
136
045
518
523
547
398
622
Triazolam
Halcion 0.25 mg
078 Trialam 0.25 mg
081 Trycam 0.25 mg
062
350
168
348
Zolpidem Tartrate
Phentermine HCl
Ephedrine HCl
143
Midazolam
Nitrazepam
Diethylpropion
Pseudoephedrine HCl
641 Pseudoephedrine
Asian Pharm 30 mg
642 Pseudoephedrine
Asian Pharm 60 mg
643
Pseudoephedrine
BJ Benjaosoth 60 mg
Pseudoephedrine
Medicine Products 60 mg
102 Pseudoephedrine
Milano 30 mg
Pseudoephedrine
Milano 60 mg
Pseudoephedrine Syrup
169
Asian Pharm
114
30 mg/5 mL x 60 mL
Pseudoephedrine Syrup
117
BJ Benjaosoth
041
30 mg/5 mL x 60 mL
038 Pseudoephedrine Syrup
Milano 30 mg/5 mL x 60 mL
425
461
110
Stilnox 10 mg
451
P3
Phentermine Resinate
Duromine 15 mg
Duromine 30 mg
Phentermine Trenker 15 mg
478 Phentermine Trenker 30 mg
Indicates brands that contain more than 1 ingredient
C:\ANNUALS\PNDEX\PIC Index\ControlSubstanceClass_Index.vp
Monday, April 05, 2010 1:45:06 PM
499
488
466 Amobarbital
424 Ama† 50 mg
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
144
Color profile: Disabled
Composite 150 lpi at 45 degrees
PN DEX 2010
Pangon
30 mg/mL x 1 mL
Sosegon
30 mg/mL x 1 mL
Pentobarbital Na
Nembutal
50 mg/mL x 20 mL
P4
Prazol 0.5 mg
Siampraxol 0.25 mg
607 Siampraxol 0.5 mg
Xanacine 0.25 mg
624 Xanacine 0.5 mg
Xanacine 1 mg
Xanax 0.25 mg
Xanax 0.5 mg
Xanax 1 mg
Xanax XR 0.5 mg
639 Xanax XR 1 mg
Xanax XR 2 mg
Xiemed 0.25 mg
Xiemed 0.5 mg
Xiemed 1 mg
Zolam 0.25 mg
Zolam 0.5 mg
Zolam 1 mg
Alprazolam
Alcelam 0.25 mg
Alcelam 0.5 mg
Alcelam 1 mg
Allam 0.25 mg
Allam 0.5 mg
Allam 1 mg
Alpralan 0.25 mg
Alpralan 0.5 mg
Alpramed 0.25 mg
Alpramed 0.5 mg
Alpramed 1 mg
Alprax 0.25 mg
Alprazolam Frx 0.5 mg
Anax 0.25 mg
Anax 0.5 mg
Anpress 0.25 mg
Anpress 0.5 mg
Anpress 1 mg
Dizolam 0.25 mg
Dizolam 0.5 mg
Dizolam 1 mg
Inzolam 0.25 mg
Inzolam 0.5 mg
Inzolam 1 mg
Manex 0.25 mg
Manex 0.5 mg
Manex 1 mg
Marzolam 0.25 mg
Marzolam 0.5 mg
Marzolam 1 mg
Mitranax 0.25 mg
Mitranax 0.5 mg
Mitranax 1 mg
Moxinax 0.25 mg
Moxinax 0.5 mg
Pharnax 0.25 mg
Pharnax 0.5 mg
Pharnax 1 mg
097
241
288
103
250
293
042
214
252
105
393
156
256
085
230
088
248
282
089
233
297
104
251
294
099
244
291
090
235
283
106
253
295
094
238
101
247
292
Bromazepam
Lexotan 1.5 mg
Lexotan 3 mg
Chlordiazepoxide HCl
Benpine 5 mg
Benpine 10 mg
Benpine 25 mg
Cebarax† 5 mg
Chlordiazepoxide
March Pharma 25 mg
Chlordiazepoxide
T Man 10 mg
Chlordixide 5 mg
Chlordixide 10 mg
Comoben 5 mg
Comoben 10 mg
Cozep 10 mg
Cozep 25 mg
Dirax† 5 mg
Kenspa† 5 mg
†
Librax 5 mg
Metaxide 10 mg
Minoxide 10 mg
Modurax† 5 mg
Pondnebium 5 mg
Tumax† 5 mg
Zepoxide 10 mg
234
098
243
091
236
284
096
240
287
344
069
353
108
249
296
093
237
285
Frisium 5 mg
C:\ANNUALS\PNDEX\PIC Index\ControlSubstanceClass_Index.vp
Monday, April 05, 2010 1:45:06 PM
Clonaril 1 mg
Povanil 0.5 mg
Povanil 2 mg
Prenarpil 0.5 mg
Prenarpil 1 mg
Prenarpil 2 mg
Rivotril 0.5 mg
Rivotril 2 mg
412
498
194
380
467
373
358
195
362
491
138
181
385
223
381
481
477
377
371
400
279
043
342
186
067
407
337
054
408
055
Clorazepate
Dipotassium
Cloraxene 5 5 mg
Cloraze 5 mg
Deda 5 mg
Deda 10 mg
Dipot 5 mg
Polizep 5 mg
Pomadom 10 mg
Tenmed 5 mg
070 Tenmed 10 mg
228 Trancap 5 mg
Trancon 5 mg
Tranmed 5 mg
Tranpate 5 mg
Tranxene 5 mg
Clobazam
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
Clonazepam
436
433
437
265
432
444
423
440
269
470
456
428
416
438
Diazepam
A-Zerax 2 mg
A-Zerax 5 mg
Diamed 2 mg
Diamed 5 mg
Diano 2 mg
Diano 5 mg
Diapam 2 mg
Diapam 5 mg
Diapine 2 mg
Diapine 2 mg
Diapine 5 mg
Diapine 5 mg
Diapine
5 mg/mL x 1 mL
Diapine 10 mg
Diapine
10 mg/2 mL x 2 mL
Diazepam
BJ Benjaosoth 2 mg
Diazepam
BJ Benjaosoth 5 mg
Diazepam
BJ Benjaosoth 10 mg
Diazepam
General Drugs House 2 mg
453
463
503
482
015
140
369
329
010
473
166
484
600
386
601
050
374
222
318
Frame Numbers in Bold Italics
CONTROLLED SUBSTANCE CLASS
Pentazocine
CONTROLLED SUBSTANCE CLASS 63
Color profile: Disabled
Composite 150 lpi at 45 degrees
CONTROLLED SUBSTANCE CLASS
64
Diazepam
General Drugs House 5 mg
Diazepam GPO 2 mg
Diazepam GPO 5 mg
Diazepam GPO 10 mg
Diazepam GPO
10 mg/2 mL x 2 mL
Diazepam
H K Pharm 2 mg
Diazepam
H K Pharm 5 mg
Diazepam
H K Pharm 10 mg
Diazepam
Lerd Singh 2 mg
Diazepam
Lerd Singh 5 mg
Diazepam
Pond’s Chemical 2 mg
Diazepam
Pond’s Chemical 5 mg
Diazepam T Man 2 mg
Diazepam T Man 5 mg
Diazepam T P Drug
10 mg/2 mL x 2 mL
Diazepam Vesco 2 mg
Diazepam Vesco 5 mg
Ditran 2 mg
Ditran 5 mg
Divopan 2 mg
Divopan 5 mg
Dizep 2 mg
Dizep 5 mg
Dizepam 2 mg
Dizepam 5 mg
Manodiazo 2 mg
Manodiazo 5 mg
Manodiazo 10 mg
Manolium
10 mg/2 mL x 2 mL
Monozide-10
10 mg/2 mL x 2 mL
Ropam
10 mg/2 mL x 2 mL
Sipam 2 mg
Sipam 5 mg
Sipam 10 mg
Sipam
10 mg/2 mL x 2 mL
Tranolan 2 mg
Tranolan 5 mg
Tranolan
10 mg/2 mL x 2 mL
V Day Zepam 2 mg
V Day Zepam 5 mg
V Day Zepam
10 mg/2 mL x 2 mL
†
PN DEX 2010
CONTROLLED SUBSTANCE CLASS
V Day Zepam NL
148
10 mg/2 mL x 2 mL
052 Vason 2 mg
149 Vescopam
334
10 mg/2 mL x 2 mL
Vispam 10 mg
603 Vorapam 2 mg
Vorapam 5 mg
218 Zepaxid 2 mg
Zepaxid 5 mg
160 Zepaxid
10 mg/2 mL x 2 mL
343 Zopam 2 mg
Zopam 5 mg
066 Zopam 10 mg
Phenobarbital Na
617 Gardenal
396
200 mg/4 mL
†
Neuramizone
20 mg
636
323 Phenobarbital
Atlantic 32.5 mg
064
159 Phenobarbital
Atlantic 65 mg
506
462 Phenobarbital
Atlantic 100 mg
634 Phenoco Elixir
20 mg/5 mL x 450 mL
048
Phenotal Elixir
145
20 mg/5 mL x 60 mL
331
638
403
011
012
277
584
517
161
367
Pinazepam
216 Anta 0.5 mg
364 Anta 1 mg
211 Anta 2 mg
Anxira 0.5 mg
627 Anxira 1 mg
325 Hawkcopax 0.5 mg
134 Kemora 0.5 mg
418 Kemora 1 mg
476 Lonza 0.5 mg
049 Lonza 1 mg
146 Lora 0.5 mg
171 Lora 1 mg
Lora 2 mg
190
Loramed 2 mg
224
Loravan 0.5 mg
151
Loravan 1 mg
469
Lorazep 0.5 mg
502
Lorazep 1 mg
335
Lorazep 2 mg
Lorazin 0.5 mg
613
Lorazin 1 mg
Lorazin 2 mg
632
Ora 0.5 mg
Ora 1 mg
608
Tranavan 0.5 mg
056
Tranavan 1 mg
154
Zeda 0.5 mg
339
Zeda 1 mg
Zora 0.5 mg
626 Zora 2 mg
130
177
615
475 Medazepam
465 Celium 5 mg
Medazine 5 mg
616 Medazine 10 mg
Indicates brands that contain more than 1 ingredient
C:\ANNUALS\PNDEX\PIC Index\ControlSubstanceClass_Index.vp
Monday, April 05, 2010 1:45:06 PM
464
Domar 5 mg
Lorazepam
304
020
125
300
022
321
411
024
313
019
368
036
217
210
302
027
309
003
357
324
044
227
310
030
307
034
014
360
328
179
Prazepam
Pozapam 5 mg
Pozapam 10 mg
459
175
Tofisopam
Grandaxin 50 mg
051
N2
Codeine Phosphate
(Analgesic)
Codeine GPO 15 mg
Codeine GPO 30 mg
004
018
Fentanyl
Durogesic
25 mcg/hr x 2.5 mg
Durogesic
50 mcg/hr x 5 mg
Durogesic
100 mcg/hr x 10 mg
Fentanyl GPO
12 mcg/hr
Fentanyl GPO
397
25 mcg/hr
487 Fentanyl GPO
50 mcg/hr
483
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
651
652
653
645
646
647
Color profile: Disabled
Composite 150 lpi at 45 degrees
PN DEX 2010
Pethidine M & H Manufacturing
50 mg/mL x 1 mL
Pethidine M & H Manufacturing
649
100 mg/2 mL x 2 mL
Pethidine T.P. Drug
650
50 mg/mL x 1 mL
648
611
†
612
631
Fentanyl Citrate
Fentanyl Antigen
0.05 mg/mL x 2 mL
Fentanyl Antigen
0.05 mg/mL x 10 mL
Fentanyl Janssen-Cilag
0.05 mg/mL x 2 mL
Fentanyl Janssen-Cilag
0.05 mg/mL x 10 mL
Fentanyl Sandoz
0.05 mg/mL x 2 mL
Fentanyl Sandoz
0.05 mg/mL x 10 mL
Methadone HCl
Methadone GPO 5 mg
Methadone GPO
10 mg/mL x 1000 mL
Morphine Sulfate
Kapanol 20 mg
Kapanol 50 mg
Kapanol 100 mg
Morphine Sulfate Inj Blue
10 mg/mL x 1 mL
Morphine Sulfate Inj Purple
10 mg/mL x 1 mL
Morphine T.P. Drug
10 mg/mL x 1 mL
Morphine T.P. Drug
10 mg/mL x 1 mL
Morphine T.P. Drug
10 mg/mL x 1 mL
MST Continus 10 mg
MST Continus 30 mg
MST Continus 60 mg
Oramorph
10 mg/5 mL x 250 mL
Oramorph
20 mg/mL x 30 mL
Pethidine HCl
Pethidine Biolab
100 mg/2 mL x 2 mL
N3
598
599
605
Camphorated Opium
Tinct
606 Brown Mixture GPO†
0.6 mL/5 mL x 180 mL
623 Brown Mixture GPO†
0.6 mL/5 mL x 450 mL
644 Brown Mixture Osoth Interlab†
0.6 mL/5 mL x 180 mL
†
Mist Tussis
0.6 mL/5 mL x 450 mL
†
Mist. Scill Ammon. GPO
126
0.6 mL/5 mL x 180 mL
†
Mixture Tussis
596
0.45 mL/5 mL x 30 mL
Mixture Tussis†
0.45 mL/5 mL x 60 mL
Mixture Tussis†
0.45 mL/5 mL x 120 mL
119
Mixture Tussis†
120
0.45 mL/5 mL x 240 mL
121
Mixture Tussis†
0.45 mL/5 mL x 450 mL
609
Squill and Ammonia Mixture†
1.3 mL/10 mL x 450 mL
610
527
528
554
590
531
574
575
576
577
578
591
628
629
Codeine Phosphate
(Analgesic)
630
406
278
183
†
Codicet 15 mg
Codicet Blue† 15 mg
†
Codigesic 15 mg
†
Masapara With Codeine
15 mg
†
594 Nasa With Codeine
15 mg
595 Para-Co 15 mg
Paradeine† 15 mg
Parcono† 8 mg
Tylenol With Codeine†
15 mg
Tylenol With Codeine†
30 mg
602
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
C:\ANNUALS\PNDEX\PIC Index\ControlSubstanceClass_Index.vp
Monday, April 05, 2010 1:45:06 PM
Codeine Phosphate
(Antitussive)
Bluco 10 mg
†
Bronpect 10 mg
†
Centrodine CD 10 mg
Clinopront† 10 mg
Co-Cof† 10 mg
†
Codee-C 10 mg
†
Codepect 10 mg
†
Codesia 10 mg
†
Codesia
10 mg/5 mL x 60 mL
Codyl Cough †
9 mg/5 mL x 60 mL
†
Codyl Cough
9 mg/5 mL x 100 mL
Decos† 9 mg/5 mL x 100 mL
†
Mila-Tercon 8 mg
Neopect† 10 mg
†
Nordyl Linctus
9 mg/5 mL x 100 mL
†
Phencodin
9 mg/5 mL x 60 mL
Phensedyl†
9 mg/5 mL x 100 mL
Poly-Cof Syrup†
9 mg/5 mL x 60 mL
Poly-Cof Syrup†
9 mg/5 mL x 100 mL
Pondnadyl†
9 mg/5 mL x 60 mL
Pondnadyl†
9 mg/5 mL x 100 mL
†
Rolar 10 mg
Ropect† 10 mg
Rotuss† 10 mg
†
Seco 10 mg
†
Terco-C 10 mg
Tussidyl†
9 mg/5 mL x 60 mL
355
298
225
378
165
388
202
391
516
540
541
572
167
199
566
586
553
548
549
563
564
203
201
204
389
387
589
Codeine Resinate
414 Codipront† 30 mg
352
112
410
494
Diphenoxylate HCl
Lomotil† 2.5 mg
080 Spasil† 2.5 mg
347
074
079
006
009
Opium Tinct
075 Camphorated Opium Tincture
†
BP 1980
5 mL/100 mL x 1000 mL
076
529
Frame Numbers in Bold Italics
CONTROLLED SUBSTANCE CLASS
Fentanyl Hexal
12 mcg/hr
Fentanyl Hexal
25 mcg/hr
Fentanyl Hexal
50 mcg/hr
CONTROLLED SUBSTANCE CLASS 65
Color profile: Disabled
Composite 150 lpi at 45 degrees
MANUFACTURER'S INDEX
´Ñª¹ÕàÀÊѪÀѳ±ì¨Ñ´àÃÕ§µÒÁª×èͼÙé¼ÅÔµ
2M (MED-MAKER)
2 àÍçÁ (àÁ´-àÁà¡ÍÃì)
Anpress 0.25 mg
Anpress 1 mg
Xiemed 0.5 mg
Dipot 5 mg
Lorazep 0.5 mg
Lorazep 1 mg
088
Lorazep 2 mg
282
Phenotal Elixir
249
20 mg/5 mL x 60 mL
3 àÍçÁ ¿ÒÃìÁÒ/ÍÂ.
A N H PRODUCTS
àÍ àÍç¹ àͪ â»Ã´Ñ¤Êì
Comoben 5 mg
Comoben 10 mg
Divopan 2 mg
Divopan 5 mg
ºÒ§¡Í¡áÅç»á͹´ì¤ÍÊàÁµÔ¤
517
BARD/FDA
3M PHARMA/FDA
Duromine 15 mg
Duromine 30 mg
432 BANGKOK LAB & COSMETIC
309
003
†
Clinopront 10 mg
378
357
†
Codigesic 15 mg
112
ºÒÃì´/ÍÂ.
ASIAN PHARM/FDA
àÍàªÕ蹿ÒÃìÁÒ«ÙµÔ¤ÑÅ/ÍÂ.
499
488 Pseudoephedrine
Asian Pharm 30 mg
Pseudoephedrine
Asian Pharm 60 mg
Pseudoephedrine Syrup
Asian Pharm
30 mg/5 mL x 60 mL
362
491
049
146
MST Continus 10 mg
MST Continus 30 mg
143 MST Continus 60 mg
406
278
183
047
BIOLAB/FDA
518
äºâÍáÅ»/ÍÂ.
Pethidine Biolab
100 mg/2 mL x 2 mL
602
ATLANTIC LAB
á͵ᏵԤ
ALPHAPHARM/FDA
ÍÑÅ¿Ò¿ÒÃìÁ/ÍÂ.
Alodorm 5 mg
Trialam 0.25 mg
078
168
ALZA CORP/FDA
ÍÑÅ«Ò ¤ÍÃìà»ÍàêÑè¹/ÍÂ.
Concerta 18 mg
Concerta 36 mg
169
114
ANTIGEN/FDA
á͹µÔਹ/ÍÂ.
Fentanyl Antigen
0.05 mg/mL x 2 mL
Fentanyl Antigen
0.05 mg/mL x 10 mL
ASIAN PHARM
598
599
Ama† 50 mg
Benpine 5 mg
Benpine 10 mg
Benpine 25 mg
Diapine 2 mg
Diapine 2 mg
Diapine 5 mg
Diapine 5 mg
Diapine 5 mg/mL x 1 mL
Diapine 10 mg
Diapine 10 mg/2 mL x 2 mL
Dizolam 0.25 mg
Dizolam 0.5 mg
Dizolam 1 mg
Lora 0.5 mg
Lora 1 mg
Lora 2 mg
Phenobarbital Atlantic
32.5 mg
Phenobarbital Atlantic
65 mg
Phenobarbital Atlantic
100 mg
àÍàªÕ蹿ÒÃìÁÒ«ÙµÔ¤ÑÅ
A-Zerax 2 mg
A-Zerax 5 mg
Codesia† 10 mg
Codesia†
10 mg/5 mL x 60 mL
†
453 B L HUA
463
391
Codicet† 15 mg
516 Terco-C† 10 mg
ºÕ àÍçÅ ÎÑéÇ
Indicates brands that contain more than 1 ingredient
C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp
Wednesday, March 31, 2010 10:04:03 AM
144
412
498
194
010
473
166
484
600
386
601
089
233
297
368
036
217
BJ BENJAOSOTH
ºÕਠ(ອ¨âÍʶ)
Diazepam BJ Benjaosoth
2 mg
Diazepam BJ Benjaosoth
5 mg
Diazepam BJ Benjaosoth
10 mg
Minoxide 10 mg
374
222
477
BJ BENJAOSOTH/FDA
ºÕਠ(ອ¨âÍʶ)/ÍÂ.
Pseudoephedrine
BJ Benjaosoth 60 mg
Pseudoephedrine Syrup
BJ Benjaosoth
011
30 mg/5 mL x 60 mL
012
277
050
135
523
BOEHRINGER
INGELHEIM/FDA
àºÍÃÔ§à¡ÍÃì ÍÔ¹à¡ÅäÎÁì/ÍÂ.
Oramorph
10 mg/5 mL x 250 mL
414 Oramorph
20 mg/mL x 30 mL
387
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
594
595
Color profile: Disabled
Composite 150 lpi at 45 degrees
PN DEX 2010
MANUFACTURER'S INDEX
BRITISH DISPENSARY
GLAXOSMITHKLINE/FDA
Íѧ¡ÄɵÃÒ§Ù (áÍÅ ¾Õ)
ÎÒàÁŹ/ÍÂ.
á¡Åç¡â«ÊÁÔ·ä¤Åì¹/ÍÂ.
014 Kapanol 20 mg
360 Kapanol 50 mg
Kapanol 100 mg
119 Keta-Hameln
50 mg/mL x 10 mL
120
121
CARDINAL HEALTH
AUSTRALIA
HEXAL AG/FDA
¤ÒÃì´Ô¹ÑÅ àÎÅ·ì ÍÍÊàµÃàÅÕÂ
Ropect† 10 mg
†
Rotuss 10 mg
CEVA ANIMAL HEALTH
«ÕÇÒ á͹ÔÁÍÅ àÎÅì·
Nembutal
50 mg/mL x 20 mL
CHAROEN BHAESAJ
à¨ÃÔ­àÀÊѪ
Paradeine
†
15 mg
ͧ¤ì¡ÒÃàÀÊѪ¡ÃÃÁ
201
204 Brown Mixture GPO†
0.6 mL/5 mL x 180 mL
†
Brown Mixture GPO
0.6 mL/5 mL x 450 mL
Camphorated Opium Tincture
†
BP 1980
5 mL/100 mL x 1000 mL
639
Diazepam GPO 2 mg
Diazepam GPO 5 mg
Diazepam GPO 10 mg
Diazepam GPO
10 mg/2 mL x 2 mL
Mist. Scill Ammon. GPO†
074
0.6 mL/5 mL x 180 mL
à´¤â«/ÍÂ.
DOUGLAS/FDA
´Ñ¡ÅÒÊ/ÍÂ.
Nitrados 5 mg
Trycam 0.25 mg
àΡ«ÒÅ àͨÕ/ÍÂ.
GPO
DEXO/FDA
Prefamone 75 mg
642
GPO/FDA
174
ͧ¤ì¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.
Codeine GPO 15 mg
Codeine GPO 30 mg
Ephedrine GPO
30 mg/mL x 1 mL
062 Methadone GPO 5 mg
Methadone GPO
348
10 mg/mL x 1000 mL
Fentanyl GPO
Fentanyl GPO
Fentanyl GPO
527
Fentanyl Hexal
Fentanyl Hexal
528
Fentanyl Hexal
12 mcg/hr
25 mcg/hr
50 mcg/hr
12 mcg/hr
25 mcg/hr
50 mcg/hr
645
646
647
648
649
650
529
052
149 INPAC PHARMA
334
ÍԹᾤ¿ÒÃìÁÒ
Inzolam
603 Inzolam
Inzolam
531 Lorazin
Lorazin
Lorazin
Tenmed
Tenmed
0.25 mg
0.5 mg
1 mg
0.5 mg
1 mg
2 mg
5 mg
10 mg
104
251
294
324
044
227
440
269
004
018 INTERTHAI
ÍÔ¹àµÍÃìä·Â
604
126 Tranxene 5 mg
438
596
JANSSEN-CILAG/FDA
ᨹà«è¹-«ÕáÅ¡/ÍÂ.
EGIS
ÍÕ¨ÕÊ
GREATER PHARMA
Grandaxin 50 mg
051
à¡Ãê·àµÍÃì¿ÒÃìÁèÒ
Diapam 2 mg
Diapam 5 mg
GEDEON RICHTER/FDA
¡Õà´Õ¹ ÃÔªàµÍÃì/ÍÂ.
Calypsol 50 mg/mL x 10 mL
641
H K PHARM
àͪ ठ¿ÒÃìÁÒ«ÙµÔ¤ÍÅ
GENERAL DRUGS HOUSE
à¹à¹ÍÃìÃÒÅ´ÃÑê¡ÊìàÎéÒÊì
Diazepam
General Drugs House 2 mg
Diazepam
General Drugs House 5 mg
Zora 0.5 mg
Zora 2 mg
318
148
328
179
Allam 0.25 mg
Allam 0.5 mg
Allam 1 mg
Deda 5 mg
Deda 10 mg
Diazepam H K Pharm 2 mg
Diazepam H K Pharm 5 mg
Diazepam H K Pharm 10 mg
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp
Wednesday, March 31, 2010 10:04:03 AM
Durogesic
25 mcg/hr x 2.5 mg
Durogesic
369
50 mcg/hr x 5 mg
329
Durogesic
100 mcg/hr x 10 mg
Fentanyl Janssen-Cilag
0.05 mg/mL x 2 mL
Fentanyl Janssen-Cilag
0.05 mg/mL x 10 mL
103
250
293
437
265
218
160
343
651
652
653
605
606
KENYAKU
हÂÒ¡Ø
†
Bronpect 10 mg
Kenspa† 5 mg
Prazol 0.5 mg
298
223
234
Frame Numbers in Bold Italics
MANUFACTURER'S INDEX
Zeda 0.5 mg
Zeda 1 mg
67
HAMELN/FDA
Color profile: Disabled
Composite 150 lpi at 45 degrees
68
PN DEX 2010
MANUFACTURER'S INDEX
LBS
Marzolam 0.5 mg
Marzolam 1 mg
áÍÅ ºÕ àÍÊ áźºÍàõÍÃÕè
Hawkcopax 0.5 mg
Pangon 30 mg/mL x 1 mL
Ropam 10 mg/2 mL x 2 mL
LERD SINGH
Alpramed 0.25 mg
Alpramed 0.5 mg
Alpramed 1 mg
Chlordixide 5 mg
Chlordixide 10 mg
Diazepam Lerd Singh 2 mg
Diazepam Lerd Singh 5 mg
252
105
393
358
195
066
161
Rubifen 10 mg
MANUFACTURER'S INDEX
àÅÔÈÊÔ§Ëì
M & H MANUFACTURING
àÍçÁ á͹´ì àÍçª áÁ¹Ùῤà¨ÍÃÔè§
†
Bluco 10 mg
†
Codicet Blue 15 mg
Diano 2 mg
Diano 5 mg
†
Mila-Tercon 8 mg
†
Parcono 8 mg
ÁÒ«Òáź
†
áÅçº ÃÙºÔâÍ/ÍÂ.
ÁÔÅÒâ¹
321
607
608 MASA LAB
Cebarax 5 mg
Dizepam 2 mg
Dizepam 5 mg
†
Masapara With Codeine
038
15 mg
†
Neopect 10 mg
Ora 0.5 mg
Ora 1 mg
LAB RUBIO/FDA
235 MILANO
283
MEDICINE PRODUCTS
àÁ´Ô«Õ¹â»Ã´Ñ¡Êì
380
224
151
MILANO/FDA
ÁÔÅÒâ¹/ÍÂ.
410
199 Pseudoephedrine
310
Milano 30 mg
030 Pseudoephedrine
Milano 60 mg
Pseudoephedrine Syrup
Milano 30 mg/5 mL x 60 mL
313
019 MILLIMED
091
236
284 Anax 0.25 mg
Anax 0.5 mg
Co-Cof† 10 mg
Nasa With Codeine† 15 mg
MEDICINE PRODUCTS/FDA
Poly-Cof Syrup†
355
9 mg/5 mL x 60 mL
352
Poly-Cof Syrup†
Pseudoephedrine
9 mg/5 mL x 100 mL
Medicine Products 60 mg
184
Vason 2 mg
Lonza 0.5 mg
Lonza 1 mg
Xanacine 0.25 mg
Xanacine 0.5 mg
Xanacine 1 mg
M & H MANUFACTURING/FDA
Morphine Sulfate Inj Blue
10 mg/mL x 1 mL
Morphine Sulfate Inj Purple
10 mg/mL x 1 mL
Pethidine M & H Manufacturing
50 mg/mL x 1 mL
Pethidine M & H Manufacturing
100 mg/2 mL x 2 mL
609
610
611
612
MACK/FDA
áÁç¤/ÍÂ.
Mirapront N 20 mg
MARCH PHARMA
áËÅÁ·Í§¡ÒÃá¾·Âì
Chlordiazepoxide
March Pharma 25 mg
Manodiazo 2 mg
Manodiazo 5 mg
Manodiazo 10 mg
Manolium
10 mg/2 mL x 2 mL
Marzolam 0.25 mg
†
504
136
045
547
ÁÔÅÅÔàÁ´
àÁ´Ô«Õ¹â»Ã´Ñ¡Êì/ÍÂ.
àÍçÁ á͹´ì àÍçª áÁ¹Ùῤà¨ÍÃÔè§/ÍÂ.
015
140
167
079
085
230
165
080
548
549
396
MEDICPHARMA
ÊËá¾·ÂìàÀÊѪ
Codee-C† 10 mg
†
Codyl Cough
9 mg/5 mL x 60 mL
†
Codyl Cough
9 mg/5 mL x 100 mL
Diamed 2 mg
Diamed 5 mg
Dirax† 5 mg
Medazine 5 mg
Medazine 10 mg
Para-Co 15 mg
Prenarpil 0.5 mg
Prenarpil 1 mg
Prenarpil 2 mg
Tranmed 5 mg
Zolam 0.25 mg
Zolam 0.5 mg
Zolam 1 mg
467
469
502 MEGA LIFESCIENCES
335
àÁ¡éÒ äÅ¿ìä«áÍ繫ì
613 Codepect† 10 mg
090 Rolar† 10 mg
Indicates brands that contain more than 1 ingredient
C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp
Wednesday, March 31, 2010 10:04:03 AM
MODERN MANU
388
âÁà´ÍÃì¹áÁ¹Ù
Cloraze 5 mg
Moxinax 0.25 mg
541 Moxinax 0.5 mg
503
482
385
487 NOVARTIS/FDA
483
347 Ritalin 10 mg
407
337
054
428 OLAN-KEMED
093
237
285 Alpralan 0.25 mg
Alpralan 0.5 mg
Kemora 0.5 mg
Kemora 1 mg
Loramed 2 mg
Tranolan 2 mg
202 Tranolan 5 mg
203 Tranolan 10 mg/2 mL x 2 mL
540
433
094
238
â¹ÇÒÃìµÕÊ/ÍÂ.
041
âÍÅѹ-à¤ÁàÁ´
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
042
214
411
024
210
130
177
615
Color profile: Disabled
Composite 150 lpi at 45 degrees
PN DEX 2010
MANUFACTURER'S INDEX
PHARMASANT LAB
âÍÅÔ¤
âê
¿ÒÃìÁÒÊѹµì áÅçº
Alprazolam Frx 0.5 mg
†
Codipront 30 mg
Librax† 5 mg
†
Lomotil 2.5 mg
†
Phensedyl
9 mg/5 mL x 100 mL
†
Tylenol With Codeine 15 mg
†
Tylenol With Codeine 30 mg
256
494
381
006
553
075
076
OSMOPHARM/FDA
ÍÍÊâÁ¿ÒÃìÁ/ÍÂ.
D-Norpseudoephedrine SR
Osmopharm 20 mg
Panbesy 15 mg
Panbesy 30 mg
Phentermine
Osmopharm 15 mg
505
425
461
Alcelam 0.25 mg
Alcelam 0.5 mg
Alcelam 1 mg
Anta 0.5 mg
Anta 1 mg
Anta 2 mg
†
Centrodine CD 10 mg
Cozep 10 mg
Cozep 25 mg
Pomadom 10 mg
Povanil 0.5 mg
Povanil 2 mg
Pozapam 5 mg
Pozapam 10 mg
Zopam 2 mg
Zopam 5 mg
Zopam 10 mg
097
241
288
304
020
125
225
138
181
423
186
067
459
175
048
145
331
451
âÍʶÍÔ¹àµÍÃì
Brown Mixture Osoth Interlab
0.6 mL/5 mL x 180 mL
P P LAB
¾Õ ¾Õ áźÍÃÒµÍÃÕèÊì
V Day Zepam 2 mg
V Day Zepam 5 mg
V Day Zepam
10 mg/2 mL x 2 mL
V Day Zepam NL
10 mg/2 mL x 2 mL
PARKE-DAVIS/FDA
¾ÒÃì¤à´ÇÔÊ/ÍÂ.
Ketalar 50 mg/mL x 10 mL
Domar 5 mg
Mitranax 0.25 mg
554 Mitranax 0.5 mg
Mitranax 1 mg
Polizep 5 mg
Tranavan 0.5 mg
Tranavan 1 mg
âê/ÍÂ.
Dalmadorm 15 mg
Dormicum 5 mg/mL x 1 mL
Dormicum 15 mg
Dormicum 15 mg/3 mL x 3 mL
Mogadon 5 mg
Rohypnol 1 mg
478
621
351
622
081
394
†
464
106
253
295 SALUTAS PHARMA/FDA
444
307
Methylphenidate Hexal 10 mg
034
617 Diazepam
Pond’s Chemical 2 mg
Diazepam
Pond’s Chemical 5 mg
†
Pondnadyl
9 mg/5 mL x 60 mL
643 Pondnadyl†
9 mg/5 mL x 100 mL
Pondnebium 5 mg
᫹´ÍÊ á¤¹Ò´Ò/ÍÂ.
Fentanyl Sandoz
0.05 mg/mL x 2 mL
367 Fentanyl Sandoz
0.05 mg/mL x 10 mL
216
623
644
563
SANOFI-AVENTIS
564
371
«Ò⹿Õè-ÍàǹµÕÊ
Frisium 5 mg
Gardenal 200 mg/4 mL
ä¿à«ÍÃì
096 R P SCHERER/FDA
240
287
344 Euhypnos 20 20 mg
069
353
117
SANDOZ CANADA/FDA
POND’S CHEMICAL
¾Í¹´ìà¤ÁÕ¤ÍÅ
566
«ÒÅÙ·ÑÊ ¿ÒÃìÁÒ/ÍÂ.
PFIZER
Xanax 0.25 mg
Xanax 0.5 mg
Xanax 1 mg
Xanax XR 0.5 mg
Xanax XR 1 mg
Xanax XR 2 mg
070
228
408
055
ROCHE/FDA
Nordyl Linctus
9 mg/5 mL x 100 mL
475
465
616
1.5 mg
3 mg
0.5 mg
2 mg
âÃÊÁ͹·ì ¿ÒÃìÁ
â»ÅÔ¿ÒÃìÁ
†
Lexotan
Lexotan
Rivotril
Rivotril
ROSEMONT PHARM
POLIPHARM
OSOTH INTERLAB
69
ROCHE
ÍÒÃì ¾Õ àªÍàÃÍÃì/ÍÂ.
043
638
SANOFI-SYNTHELABO
398
«Ò⹿Õè-«Ô¹àµÅÒâº
Sosegon 30 mg/mL x 1 mL
624
RECKITT BENCKISER/FDA
àá¤Ô··ì ູ¤Õà«ÍÃì/ÍÂ.
PHARMACIA/FDA
¿ÒÃìÁÒà«ÕÂ/ÍÂ.
Halcion 0.25 mg
Temgesic 0.2 mg
350 Temgesic 0.3 mg/mL x 1 mL
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp
Wednesday, March 31, 2010 10:04:03 AM
SANOFI-WINTHROP/FDA
«Ò⹿Õè-ÇÔ¹·ÃÍ»/ÍÂ.
007
619 Stilnox 10 mg
110
Frame Numbers in Bold Italics
MANUFACTURER'S INDEX
OLIC
Color profile: Disabled
Composite 150 lpi at 45 degrees
70
Phenoco Elixir
20 mg/5 mL x 450 mL
ÊÂÒÁàÀÊѪ
Siampraxol 0.25 mg
Siampraxol 0.5 mg
Sipam 2 mg
Sipam 5 mg
Sipam 10 mg
Sipam 10 mg/2 mL x 2 mL
SIAM BHEASACH/FDA
098
243
056 T P DRUG
154
339
626 Diazepam T P Drug
10 mg/2 mL x 2 mL
Trancap 5 mg
Zepoxide 10 mg
Buprine 0.2 mg
002
T P DRUG/FDA
·Õ ¾Õ ´ÃÑ¡/ÍÂ.
SRIPRASIT PHARMA
àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì
†
Decos 9 mg/5 mL x 100 mL
†
Neuramizone 20 mg
†
Seco 10 mg
†
Spasil 2.5 mg
Tumax† 5 mg
UDOMPHON (PHIHALAB)
584
572
403
389
009
400
Morphine T.P. Drug
10 mg/mL x 1 mL
Morphine T.P. Drug
10 mg/mL x 1 mL
Morphine T.P. Drug
10 mg/mL x 1 mL
Pethidine T.P. Drug
50 mg/mL x 1 mL
ÍØ´Á¾Ã (¿ÕÎÒáÅçº)
Metaxide
Zepaxid
Zepaxid
Zepaxid
·Õ ¾Õ ´ÃÑ¡
ÊÂÒÁàÀÊѪ/ÍÂ.
MANUFACTURER'S INDEX
PN DEX 2010
MANUFACTURER'S INDEX
SIAM BHEASACH
10 mg
2 mg
5 mg
10 mg/2 mL x 2 mL
481
506
462
634
627
470 UTOPIAN
279
ÂÙâ·à»Õé¹
Anpress 0.5 mg
Anxira 0.5 mg
Anxira 1 mg
Celium 5 mg
Clonaril 1 mg
†
628 Modurax 5 mg
Trancon 5 mg
629 Vispam 10 mg
Xiemed 0.25 mg
630 Xiemed 1 mg
248
300
022
397
342
377
456
323
108
296
631
V S PHARMA
SUPHONG BHAESAJ
Êؾ§ÉìàÀÊѪ
Dizep 2 mg
Dizep 5 mg
Loravan 0.5 mg
Loravan 1 mg
Mixture Tussis†
0.45 mL/5 mL x 30 mL
Mixture Tussis†
0.45 mL/5 mL x 60 mL
Mixture Tussis†
0.45 mL/5 mL x 120 mL
†
Mixture Tussis
0.45 mL/5 mL x 240 mL
†
Mixture Tussis
0.45 mL/5 mL x 450 mL
T MAN PHARMA
·Õ áÁ¹ ¿ÒÃìÁÒ
Chlordiazepoxide
T Man 10 mg
Diazepam T Man 2 mg
Diazepam T Man 5 mg
Manex 0.25 mg
Manex 0.5 mg
Manex 1 mg
Tranpate 5 mg
T O CHEMICALS
·Õ âÍ à¤ÁÕ¤ÍÅÊì
Cloraxene 5 5 mg
†
ÇÕ àÍÊ ¿ÒÃìÁèÒ
TEMMLER/FDA
à·ÁàÅÍÃì/ÍÂ.
575
ä·Â ¾Õ ´Õ à¤ÁÕ¤ÍÅÊì
Pharnax 0.25 mg
Pharnax 0.5 mg
115 Pharnax 1 mg
486 Phencodin†
9 mg/5 mL x 60 mL
Tussidyl†
9 mg/5 mL x 60 mL
Vorapam 2 mg
Vorapam 5 mg
576
Monozide-10
10 mg/2 mL x 2 mL
632
171
Regenon Retard 75 mg
190
Regenon Retard 75 mg
302
027
574 THAI P D CHEMICALS
586
589
064
159
VESCO PHARM
577
578
101
247
292
THAIPHARMED 1942
ËéÒ§ÂÒä·Â 1942
Ditran 2 mg
Ditran 5 mg
373 TORRENT
364
211
099 Alprax 0.25 mg
244
291
416 TRENKER/FDA
·ÍÃìàù·ì
àÇÊâ¡¿ÒÃìÁÒ«ÙµÔ¤ÍÅ
Diazepam Vesco 2 mg
325
Diazepam Vesco 5 mg
134
418 Vescopam 10 mg/2 mL x 2 mL 636
476
VIDHYASOM
ÇÔ·ÂÒÈÃÁ
†
156 Mist Tussis
0.6 mL/5 mL x 450 mL
Squill and Ammonia Mixture†
1.3 mL/10 mL x 450 mL
590
591
à·Ã¹à¡ÍÃì/ÍÂ.
Atractil 75 mg
Dietil Retard 75 mg
Phentermine Trenker 15 mg
436 Phentermine Trenker 30 mg
Indicates brands that contain more than 1 ingredient
C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp
Wednesday, March 31, 2010 10:04:03 AM
497 WYETH-AYERST/FDA
084
466
424 Loramet 1 mg
äÇàÍ·-àÍàÂÔÃìÊ·ì/ÍÂ.
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
102
Color profile: Disabled
Composite 150 lpi at 45 degrees
GENERIC & BRAND NAME INDEX
´Ñª¹ÕÃÇÁª×èÍÊÒÁÑ­áÅЪ×èÍ·Ò§¡ÒäéÒ
Registration No. Frame No.
A
Alcelam 0.25 mg
Alcelam 0.5 mg
Alcelam 1 mg
Allam 0.25 mg
Allam 0.5 mg
Allam 1 mg
Alnax 0.25 mg
Alnax 0.5 mg
Alnax 1 mg
Alodorm 5 mg
Alpazam 0.25 mg
Alpazam 0.5 mg
Alpazam 1 mg
Alpralan 0.25 mg
Alpralan 0.5 mg
Alpramed 0.25 mg
Alpramed 0.5 mg
Alpramed 1 mg
Alprax 0.25 mg
Alprax 0.5 mg
Alprax 1 mg
Alprazolam:
- Alcelam 0.25 mg
- Alcelam 0.5 mg
- Alcelam 1 mg
- Allam 0.25 mg
- Allam 0.5 mg
- Allam 1 mg
- Alnax 0.25 mg
- Alnax 0.5 mg
- Alnax 1 mg
- Alpazam 0.25 mg
- Alpazam 0.5 mg
- Alpazam 1 mg
- Alpralan 0.25 mg
- Alpralan 0.5 mg
- Alpramed 0.25 mg
- Alpramed 0.5 mg
- Alpramed 1 mg
- Alprax 0.25 mg
- Alprax 0.5 mg
- Alprax 1 mg
- Alprazolam Frx
0.25 mg
P1A 1/52
P1A 23/49
P1A 24/49
P1A 1/48
P1A 2/48
P1A 3/48
P1A 51/50
P1A 52/50
P1A 47/50
P1A 48/50
P1A 7/48
P1C 1/46
-
097
241
288
103
250
293
087
232
281
078
100
245
246
042
214
252
105
393
156
409
057
P1A 1/52
P1A 23/49
P1A 24/49
P1A 1/48
P1A 2/48
P1A 3/48
P1A 51/50
P1A 52/50
P1A 47/50
P1A 48/50
P1A 7/48
P1C 1/46
-
097
241
288
103
250
293
087
232
281
100
245
246
042
214
252
105
393
156
409
057
-
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:49 AM
109
Registration No. Frame No.
- Alprazolam Frx
0.5 mg
- Anax 0.25 mg
- Anax 0.5 mg
- Anpress 0.25 mg
- Anpress 0.5 mg
- Anpress 1 mg
- Anzion 0.25 mg
- Anzion 0.5 mg
- Anzion 1 mg
- Dizolam 0.25 mg
- Dizolam 0.5 mg
- Dizolam 1 mg
- Farzolam 0.25 mg
- Farzolam 0.5 mg
- Farzolam 1 mg
- Inzolam 0.25 mg
- Inzolam 0.5 mg
- Inzolam 1 mg
- Manex 0.25 mg
- Manex 0.5 mg
- Manex 1 mg
- Marzolam 0.25 mg
- Marzolam 0.5 mg
- Marzolam 1 mg
- Mitranax 0.25 mg
- Mitranax 0.5 mg
- Mitranax 1 mg
- Moxinax 0.25 mg
- Moxinax 0.5 mg
- Pharnax 0.25 mg
- Pharnax 0.5 mg
- Pharnax 1 mg
- Prazol 0.5 mg
- Siampraxol 0.25 mg
- Siampraxol 0.5 mg
- Siampraxol 1 mg
- Sunax 0.25 mg
- Sunax 0.5 mg
- Xalam 0.25 mg
- Xalam 0.5 mg
- Xalam 1 mg
- Xanacine 0.25 mg
- Xanacine 0.5 mg
- Xanacine 1 mg
- Xanax 0.25 mg
P1A 10/51
P1A 9/46
P1A 10/46
P1A 33/50
P1A 4/48
P1A 35/50
P1A 5/48
P1A 15/50
P1A 6/48
P1A 58/50
P1A 59/50
P1A 60/50
P1A 36/51
P1A 21/46
P1A 8/47
P1A 5/47
P1A 42/52
P1A 43/52
P1A 36/50
P1A 37/50
P1A 38/50
P1A 19/49
P1A 20/49
P1A 28/51
P1A 29/51
P1A 30/51
P1A 3/51
P1A 6/52
P1A 7/52
P1A 13/48
P1A 14/48
P1A 15/48
P1C 20/52
256
085
230
088
248
282
086
231
280
089
233
297
092
242
289
104
251
294
099
244
291
090
235
283
106
253
295
094
238
101
247
292
234
098
243
290
107
254
095
239
286
091
236
284
096
Frame Numbers in Bold Italics
Color profile: Disabled
Composite 150 lpi at 45 degrees
72
PN DEX 2010
GENERIC & BRAND NAME INDEX
Registration No. Frame No.
GENERIC & BRAND NAME INDEX
- Xanax 0.5 mg
- Xanax 1 mg
- Xanax XR 0.5 mg
- Xanax XR 1 mg
- Xanax XR 2 mg
- Xiemed 0.25 mg
- Xiemed 0.5 mg
- Xiemed 1 mg
- Zolam 0.25 mg
- Zolam 0.5 mg
- Zolam 1 mg
Alprazolam Frx
0.25 mg
Alprazolam Frx
0.5 mg
†
Ama 50 mg
Amobarbital:
- Ama † 50 mg
Amobarbital Na:
- Amytal 0.5 g
Amytal 0.5 g
Anax 0.25 mg
Anax 0.5 mg
Anpress 0.25 mg
Anpress 0.5 mg
Anpress 1 mg
Anta 0.5 mg
Anta 1 mg
Anta 2 mg
Anxene 5 mg
Anxene 10 mg
Anxielax 5 mg
Anxira 0.5 mg
Anxira 1 mg
Anzion 0.25 mg
Anzion 0.5 mg
Anzion 1 mg
Ativan 0.5 mg
Ativan 1 mg
Ativan 2 mg
Atractil 75 mg
Azepam 2 mg
Azepam 5 mg
A-Zerax 2 mg
A-Zerax 5 mg
P1C 21/52
P1C 22/52
P1C 17/50
P1C 18/50
P1C 19/50
P1A 27/49
P1A 34/50
P1A 28/49
P1A 44/50
P1A 45/50
P1A 46/50
240
287
344
069
353
108
249
296
093
237
285
-
109
P1A 10/51
P2A 60/43
256
144
P2A 60/43
144
P1A 9/46
P1A 10/46
P1A 33/50
P1A 4/48
P1A 35/50
P1A 29/50
P1A 28/50
P1A 29/52
P1A 24/52
P1A 25/52
P1A 37/52
P1A 38/52
640
640
085
230
088
248
282
304
020
125
430
262
460
300
022
086
231
280
308
028
129
497
219
299
453
463
B
Belladonna Alkaloids With
Phenobarbital† 16.2 mg
Bellergal† 20 mg
Belloid† 30 mg
Benadryl CD† 60 mL
Benadryl CD† 1000 mL
Benera† 20 mg
†
-
221
207
124
550
551
404
Registration No. Frame No.
Benpine 5 mg
Benpine 10 mg
Benpine 25 mg
†
Benylin CD 60 mL
†
Bluco 10 mg
†
Blucon 10 mg
†
Bonadine CD 60 mL
Bromazepam:
- Lexotan 1.5 mg
- Lexotan 3 mg
†
Bromtussia DC 60 mL
†
Bronpect 10 mg
Brown Mixture GPO†
0.6 mL/5 mL x 180 mL
†
Brown Mixture GPO
0.6 mL/5 mL x 450 mL
Brown Mixture
Osoth Interlab†
0.6 mL/5 mL x 180 mL
Buprenorphine HCl:
- Buprine 0.2 mg
- Temgesic 0.2 mg
- Temgesic
0.3 mg/mL x 1 mL
Buprine 0.2 mg
412
498
194
552
355
332
561
P1C 5/49
P1C 6/49
N2A 1/51
070
228
515
298
N2A 15/45
527
N2A 15/45
528
N2A 7/43
554
-
002
007
-
619
002
-
124
-
361
276
641
Butobarbital:
- Belloid † 30 mg
C
Calmipam 2 mg
Calmipam 5 mg
Calypsol 50 mg/mL x 10 mL
Camphorated Opium Tinct:
- Brown Mixture GPO †
0.6 mL/5 mL x 180 mL N2A 15/45
- Brown Mixture GPO †
0.6 mL/5 mL x 450 mL N2A 15/45
- Brown Mixture
Osoth Interlab †
0.6 mL/5 mL x 180 mL N2A 7/43
- Cough Syrup GPO †
0.6 mL/5 mL x 60 mL
- Mist. Scill Ammon. GPO †
0.6 mL/5 mL x 180 mL N2A 13/46
- Mist Tussis †
0.6 mL/5 mL x 450 mL N2A 14/45
- Mixture Scillae Ammon †
2 mL/15 mL x 180 mL
- Mixture Tussis †
0.45 mL/5 mL x 30 mL N2A 11/46
- Mixture Tussis †
0.45 mL/5 mL x 60 mL N2A 11/46
- Mixture Tussis †
0.45 mL/5 mL x 120 mL N2A 11/46
- Mixture Tussis †
0.45 mL/5 mL x 240 mL N2A 11/46
- Mixture Tussis †
0.45 mL/5 mL x 450 mL N2A 11/46
Indicates brands that contain more than 1 ingredient
C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:49 AM
P1A 8/49
P1A 3/49
P1A 1/49
N2A 12/47
-
527
528
554
530
531
590
557
574
575
576
577
578
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
Color profile: Disabled
Composite 150 lpi at 45 degrees
GENERIC & BRAND NAME INDEX
Registration No. Frame No.
- Mixture Tussis
0.45 mL/5 mL x 1800 mL
- Mixture Tussis †
0.45 mL/5 mL x 3600 mL
- Squill and Ammonia Mixture †
1.33 mL/10 mL x 450 mL N2A 9/47
Camphorated Opium Tincture
BP 1980†
5 mL/100 mL x 1000 mL
N2A 9/45
†
Cebarax 5 mg
P2A 22/51
Celium 5 mg
P1A 24/51
†
Cemol Codeine 15 mg
Centrodine CD† 10 mg
N2A 11/47
Cexene 5 mg
Cexene 10 mg
Chlordiazepoxide
Acdhon 10 mg
Chlordiazepoxide
Charoen Bhaesaj 10 mg
Chlordiazepoxide HCl:
- Benpine 5 mg
P1A 8/49
- Benpine 10 mg
P1A 3/49
- Benpine 25 mg
P1A 1/49
- Cebarax † 5 mg
P2A 22/51
- Chlordiazepoxide
Acdhon 10 mg
- Chlordiazepoxide
Charoen Bhaesaj 10 mg
- Chlordiazepoxide
March Pharma 25 mg P1A 13/44
- Chlordiazepoxide
T Man 10 mg
P1A 4/51
- Chlordibrax † 5 mg
- Chlordixide 5 mg
P1A 9/51
- Chlordixide 10 mg
P1A 26/51
- Chlorzep 5 mg
- Comoben 5 mg
P1A 30/49
- Comoben 10 mg
P1A 31/49
- Cozep 10 mg
P1A 3/50
- Cozep 25 mg
P1A 4/50
- Dirax † 5 mg
P2A 4/46
- Epoxide 10 mg
- Epoxide 25 mg
- Kenspa † 5 mg
P2A 36/52
- Librax † 5 mg
P2A 85/43
- Licon † 5 mg
- Med-Zepoxide 5 mg
- Med-Zepoxide 10 mg
- Metaxide 10 mg
P1A 7/51
- Minoxide 10 mg
P1A 47/44
- Modurax † 5 mg
P2A 46/44
- Pobrax † 5 mg
- Pondnebium 5 mg
P1A 13/49
- Pondnebium 10 mg
- Radibrax † 5 mg
- Tumax † 5 mg
P2A 25/51
- Utorax † 5 mg
-
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:49 AM
Registration No. Frame No.
†
†
579
580
591
529
380
397
072
225
450
273
501
500
412
498
194
380
501
500
467
373
382
358
195
359
362
491
138
181
385
187
193
223
381
379
468
053
481
477
377
376
371
192
392
400
383
73
- Zepobrax 5 mg
- Zepoxide 5 mg
- Zepoxide 10 mg
- Zepoxin 5 mg
- Zepoxin 10 mg
Chlordiazepoxide
March Pharma 25 mg
Chlordiazepoxide
T Man 10 mg
†
Chlordibrax 5 mg
Chlordixide 5 mg
Chlordixide 10 mg
Chlorzep 5 mg
†
Clinepect 10 mg
†
Clinopect 10 mg
†
Clinopront 10 mg
Clobazam:
- Frisium 5 mg
- Frisium 10 mg
Clonaril 1 mg
P1A 3/44
-
384
413
279
205
118
P1A 13/44
467
P1A 4/51
P1A 9/51
P1A 26/51
N2A 1/50
373
382
358
195
359
495
196
378
P1C 25/49,
P1B 26/49
P1A 15/51
043
037
342
Clonazepam:
- Clonaril 1 mg
- Povanil 0.5 mg
- Povanil 2 mg
- Prenarpil 0.5 mg
- Prenarpil 1 mg
- Prenarpil 2 mg
- Rivotril 0.5 mg
- Rivotril
1 mg/mL x 1 mL
- Rivotril 2 mg
Cloramed 5 mg
Cloramed 10 mg
Cloraxene 5 5 mg
Cloraze 5 mg
Cloraze 10 mg
P1A 15/51
P1A 33/52
P1A 34/52
P1A 30/52
P1A 31/52
P1A 32/52
P1C 7/49
342
186
067
407
337
054
408
P1C 17/48
P1A 4/49
P1A 32/51
-
637
055
429
264
436
433
266
Clorazepate Dipotassium:
- Anxene 5 mg
- Anxene 10 mg
- Anxielax 5 mg
- Cexene 5 mg
- Cexene 10 mg
- Cloramed 5 mg
- Cloramed 10 mg
- Cloraxene 5 5 mg
- Cloraze 5 mg
- Cloraze 10 mg
- Clozene 5 mg
- Clozene 10 mg
- Clozepate 5 mg
- Conzep 5 mg
- Conzep 10 mg
- Deda 5 mg
- Deda 10 mg
P1A 4/49
P1A 32/51
P1A 14/46
P1A 15/46
430
262
460
450
273
429
264
436
433
266
421
452
442
454
420
437
265
Frame Numbers in Bold Italics
GENERIC & BRAND NAME INDEX
PN DEX 2010
Color profile: Disabled
Composite 150 lpi at 45 degrees
74
PN DEX 2010
GENERIC & BRAND NAME INDEX
GENERIC & BRAND NAME INDEX
Registration No. Frame No.
- Diposef 5 mg
- Diposef 10 mg
- Dipot 5 mg
- Dopam 5 mg
- Exan 5 mg
- Exan 10 mg
- Flulium 5 mg
- Flulium 10 mg
- Frexene 5 mg
- Frexene 10 mg
- Gaxene 5 mg
- Manotran 5 mg
- Manotran 10 mg
- Polizep 5 mg
- Polizep 10 mg
- Pomadom 5 mg
- Pomadom 10 mg
- Posene 5 mg
- Posene 10 mg
- Sanor 5 mg
- Sanor 10 mg
- Serene
Masa Lab 10 mg
- Serene
V S Pharma 5 mg
- Tamylab-S 5 mg
- Tenmed 5 mg
- Tenmed 10 mg
- T-Five 5 mg
- Tranadon-S 5 mg
- Trancap 5 mg
- Trancap 10 mg
- Tranclor 5 mg
- Tranclor 10 mg
- Trancon 5 mg
- Trancon 10 mg
- Tranmed 5 mg
- Tranmed 10 mg
- Tranpate 5 mg
- Tranpon 5 mg
- Transpon Forte
10 mg
- Tranxene 5 mg
- Tranxene 10 mg
- Tranzep 5 mg
- Uptran 10 mg
- Upzene 5 mg
- Zetran 5 mg
Clozene 5 mg
Clozene 10 mg
Clozepate 5 mg
†
Cocet 15 mg
†
Co-Cof 10 mg
†
Codee-C 10 mg
Codeine GPO 15 mg
†
P1A 40/52
P1A 23/50
P1A 2/46
-
427
260
432
133
489
492
443
274
415
419
448
435
263
444
268
455
423
172
402
426
258
-
259
P1A 54/42
P1A 55/42
P1A 27/42
P1A 4/44
P1A 39/52
P1A 61/43
-
431
445
440
269
446
447
470
173
439
272
456
422
428
261
416
441
257
P1A 16/46
N2A 6/51
N2A 5/45
-
438
271
434
267
490
449
421
452
442
071
165
388
004
Registration No. Frame No.
Codeine GPO 30 mg
Codeine Phosphate (Analgesic):
- Cemol Codeine † 15 mg
- Cocet † 15 mg
- Codeine GPO 15 mg
- Codeine GPO 30 mg
N1A 1/52
- Codicet † 15 mg
N2A 10/51
- Codicet Blue † 15 mg
- Codicet Pink † 15 mg
N2A 3/50
- Codigesic † 15 mg
- Cotenol † 15 mg
- Masapara With Codeine †
15 mg
N2A 5/50
- Nasa With Codeine †
15 mg
N2A 4/51
- Pacogesic † 8 mg
N2A 7/42
- Para-Co 15 mg
N2A 2/50
- Paradeine † 15 mg
- Paradyl 8 mg
- Paragen Co † 15 mg
- Paramed-Co † 15 mg
- Parcod † 15 mg
N2A 4/50
- Parcono † 8 mg
- Tylenol With Codeine †
15 mg
N2A 6/43
- Tylenol With Codeine †
30 mg
N2A 11/43
Codeine Phosphate (Antitussive):
- Benadryl CD † 60 mL
- Benadryl CD † 1000 mL
- Benylin CD † 60 mL
N2A 12/47
- Bluco † 10 mg
- Blucon † 10 mg
- Bonadine CD † 60 mL
- Bromtussia DC † 60 mL
N2A 1/51
- Bronpect † 10 mg
- Centrodine CD † 10 mg N2A 11/47
- Clinepect † 10 mg
- Clinopect † 10 mg
N2A 1/50
- Clinopront † 10 mg
N2A 6/51
- Co-Cof † 10 mg
N2A 5/45
- Codee-C † 10 mg
N2A 4/52
- Codepect † 10 mg
N2A 4/47
- Codesia † 10 mg
- Codesia †
10 mg/5 mL x 60 mL
N2A 3/47
- Codyl Cough †
9 mg/5 mL x 60 mL
N2A 6/50
- Codyl Cough †
9 mg/5 mL x 100 mL
N2A 6/50
- Codyl Cough †
9 mg/5 mL x 1000 mL
- Codyl Cough †
9 mg/5 mL x 4500 mL
- Cofcodyl Cough † 60 mL
- Cofcodyl Cough † 100 mL
Indicates brands that contain more than 1 ingredient
C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
018
072
071
004
018
414
352
255
112
073
410
080
189
347
074
083
113
395
077
079
075
076
550
551
552
355
332
561
515
298
225
495
196
378
165
388
202
391
516
540
541
542
543
521
522
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
Color profile: Disabled
Composite 150 lpi at 45 degrees
GENERIC & BRAND NAME INDEX
Registration No. Frame No.
†
- Comodine Cough 60 mL
- Conadyl † 60 mL
- Corynil † 10 mg
- Cosedyl Cough Linctus †
60 mL
- Decos †
9 mg/5 mL x 100 mL
N2A 8/51
- Dimetane Expectorant DC †
2.5 L
- Hisedyl † 60 mL
- Hisedyl † 120 mL
- Mantadyl Cough † 60 mL
- Masadyl Cough † 60 mL
- Masadyl Cough † 100 mL
- Masadyl Cough † 240 mL
- Mila-Cono † 60 mL
N2A 7/47
- Mila-Tercon † 8 mg
- Neo Cough † 60 mL
- Neo Cough † 100 mL
- Neo Cough † 240 mL
- Neocod † 10 mg
- Neo-Codein † 10 mg
- Neocof † 10 mg
- Neo-Cophen 10 mg
N2A 10/46
- Neopect † 10 mg
- Nordyl Linctus †
9 mg/5 mL x 100 mL
N2C 3/51
- Nordyl Linctus †
9 mg/5 mL x 500 mL
- Nortuss Linctus †
100 mL
- Nortuss Linctus †
500 mL
- P-Codyl †
9 mg/5 mL x 60 mL
- P-Codyl †
9 mg/5 mL x 120 mL
- Percidyl Cough † 100 mL
- Phencodin †
9 mg/5 mL x 60 mL
N2A 10/43
- Phencodin †
9 mg/5 mL x 500 mL
- Phencodin †
9 mg/5 mL x 1000 mL
- Phensedyl †
9 mg/5 mL x 100 mL
N2A 8/43
- Phensodi † 60 mL
- Phensodi † 120 mL
- Phensodi † 1000 mL
- Poly-Cof Syrup †
9 mg/5 mL x 60 mL
N2A 5/51
- Poly-Cof Syrup †
9 mg/5 mL x 100 mL
N2A 5/51
- Polydine CD † 10 mg
- Pondnadyl †
9 mg/5 mL x 60 mL
N2A 3/48
- Pondnadyl †
9 mg/5 mL x 100 mL
N2A 3/48
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
507
583
200
582
572
592
555
556
581
534
535
536
546
167
537
538
539
345
346
188
198
199
566
567
568
569
558
559
562
586
587
588
553
524
525
526
548
549
270
563
564
75
Registration No. Frame No.
†
- Pondnadyl
9 mg/5 mL x 1000 mL
- Rolar † 10 mg
- Ropect † 10 mg
- Rotuss † 10 mg
- Seco † 10 mg
- Tenadrin-C † 60 mL
- Teradene † 60 mL
- Teradyl Syrup † 60 mL
- Teradyl Syrup † 1000 mL
- Terco-C † 10 mg
- Tocodyl † 10 mg
- Tussidyl †
9 mg/5 mL x 60 mL
- Zorituss 10 mg
Codeine Resinate:
- Codipront † 30 mg
- Codipront † 30 mg
- Codipront † 60 mL
Codepect† 10 mg
Codesia† 10 mg
Codesia†
10 mg/5 mL x 60 mL
Codicet† 15 mg
Codicet Blue† 15 mg
Codicet Pink† 15 mg
Codigesic† 15 mg
Codipront† 30 mg
Codipront† 30 mg
Codipront† 60 mL
Codyl Cough †
9 mg/5 mL x 60 mL
Codyl Cough †
9 mg/5 mL x 100 mL
†
Codyl Cough
9 mg/5 mL x 1000 mL
Codyl Cough †
9 mg/5 mL x 4500 mL
Cofcodyl Cough† 60 mL
†
Cofcodyl Cough 100 mL
Comoben 5 mg
Comoben 10 mg
Comodine Cough† 60 mL
Conadyl† 60 mL
Concerta 18 mg
Concerta 36 mg
Conzep 5 mg
Conzep 10 mg
Corynil† 10 mg
Cosedyl Cough Linctus†
60 mL
Cotenol† 15 mg
Cough Syrup GPO†
0.6 mL/5 mL x 60 mL
Cozep 10 mg
Cozep 25 mg
N2A 3/52
N2C 12/46
N2C 9/46
N2A 2/47
N2A 1/49
-
565
203
201
204
389
519
520
532
533
387
390
N2A 6/45
-
589
197
N2A 9/51
N2A 4/52
N2A 4/47
493
494
593
202
391
N2A 3/47
N1A 1/52
N2A 10/51
N2A 3/50
N2A 9/51
-
516
414
352
255
112
493
494
593
N2A 6/50
540
N2A 6/50
541
-
542
P1A 30/49
P1A 31/49
-
543
521
522
362
491
507
583
169
114
454
420
200
582
P1A 3/50
P1A 4/50
073
530
138
181
Frame Numbers in Bold Italics
GENERIC & BRAND NAME INDEX
PN DEX 2010
Color profile: Disabled
Composite 150 lpi at 45 degrees
76
Registration No. Frame No.
D
Dalmadorm 15 mg
Davol† 32.5 mg
†
Decos
9 mg/5 mL x 100 mL
Deda 5 mg
Deda 10 mg
N2A 8/51
P1A 14/46
P1A 15/46
GENERIC & BRAND NAME INDEX
Dextropropoxyphene HCl:
- Davol † 32.5 mg
Dextropropoxyphene Napsylate:
- Pardex 32.5 mg
Diadon 5 mg
Diamed 2 mg
P1A 9/49
Diamed 5 mg
P1A 10/49
Diano 2 mg
P1A 9/48
Diano 5 mg
P1A 10/48
Diapam 2 mg
P1A 5/51
Diapam 5 mg
P1A 6/51
Diapine 2 mg
P1A 13/50
Diapine 2 mg
P1A 12/50
Diapine 5 mg
P1A 11/51
Diapine 5 mg
P1A 14/50
Diapine
5 mg/mL x 1 mL
P1A 21/51
Diapine 10 mg
P1A 18/49
Diapine
10 mg/2 mL x 2 mL
P1A 21/51
Diaz 2 mg
Diaz 5 mg
Diaz 10 mg
Diaza 2 mg
Diaza 5 mg
Diaza
10 mg/2 mL x 2 mL
Diazepam:
- Azepam 2 mg
- Azepam 5 mg
- A-Zerax 2 mg
- A-Zerax 5 mg
- Calmipam 2 mg
- Calmipam 5 mg
- Diadon 5 mg
- Diamed 2 mg
- Diamed 5 mg
- Diano 2 mg
- Diano 5 mg
- Diapam 2 mg
- Diapam 5 mg
- Diapine 2 mg
- Diapine 2 mg
- Diapine 5 mg
- Diapine 5 mg
- Diapine
5 mg/mL x 1 mL
†
PN DEX 2010
GENERIC & BRAND NAME INDEX
478
275
572
437
265
275
116
349
503
482
015
140
369
329
010
473
166
484
600
386
601
061
157
341
338
153
625
P1A 37/52
P1A 38/52
P1A 9/49
P1A 10/49
P1A 9/48
P1A 10/48
P1A 5/51
P1A 6/51
P1A 13/50
P1A 12/50
P1A 11/51
P1A 14/50
219
299
453
463
361
276
349
503
482
015
140
369
329
010
473
166
484
P1A 21/51
600
Indicates brands that contain more than 1 ingredient
C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
Registration No. Frame No.
- Diapine 10 mg
- Diapine
10 mg/2 mL x 2 mL
- Diaz 2 mg
- Diaz 5 mg
- Diaz 10 mg
- Diaza 2 mg
- Diaza 5 mg
- Diaza
10 mg/2 mL x 2 mL
- Diazepam Acdhon 2 mg
- Diazepam
BJ Benjaosoth 2 mg
- Diazepam
BJ Benjaosoth 5 mg
- Diazepam
BJ Benjaosoth 10 mg
- Diazepam
Charoen Bhaesaj 2 mg
- Diazepam
General Drugs House
2 mg
- Diazepam
General Drugs House
5 mg
- Diazepam GPO 2 mg
- Diazepam GPO 5 mg
- Diazepam GPO 10 mg
- Diazepam GPO
10 mg/2 mL x 2 mL
- Diazepam
H K Pharm 2 mg
- Diazepam
H K Pharm 5 mg
- Diazepam
H K Pharm 10 mg
- Diazepam
Lerd Singh 2 mg
- Diazepam
Lerd Singh 5 mg
- Diazepam
Pond’s Chemical 2 mg
- Diazepam
Pond’s Chemical 5 mg
- Diazepam
Pond’s Chemical 5 mg
- Diazepam
Samakeephaesaj 2 mg
- Diazepam
Samakeephaesaj 5 mg
- Diazepam
Sommai Bhaesaj 5 mg
- Diazepam T Man 2 mg
- Diazepam T Man 5 mg
- Diazepam T Man 5 mg
- Diazepam T Man 10 mg
- Diazepam
T P Drug 2 mg
- Diazepam
T P Drug 5 mg
P1A 18/49
386
P1A 21/51
-
601
061
157
341
338
153
-
625
472
P1A 13/52
050
P1A 14/52
374
P1A 15/52
222
-
333
P1A 14/49
318
P1A 24/50
-
148
052
149
334
-
603
P1A 32/49
218
P1A 33/49
160
P1A 34/49
343
P1A 49/50
066
P1A 50/50
161
P1A 32/45
367
P1A 33/45
162
216
-
363
-
142
P1A 12/52
P1A 62/44
-
320
364
163
211
327
-
017
-
155
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
Color profile: Disabled
Composite 150 lpi at 45 degrees
GENERIC & BRAND NAME INDEX
Registration No. Frame No.
- Diazepam T P Drug
10 mg
- Diazepam T P Drug
10 mg/2 mL x 2 mL
- Diazepam Vesco 2 mg
- Diazepam Vesco 5 mg
- Diazepion 2 mg
- Diazepion 5 mg
- Diazepion 10 mg
- Dilium 2 mg
- Dilium 5 mg
- Dimed 2 mg
- Dimed 5 mg
- Dipam 2 mg
- Dipam 5 mg
- Dipam 10 mg
- Ditran 2 mg
- Ditran 5 mg
- Divopan 2 mg
- Divopan 5 mg
- Dizan 2 mg
- Dizan 5 mg
- Dizep 2 mg
- Dizep 5 mg
- Dizepam 2 mg
- Dizepam 5 mg
- DZP2 2 mg
- Laylium-10
10 mg/2 mL x 2 mL
- Manodiazo 2 mg
- Manodiazo 5 mg
- Manodiazo 10 mg
- Manolium
10 mg/2 mL x 2 mL
- Med-Zepam 2 mg
- Med-Zepam 5 mg
- Monozide 2 mg
- Monozide-10
10 mg/2 mL x 2 mL
- Pam-5 5 mg
- Popam 2 mg
- Popam 5 mg
- Ropam 5 mg
- Ropam
10 mg/2 mL x 2 mL
- S.Co Zepam 5 mg
- Sipam 2 mg
- Sipam 5 mg
- Sipam 10 mg
- Sipam
10 mg/2 mL x 2 mL
- Stesolid 2 mg
- Stesolid 5 mg
- Stesolid 10 mg
- Tranolan 2 mg
- Tranolan 5 mg
-
340
P1A 27/51
P1A 53/50
P1A 54/50
P1A 8/50
P1A 61/50
P1A 11/48
P1A 12/48
P1A 5/50
P1A 6/50
P1A 21/49
P1A 22/49
-
627
325
134
480
474
191
178
326
068
164
040
137
330
418
476
049
146
457
417
171
190
224
151
471
P1A 83/43
P1A 84/43
P1A 23/51
635
469
502
335
P1A 12/49
-
613
039
336
496
P1A 37/49
-
632
206
111
170
158
P1A 13/45
P1A 15/49
P1A 16/49
P1A 17/49
608
220
056
154
339
P1A 39/50
P1A 42/50
P1A 43/50
626
401
485
479
130
177
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
77
Registration No. Frame No.
- Tranolan
10 mg/2 mL x 2 mL
- V Day Zepam 2 mg
- V Day Zepam 5 mg
- V Day Zepam
10 mg/2 mL x 2 mL
- V Day Zepam NL
10 mg/2 mL x 2 mL
- Valax 2 mg
- Valax 5 mg
- Valax 10 mg
- Valenium 2 mg
- Valenium 5 mg
- Valium 5 mg
- Valium
10 mg/2 mL x 2 mL
- Vason 2 mg
- Vescopam
10 mg/2 mL x 2 mL
- Vispam 2 mg
- Vispam 5 mg
- Vispam 10 mg
- Vomed 2 mg
- Vomed 5 mg
- Vorapam 2 mg
- Vorapam 5 mg
- Winopam 2 mg
- Winopam 5 mg
- Zepam 2 mg
- Zepam 5 mg
- Zepam
10 mg/2 mL x 2 mL
- Zepaxid 2 mg
- Zepaxid 5 mg
- Zepaxid
10 mg/2 mL x 2 mL
- Zopam 2 mg
- Zopam 5 mg
- Zopam 10 mg
Diazepam Acdhon 2 mg
Diazepam
BJ Benjaosoth 2 mg
Diazepam
BJ Benjaosoth 5 mg
Diazepam
BJ Benjaosoth 10 mg
Diazepam
Charoen Bhaesaj 2 mg
Diazepam
General Drugs House
2 mg
Diazepam
General Drugs House
5 mg
Diazepam GPO 2 mg
Diazepam GPO 5 mg
Diazepam GPO 10 mg
P1A 41/52
P1A 88/42
P1A 89/42
615
475
465
P2A 82/43
616
P1A 11/46
-
617
031
132
322
065
150
152
P1A 16/48
620
396
P1A 7/50
P1A 16/50
P1A 40/50
P1A 41/50
-
636
366
213
323
059
147
064
159
063
375
399
354
P1A 20/50
P1A 21/50
614
506
462
P1A 32/50
P1A 35/49
P1A 36/49
P1A 3/46
-
634
048
145
331
472
P1A 13/52
050
P1A 14/52
374
P1A 15/52
222
-
333
P1A 14/49
318
P1A 24/50
-
148
052
149
334
Frame Numbers in Bold Italics
GENERIC & BRAND NAME INDEX
PN DEX 2010
Color profile: Disabled
Composite 150 lpi at 45 degrees
78
PN DEX 2010
GENERIC & BRAND NAME INDEX
Registration No. Frame No.
Diazepam GPO
10 mg/2 mL x 2 mL
Diazepam
H K Pharm 2 mg
Diazepam
H K Pharm 5 mg
Diazepam
H K Pharm 10 mg
Diazepam
Lerd Singh 2 mg
Diazepam
Lerd Singh 5 mg
Diazepam
Pond’s Chemical 2 mg
Diazepam
Pond’s Chemical 5 mg
Diazepam
Pond’s Chemical 5 mg
Diazepam
Samakeephaesaj 2 mg
Diazepam
Samakeephaesaj 5 mg
Diazepam
Sommai Bhaesaj 5 mg
Diazepam T Man 2 mg
Diazepam T Man 5 mg
Diazepam T Man 5 mg
Diazepam T Man 10 mg
Diazepam T P Drug 2 mg
Diazepam T P Drug 5 mg
Diazepam T P Drug 10 mg
Diazepam T P Drug
10 mg/2 mL x 2 mL
Diazepam Vesco 2 mg
Diazepam Vesco 5 mg
Diazepion 2 mg
Diazepion 5 mg
Diazepion 10 mg
GENERIC & BRAND NAME INDEX
Diethylpropion HCl:
- Dietil Retard 75 mg
- Prefamone 75 mg
- Regenon Retard 75 mg
- Regenon Retard 75 mg
Diethylpropion Resinate:
- Atractil 75 mg
Dietil Retard 75 mg
Dilium 2 mg
Dilium 5 mg
Dilomil† 2.5 mg
Dimed 2 mg
Dimed 5 mg
†
Dimetane Expectorant DC
2.5 L
Dipam 2 mg
Dipam 5 mg
Dipam 10 mg
†
-
603
P1A 32/49
218
P1A 33/49
160
P1A 34/49
343
P1A 49/50
066
P1A 50/50
161
P1A 32/45
367
-
162
P1A 33/45
216
-
363
-
142
P1A 12/52
P1A 62/44
-
320
364
163
211
327
017
155
340
P1A 27/51
P1A 53/50
P1A 54/50
-
627
325
134
480
474
191
-
-
084
174
115
486
-
497
084
178
326
001
068
164
-
592
040
137
330
-
Registration No. Frame No.
Diphenoxylate HCl:
- Dilomil † 2.5 mg
- Ditropine † 2.5 mg
- Lomotil † 2.5 mg
- Spasil † 2.5 mg
Diposef 5 mg
Diposef 10 mg
Dipot 5 mg
†
Dirax 5 mg
Ditran 2 mg
Ditran 5 mg
Ditropine† 2.5 mg
Divopan 2 mg
Divopan 5 mg
Dizan 2 mg
Dizan 5 mg
Dizep 2 mg
Dizep 5 mg
Dizepam 2 mg
Dizepam 5 mg
Dizolam 0.25 mg
Dizolam 0.5 mg
Dizolam 1 mg
D-Norpseudoephedrine HCl:
- Mirapront N 20 mg
D-Norpseudoephedrine Resinate:
D-Norpseudoephedrine SR
Osmopharm 20 mg
D-Norpseudoephedrine SR
Osmopharm 20 mg
Domar 5 mg
P1A 5/52
†
Donnatal 16.2 mg
Dopam 5 mg
Dormicum
5 mg/mL x 1 mL
Dormicum 15 mg
Dormicum
15 mg/3 mL x 3 mL
Durogesic
25 mcg/hr x 2.5 mg
Durogesic
50 mcg/hr x 5 mg
Durogesic
100 mcg/hr x 10 mg
Duromine 15 mg
Duromine 30 mg
DZP2 2 mg
-
001
008
006
009
427
260
432
385
418
476
008
049
146
457
417
171
190
224
151
089
233
297
504
505
505
464
060
133
621
351
622
651
652
653
499
488
471
E
Elixir Phenobarb 60 mL
Ephedrine GPO
30 mg/mL x 1 mL
Ephedrine HCl:
- Ephedrine GPO
30 mg/mL x 1 mL
Epoxide 10 mg
Indicates brands that contain more than 1 ingredient
C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
N2A 4/48
N2A 2/51
P1A 40/52
P2A 4/46
P1A 8/50
P1A 61/50
P1A 11/48
P1A 12/48
P1A 5/50
P1A 6/50
P1A 21/49
P1A 22/49
P1A 5/48
P1A 15/50
P1A 6/48
-
573
-
604
-
604
187
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
Color profile: Disabled
Composite 150 lpi at 45 degrees
PN DEX 2010
GENERIC & BRAND NAME INDEX
Registration No. Frame No.
Epoxide 25 mg
-
193
Ethyl Loflazepate:
- Meilax 1 mg
- Meilax 2 mg
- Victan 2 mg
Euhypnos 20 20 mg
Exan 5 mg
Exan 10 mg
-
021
176
182
398
489
492
-
092
242
289
-
651
-
652
-
653
645
646
647
648
649
650
-
598
-
599
-
598
-
599
-
605
-
606
-
623
-
644
645
646
647
648
649
650
-
605
-
606
-
623
F
Fentanyl:
- Durogesic
25 mcg/hr x 2.5 mg
- Durogesic
50 mcg/hr x 5 mg
- Durogesic
100 mcg/hr x 10 mg
- Fentanyl GPO 12 mcg/hr
- Fentanyl GPO 25 mcg/hr
- Fentanyl GPO 50 mcg/hr
- Fentanyl Hexal 12 mcg/hr
- Fentanyl Hexal 25 mcg/hr
- Fentanyl Hexal 50 mcg/hr
Fentanyl Antigen
0.05 mg/mL x 2 mL
Fentanyl Antigen
0.05 mg/mL x 10 mL
Fentanyl Citrate:
- Fentanyl Antigen
0.05 mg/mL x 2 mL
- Fentanyl Antigen
0.05 mg/mL x 10 mL
- Fentanyl Janssen-Cilag
0.05 mg/mL x 2 mL
- Fentanyl Janssen-Cilag
0.05 mg/mL x 10 mL
- Fentanyl Sandoz
0.05 mg/mL x 2 mL
- Fentanyl Sandoz
0.05 mg/mL x 10 mL
Fentanyl GPO 12 mcg/hr
Fentanyl GPO 25 mcg/hr
Fentanyl GPO 50 mcg/hr
Fentanyl Hexal 12 mcg/hr
Fentanyl Hexal 25 mcg/hr
Fentanyl Hexal 50 mcg/hr
Fentanyl Janssen-Cilag
0.05 mg/mL x 2 mL
Fentanyl Janssen-Cilag
0.05 mg/mL x 10 mL
Fentanyl Sandoz
0.05 mg/mL x 2 mL
Registration No. Frame No.
Fentanyl Sandoz
0.05 mg/mL x 10 mL
Flulium 5 mg
Flulium 10 mg
-
644
443
274
Flunitrazepam:
- Rohypnol 1 mg
-
394
Flurazepam:
- Dalmadorm 15 mg
Fortwin 30 mg/mL x 1 mL
Frexene 5 mg
Frexene 10 mg
Frisium 5 mg
P1C 25/49,
P1B 26/49
-
Frisium 10 mg
478
618
415
419
043
037
G
Gardenal 200 mg/4 mL
Gaxene 5 mg
Grandaxin 50 mg
P1C 1/50
P1C 27/50
638
448
051
H
Halcion 0.25 mg
Hawkcopax 0.5 mg
Hawkcopax 1 mg
Hisedyl† 60 mL
Hisedyl† 120 mL
P1A 8/51
-
350
321
365
555
556
P1A 58/50
P1A 59/50
P1A 60/50
104
251
294
I
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
Inzolam 0.25 mg
Inzolam 0.5 mg
Inzolam 1 mg
K
Kapanol 20 mg
Kapanol 50 mg
Kapanol 100 mg
Kemora 0.5 mg
P1A 18/47
Kemora 1 mg
P1A 21/47
†
Kenspa 5 mg
P2A 36/52
Keta-Hameln
50 mg/mL x 10 mL
Ketalar 50 mg/mL x 10 mL
Ketamine HCl:
- Calypsol
50 mg/mL x 10 mL
- Keta-Hameln
50 mg/mL x 10 mL
- Ketalar 50 mg/mL x 10 mL
119
120
121
411
024
223
642
643
-
641
-
642
643
-
Frame Numbers in Bold Italics
GENERIC & BRAND NAME INDEX
Farzolam 0.25 mg
Farzolam 0.5 mg
Farzolam 1 mg
79
Color profile: Disabled
Composite 150 lpi at 45 degrees
80
PN DEX 2010
GENERIC & BRAND NAME INDEX
Registration No. Frame No.
GENERIC & BRAND NAME INDEX
L
Laylium-10
10 mg/2 mL x 2 mL
Lexotan 1.5 mg
Lexotan 3 mg
†
Librax 5 mg
†
Licon 5 mg
Lizavan 0.5 mg
Lizavan 1 mg
Lomotil† 2.5 mg
Lonza 0.5 mg
Lonza 1 mg
Lora 0.5 mg
Lora 1 mg
Lora 2 mg
Lora-P 0.5 mg
Lora-P 1 mg
Lora-P 2 mg
Loramed 0.5 mg
Loramed 1 mg
Loramed 2 mg
Loramet 1 mg
Lorapam 0.5 mg
Lorapam 1 mg
Lorapam 2 mg
Lorapine 0.5 mg
Lorapine 1 mg
Loravan 0.5 mg
Loravan 1 mg
Lorazene 0.5 mg
Lorazene 1 mg
Lorazene 2 mg
Lorazep 0.5 mg
Lorazep 1 mg
Lorazep 2 mg
P1C 5/49
P1C 6/49
P2A 85/43
N2A 4/48
P1A 11/49
P1A 18/48
P1A 17/51
P1A 18/51
P1A 19/51
P1A 23/47
P1A 22/50
P1A 2/49
P1A 17/47
P1A 20/47
P1A 22/47
635
070
228
381
379
305
023
006
313
019
368
036
217
319
016
123
306
025
210
102
311
026
128
314
035
302
027
301
013
127
309
003
357
Lorazepam:
- Anta 0.5 mg
- Anta 1 mg
- Anta 2 mg
- Anxira 0.5 mg
- Anxira 1 mg
- Ativan 0.5 mg
- Ativan 1 mg
- Ativan 2 mg
- Hawkcopax 0.5 mg
- Hawkcopax 1 mg
- Kemora 0.5 mg
- Kemora 1 mg
- Lizavan 0.5 mg
- Lizavan 1 mg
- Lonza 0.5 mg
- Lonza 1 mg
- Lora 0.5 mg
P1A 29/50
P1A 28/50
P1A 29/52
P1A 24/52
P1A 25/52
P1A 8/51
P1A 18/47
P1A 21/47
P1A 11/49
P1A 18/48
P1A 17/51
304
020
125
300
022
308
028
129
321
365
411
024
305
023
313
019
368
†
Registration No. Frame No.
- Lora 1 mg
- Lora 2 mg
- Lora-P 0.5 mg
- Lora-P 1 mg
- Lora-P 2 mg
- Loramed 0.5 mg
- Loramed 1 mg
- Loramed 2 mg
- Lorapam 0.5 mg
- Lorapam 1 mg
- Lorapam 2 mg
- Lorapine 0.5 mg
- Lorapine 1 mg
- Loravan 0.5 mg
- Loravan 1 mg
- Lorazene 0.5 mg
- Lorazene 1 mg
- Lorazene 2 mg
- Lorazep 0.5 mg
- Lorazep 1 mg
- Lorazep 2 mg
- Lorazepam
Acdhon 0.5 mg
- Lorazepam
Acdhon 1 mg
- Lorazepam
Macrophar 1 mg
- Lorazin 0.5 mg
- Lorazin 1 mg
- Lorazin 2 mg
- Lozepam 0.5 mg
- Lozepam 1 mg
- Ora 0.5 mg
- Ora 1 mg
- Ora 2 mg
- Pora 0.5 mg
- Pora 1 mg
- Pora 2 mg
- Razepam 0.5 mg
- Razepam 1 mg
- Razepam 2 mg
- Tranavan 0.5 mg
- Tranavan 1 mg
- Vemed 0.5 mg
- Zeda 0.5 mg
- Zeda 1 mg
- Zora 0.5 mg
- Zora 2 mg
Lorazepam
Acdhon 0.5 mg
Lorazepam
Acdhon 1 mg
Lorazepam
Macrophar 1 mg
Lorazin 0.5 mg
Indicates brands that contain more than 1 ingredient
C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
P1A 18/51
P1A 19/51
P1A 23/47
P1A 22/50
P1A 2/49
P1A 17/47
P1A 20/47
P1A 22/47
036
217
319
016
123
306
025
210
311
026
128
314
035
302
027
301
013
127
309
003
357
-
317
-
033
P1A 28/45
P1A 29/45
P1A 30/45
P1A 12/51
P1A 13/51
P1A 3/52
P1A 4/52
P1A 8/52
P1A 9/52
P1A 25/50
P1A 26/50
372
324
044
227
303
405
310
030
212
370
139
215
315
032
131
307
034
316
014
360
328
179
-
317
-
033
P1A 28/45
372
324
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
Color profile: Disabled
Composite 150 lpi at 45 degrees
GENERIC & BRAND NAME INDEX
Registration No. Frame No.
Lorazin 1 mg
Lorazin 2 mg
P1A 29/45
P1A 30/45
044
227
-
102
303
405
Lormetazepam:
- Loramet 1 mg
Lozepam 0.5 mg
Lozepam 1 mg
M
Manex 0.25 mg
Manex 0.5 mg
Manex 1 mg
Manodiazo 2 mg
Manodiazo 5 mg
Manodiazo 10 mg
Manolium
10 mg/2 mL x 2 mL
Manotran 5 mg
Manotran 10 mg
Mantadyl Cough† 60 mL
Marzolam 0.25 mg
Marzolam 0.5 mg
Marzolam 1 mg
Masadyl Cough† 60 mL
Masadyl Cough† 100 mL
Masadyl Cough† 240 mL
Masapara With Codeine†
15 mg
Medazepam:
- Celium 5 mg
- Medazine 5 mg
- Medazine 10 mg
Medazine 5 mg
Medazine 10 mg
Med-Zepam 2 mg
Med-Zepam 5 mg
Med-Zepoxide 5 mg
Med-Zepoxide 10 mg
Meilax 1 mg
Meilax 2 mg
Menobarb 60 mg
Menobarb Elixir
15 mg/5 mL x 60 mL
Menobarb-20 Elixir
20 mg/5 mL x 60 mL
Meprobamate:
- Reinbamate 400 mg
Metaxide 10 mg
Methadone GPO 5 mg
Methadone GPO
10 mg/mL x 1000 mL
Methadone HCl:
- Methadone GPO 5 mg
- Methadone GPO
10 mg/mL x 1000 mL
P1A 36/51
P1A 21/46
P1A 8/47
P1A 83/43
P1A 84/43
P1A 23/51
099
244
291
469
502
335
P1A 12/49
P1A 5/47
P1A 42/52
P1A 43/52
-
613
435
263
581
090
235
283
534
535
536
N2A 5/50
410
P1A 24/51
P1A 30/50
P1A 31/50
P1A 30/50
P1A 31/50
-
397
487
483
487
483
039
336
468
053
021
176
185
-
544
-
545
P1A 7/51
-
082
481
126
-
596
-
126
-
596
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
81
Registration No. Frame No.
Methylphenidate HCl:
- Concerta 18 mg
- Concerta 36 mg
- Methylphenidate
Hexal 10 mg
- Ritalin 10 mg
- Rubifen 10 mg
Methylphenidate
Hexal 10 mg
Midazolam:
- Dormicum
5 mg/mL x 1 mL
- Dormicum 15 mg
- Dormicum
15 mg/3 mL x 3 mL
†
Mila-Cono 60 mL
Mila-Tercon† 8 mg
Minoxide 10 mg
Mirapront N 20 mg
Mist Tussis†
0.6 mL/5 mL x 450 mL
Mist. Scill Ammon. GPO†
0.6 mL/5 mL x 180 mL
Mitranax 0.25 mg
Mitranax 0.5 mg
Mitranax 1 mg
†
Mixture Scillae Ammon
2 mL/15 mL x 180 mL
Mixture Tussis†
0.45 mL/5 mL x 30 mL
Mixture Tussis†
0.45 mL/5 mL x 60 mL
Mixture Tussis†
0.45 mL/5 mL x 120 mL
†
Mixture Tussis
0.45 mL/5 mL x 240 mL
Mixture Tussis†
0.45 mL/5 mL x 450 mL
Mixture Tussis†
0.45 mL/5 mL x 1800 mL
Mixture Tussis†
0.45 mL/5 mL x 3600 mL
†
Modurax 5 mg
Mogadon 5 mg
Monozide 2 mg
Monozide-10
10 mg/2 mL x 2 mL
-
169
114
-
117
041
038
-
117
-
621
351
N2A 7/47
P1A 47/44
-
622
546
167
477
504
N2A 14/45
590
N2A 13/46
P1A 36/50
P1A 37/50
P1A 38/50
531
106
253
295
-
557
N2A 11/46
574
N2A 11/46
575
N2A 11/46
576
N2A 11/46
577
N2A 11/46
578
-
579
P2A 46/44
-
580
377
081
496
P1A 37/49
632
Morphine Sulfate:
- Kapanol 20 mg
- Kapanol 50 mg
- Kapanol 100 mg
- Morphine Sulfate Inj Blue
10 mg/mL x 1 mL
- Morphine Sulfate Inj Purple
10 mg/mL x 1 mL
- Morphine T.P. Drug
10 mg/mL x 1 mL
- Morphine T.P. Drug
10 mg/mL x 1 mL
-
119
120
121
-
609
-
610
-
628
-
629
Frame Numbers in Bold Italics
GENERIC & BRAND NAME INDEX
PN DEX 2010
Color profile: Disabled
Composite 150 lpi at 45 degrees
82
PN DEX 2010
GENERIC & BRAND NAME INDEX
Registration No. Frame No.
- Morphine T.P. Drug
10 mg/mL x 1 mL
- MST Continus 10 mg
- MST Continus 30 mg
- MST Continus 60 mg
- Oramorph
10 mg/5 mL x 250 mL
- Oramorph
20 mg/mL x 30 mL
Morphine Sulfate Inj Blue
10 mg/mL x 1 mL
Morphine Sulfate Inj Purple
10 mg/mL x 1 mL
Morphine T.P. Drug
10 mg/mL x 1 mL
Morphine T.P. Drug
10 mg/mL x 1 mL
Morphine T.P. Drug
10 mg/mL x 1 mL
Moxinax 0.25 mg
Moxinax 0.5 mg
MST Continus 10 mg
MST Continus 30 mg
MST Continus 60 mg
-
630
406
278
183
-
594
-
595
-
609
-
610
-
628
-
629
P1A 19/49
P1A 20/49
-
630
094
238
406
278
183
N
GENERIC & BRAND NAME INDEX
†
Nasa With Codeine
15 mg
Nembutal
50 mg/mL x 20 mL
Neo Cough† 60 mL
Neo Cough† 100 mL
Neo Cough† 240 mL
Neocod† 10 mg
Neo-Codein† 10 mg
Neocof† 10 mg
Neo-Cophen 10 mg
Neopect† 10 mg
Neuramizone† 20 mg
Nitrados 5 mg
Nitrazepam:
- Alodorm 5 mg
- Mogadon 5 mg
- Nitrados 5 mg
Nordyl Linctus†
9 mg/5 mL x 100 mL
†
Nordyl Linctus
9 mg/5 mL x 500 mL
Nortuss Linctus† 100 mL
Nortuss Linctus† 500 mL
N2A 4/51
080
P1F 2/50
N2A 10/46
P2A 5/45
-
639
537
538
539
345
346
188
198
199
403
062
-
078
081
062
N2C 3/51
566
-
567
568
569
O
Opium Tinct:
- Camphorated Opium Tincture
BP 1980 †
5 mL/100 mL x 1000 mL N2A 9/45
†
529
Registration No. Frame No.
Ora 0.5 mg
Ora 1 mg
Ora 2 mg
Oramorph
10 mg/5 mL x 250 mL
Oramorph
20 mg/mL x 30 mL
310
030
212
-
594
-
595
-
189
206
425
461
P1A 20/51
N2A 7/42
N2A 2/50
N2A 4/50
-
607
347
074
083
113
395
077
079
116
-
558
-
559
-
618
P
†
Pacogesic 8 mg
Pam-5 5 mg
Panbesy 15 mg
Panbesy 30 mg
Pangon
30 mg/mL x 1 mL
Para-Co 15 mg
Paradeine† 15 mg
Paradyl 8 mg
†
Paragen Co 15 mg
Paramed-Co† 15 mg
†
Parcod 15 mg
Parcono† 8 mg
Pardex 32.5 mg
P-Codyl†
9 mg/5 mL x 60 mL
†
P-Codyl
9 mg/5 mL x 120 mL
Pentazocine:
- Fortwin
30 mg/mL x 1 mL
- Pangon
30 mg/mL x 1 mL
- Pentazocine All Plants
30 mg/mL x 1 mL
- Sosegon
30 mg/mL x 1 mL
- Tazcine
30 mg/mL x 1 mL
Pentazocine All Plants
30 mg/mL x 1 mL
Pentazocine HCl:
- Tazcine 25 mg
- Tazcine 50 mg
Pentobarbital Na:
- Nembutal
50 mg/mL x 20 mL
Percidyl Cough† 100 mL
Pethidine Biolab
100 mg/2 mL x 2 mL
Pethidine HCl:
- Pethidine Biolab
100 mg/2 mL x 2 mL
- Pethidine
M & H Manufacturing
50 mg/mL x 1 mL
- Pethidine
M & H Manufacturing
100 mg/2 mL x 2 mL
Indicates brands that contain more than 1 ingredient
C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
P1A 12/51
P1A 13/51
-
P1A 20/51
P1C 29/49
607
597
624
-
633
-
597
-
058
226
P1F 2/50
-
639
562
-
602
-
602
-
611
-
612
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
Color profile: Disabled
Composite 150 lpi at 45 degrees
GENERIC & BRAND NAME INDEX
Registration No. Frame No.
- Pethidine T.P. Drug
50 mg/mL x 1 mL
Pethidine M & H Manufacturing
50 mg/mL x 1 mL
Pethidine M & H Manufacturing
100 mg/2 mL x 2 mL
Pethidine T.P. Drug
50 mg/mL x 1 mL
Pharnax 0.25 mg
P1A 28/51
Pharnax 0.5 mg
P1A 29/51
Pharnax 1 mg
P1A 30/51
†
Phencodin
9 mg/5 mL x 60 mL
N2A 10/43
†
Phencodin
9 mg/5 mL x 500 mL
Phencodin†
9 mg/5 mL x 1000 mL
Phenobarb 30 mg
Phenobarb 60 mg
Phenobarb Elixir
20 mg/5 mL x 60 mL
Phenobarbital
Acdhon 15 mg
Phenobarbital
Acdhon 30 mg
Phenobarbital
Acdhon 60 mg
Phenobarbital
Atlantic 16.25 mg
Phenobarbital
Atlantic 32.5 mg
P1A 33/51
Phenobarbital
Atlantic 65 mg
P1A 34/51
Phenobarbital
Atlantic 100 mg
P1A 35/51
Phenobarbital
Chew Brothers 30 mg
Phenobarbital Elixir Acdhon
20 mg/5 mL x 30 mL
Phenobarbital Elixir Acdhon
20 mg/5 mL x 60 mL
Phenobarbital Elixir Acdhon
20 mg/5 mL x 120 mL
Phenobarbital Elixir Acdhon
20 mg/5 mL x 240 mL
Phenobarbital Elixir Acdhon
20 mg/5 mL x 450 mL
Phenobarbital Elixir Acdhon
20 mg/5 mL x 500 mL
Phenobarbital Elixir Acdhon
20 mg/5 mL x 1000 mL
Phenobarbital Na:
- Belladonna Alkaloids With
Phenobarbital † 16.2 mg
631
611
612
631
101
247
292
586
587
588
209
046
560
356
122
029
208
011
012
277
312
508
509
510
511
512
513
514
-
221
- Bellergal † 20 mg
-
207
- Benera † 20 mg
-
404
- Donnatal † 16.2 mg
-
060
- Elixir Phenobarb 60 mL
-
573
- Gardenal 200 mg/4 mL
P1C 1/50
638
-
185
- Menobarb 60 mg
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
83
Registration No. Frame No.
- Menobarb Elixir
15 mg/5 mL x 60 mL
- Menobarb-20 Elixir
20 mg/5 mL x 60 mL
P2A 5/45
- Neuramizone † 20 mg
- Phenobarb 30 mg
- Phenobarb 60 mg
- Phenobarb Elixir
20 mg/5 mL x 60 mL
- Phenobarbital
Acdhon 15 mg
- Phenobarbital
Acdhon 30 mg
- Phenobarbital
Acdhon 60 mg
- Phenobarbital
Atlantic 16.25 mg
- Phenobarbital
P1A 33/51
Atlantic 32.5 mg
- Phenobarbital
P1A 34/51
Atlantic 65 mg
- Phenobarbital
Atlantic 100 mg
P1A 35/51
- Phenobarbital
Chew Brothers 30 mg
- Phenobarbital Elixir Acdhon
20 mg/5 mL x 30 mL
- Phenobarbital Elixir Acdhon
20 mg/5 mL x 60 mL
- Phenobarbital Elixir Acdhon
20 mg/5 mL x 120 mL
- Phenobarbital Elixir Acdhon
20 mg/5 mL x 240 mL
- Phenobarbital Elixir Acdhon
20 mg/5 mL x 450 mL
- Phenobarbital Elixir Acdhon
20 mg/5 mL x 500 mL
- Phenobarbital Elixir Acdhon
20 mg/5 mL x 1000 mL
- Phenobarbitone
New Life Pharma 30 mg
- Phenobarbitone
New Life Pharma 60 mg
- Phenoco Elixir
20 mg/5 mL x 450 mL P1A 26/47
- Phenoco Elixir
20 mg/5 mL x 3800 mL
- Phenocon 60 mg
- Phenosil Elixir
20 mg/5 mL x 60 mL
- Phenosil Elixir
20 mg/5 mL x 450 mL
- Phenotal Elixir
P1A 16/52
20 mg/5 mL x 60 mL
Phenobarbitone
New Life Pharma 30 mg
Phenobarbitone
New Life Pharma 60 mg
-
544
545
403
209
046
560
356
122
029
208
011
012
277
312
508
509
510
511
512
513
514
005
180
584
585
229
570
571
517
005
180
Frame Numbers in Bold Italics
GENERIC & BRAND NAME INDEX
PN DEX 2010
Color profile: Disabled
Composite 150 lpi at 45 degrees
84
PN DEX 2010
GENERIC & BRAND NAME INDEX
Registration No. Frame No.
Phenoco Elixir
20 mg/5 mL x 450 mL
Phenoco Elixir
20 mg/5 mL x 3800 mL
Phenocon 60 mg
Phenosil Elixir
20 mg/5 mL x 60 mL
Phenosil Elixir
20 mg/5 mL x 450 mL
Phenotal Elixir
20 mg/5 mL x 60 mL
Phensedyl†
9 mg/5 mL x 100 mL
†
Phensodi 60 mL
†
Phensodi 120 mL
Phensodi† 1000 mL
Phentermine HCl:
- Panbesy 15 mg
- Panbesy 30 mg
- Phentermine
Osmopharm 15 mg
Phentermine Osmopharm
15 mg
Phentermine Resinate:
- Duromine 15 mg
- Duromine 30 mg
- Phentermine
Trenker 15 mg
- Phentermine
Trenker 30 mg
Phentermine Trenker 15 mg
Phentermine Trenker 30 mg
GENERIC & BRAND NAME INDEX
Phenylpropanolamine HCl:
- Phenylpropanolamine
Pharmasant 25 mg
Phenylpropanolamine
Pharmasant 25 mg
Pinazepam:
- Domar 5 mg
†
Pobrax 5 mg
Polizep 5 mg
Polizep 10 mg
†
Poly-Cof Syrup
9 mg/5 mL x 60 mL
Poly-Cof Syrup†
9 mg/5 mL x 100 mL
†
Polydine CD 10 mg
Pomadom 5 mg
Pomadom 10 mg
†
Pondnadyl
9 mg/5 mL x 60 mL
Pondnadyl†
9 mg/5 mL x 100 mL
†
Pondnadyl
9 mg/5 mL x 1000 mL
Pondnebium 5 mg
†
P1A 26/47
584
-
585
229
-
570
-
571
P1A 16/52
517
N2A 8/43
-
553
524
525
526
-
425
461
-
451
-
451
-
499
488
-
466
-
424
466
424
-
-
141
-
141
P1A 5/52
P1A 23/50
-
Registration No. Frame No.
Pondnebium 10 mg
Popam 2 mg
Popam 5 mg
Pora 0.5 mg
Pora 1 mg
Pora 2 mg
Posene 5 mg
Posene 10 mg
Povanil 0.5 mg
Povanil 2 mg
Pozapam 5 mg
Pozapam 10 mg
Prasepine 5 mg
P1A 33/52
P1A 34/52
P1A 23/52
P1A 39/51
-
192
111
170
370
139
215
172
402
186
067
459
175
458
Prazepam:
- Pozapam 5 mg
P1A 23/52
459
P1A 39/51
175
P1A 3/51
P1A 30/52
P1A 31/52
P1A 32/52
458
234
174
407
337
054
-
143
-
047
- Pozapam 10 mg
- Prasepine 5 mg
Prazol 0.5 mg
Prefamone 75 mg
Prenarpil 0.5 mg
Prenarpil 1 mg
Prenarpil 2 mg
Pseudoephedrine
Asian Pharm 30 mg
Pseudoephedrine
Asian Pharm 60 mg
Pseudoephedrine
BJ Benjaosoth 60 mg
-
135
Pseudoephedrine HCl:
- Pseudoephedrine
Asian Pharm 30 mg
-
143
- Pseudoephedrine
Asian Pharm 60 mg
-
047
- Pseudoephedrine
BJ Benjaosoth 60 mg
-
135
- Pseudoephedrine
Medicine Products 60 mg
-
184
- Pseudoephedrine
Milano 30 mg
-
136
- Pseudoephedrine
Milano 60 mg
-
045
- Pseudoephedrine Syrup
Asian Pharm
30 mg/5 mL x 60 mL
-
518
- Pseudoephedrine Syrup
BJ Benjaosoth
30 mg/5 mL x 60 mL
-
523
-
547
-
184
-
136
-
045
464
376
444
268
N2A 5/51
548
N2A 5/51
P1A 2/46
549
270
455
423
N2A 3/48
563
N2A 3/48
564
P1A 13/49
565
371
- Pseudoephedrine Syrup
Milano 30 mg/5 mL x 60 mL
Pseudoephedrine
Medicine Products 60 mg
Pseudoephedrine
Milano 30 mg
Pseudoephedrine
Milano 60 mg
Indicates brands that contain more than 1 ingredient
C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
Color profile: Disabled
Composite 150 lpi at 45 degrees
GENERIC & BRAND NAME INDEX
Registration No. Frame No.
Pseudoephedrine Syrup
Asian Pharm
30 mg/5 mL x 60 mL
Pseudoephedrine Syrup
BJ Benjaosoth
30 mg/5 mL x 60 mL
Pseudoephedrine Syrup
Milano 30 mg/5 mL x 60 mL
-
518
-
523
-
547
R
†
Radibrax 5 mg
Razepam 0.5 mg
Razepam 1 mg
Razepam 2 mg
Regenon Retard 75 mg
Regenon Retard 75 mg
Reinbamate 400 mg
Ritalin 10 mg
Rivotril 0.5 mg
Rivotril
1 mg/mL x 1 mL
Rivotril 2 mg
Rohypnol 1 mg
Rolar† 10 mg
Ropam 5 mg
Ropam
10 mg/2 mL x 2 mL
Ropect† 10 mg
Rotuss† 10 mg
Rubifen 10 mg
P1C 7/49
392
315
032
131
115
486
082
041
408
P1C 17/48
N2A 3/52
-
637
055
394
203
158
P1A 13/45
N2C 12/46
N2C 9/46
-
608
201
204
038
S
S.Co Zepam 5 mg
Sanor 5 mg
Sanor 10 mg
†
Seco 10 mg
N2A 2/47
Serene
Masa Lab 10 mg
Serene
V S Pharma 5 mg
Siampraxol 0.25 mg
P1A 6/52
Siampraxol 0.5 mg
P1A 7/52
Siampraxol 1 mg
Sipam 2 mg
P1A 15/49
Sipam 5 mg
P1A 16/49
Sipam 10 mg
P1A 17/49
Sipam
10 mg/2 mL x 2 mL
P1A 39/50
Sosegon
30 mg/mL x 1 mL
P1C 29/49
Spasil† 2.5 mg
N2A 2/51
Squill And Ammonia Mixture†
1.3 mL/10 mL x 450 mL
N2A 9/47
Stesolid 2 mg
-
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:51 AM
220
426
258
389
259
431
098
243
290
056
154
339
626
624
009
591
401
85
Registration No. Frame No.
Stesolid 5 mg
Stesolid 10 mg
Stilnox 10 mg
Sunax 0.25 mg
Sunax 0.5 mg
-
485
479
110
107
254
-
445
058
633
226
T
Tamylab-S 5 mg
Tazcine 25 mg
Tazcine 30 mg/mL x 1 mL
Tazcine 50 mg
Temazepam:
- Euhypnos 20 20 mg
Temgesic 0.2 mg
Temgesic 0.3 mg/mL x 1 mL
Tenadrin-C† 60 mL
Tenmed 5 mg
P1A 54/42
Tenmed 10 mg
P1A 55/42
Teradene† 60 mL
Teradyl Syrup† 60 mL
†
Teradyl Syrup 1000 mL
Terco-C† 10 mg
N2A 1/49
T-Five 5 mg
Tocodyl† 10 mg
Tofisopam:
- Grandaxin 50 mg
Tranadon-S 5 mg
Tranavan 0.5 mg
Tranavan 1 mg
Trancap 5 mg
Trancap 10 mg
Tranclor 5 mg
Tranclor 10 mg
Trancon 5 mg
Trancon 10 mg
Tranmed 5 mg
Tranmed 10 mg
Tranolan 2 mg
Tranolan 5 mg
Tranolan
10 mg/2 mL x 2 mL
Tranpate 5 mg
Tranpon 5 mg
Transpon Forte 10 mg
Tranxene 5 mg
Tranxene 10 mg
Tranzep 5 mg
Trialam 0.25 mg
Triazolam:
- Halcion 0.25 mg
- Trialam 0.25 mg
- Trycam 0.25 mg
Trycam 0.25 mg
398
007
619
519
440
269
520
532
533
387
446
390
P1C 27/50
P1A 3/52
P1A 4/52
P1A 27/42
P1A 4/44
P1A 39/52
P1A 42/50
P1A 43/50
051
447
307
034
470
173
439
272
456
422
428
261
130
177
P1A 41/52
P1A 61/43
P1A 16/46
-
615
416
441
257
438
271
434
168
-
350
168
348
348
Frame Numbers in Bold Italics
GENERIC & BRAND NAME INDEX
PN DEX 2010
Color profile: Disabled
Composite 150 lpi at 45 degrees
86
PN DEX 2010
GENERIC & BRAND NAME INDEX
Registration No. Frame No.
†
Tumax 5 mg
†
Tussidyl
9 mg/5 mL x 60 mL
†
Tylenol With Codeine
15 mg
†
Tylenol With Codeine
30 mg
P2A 25/51
400
N2A 6/45
589
N2A 6/43
075
N2A 11/43
076
U
Uptran 10 mg
Upzene 5 mg
†
Utorax 5 mg
267
490
383
-
GENERIC & BRAND NAME INDEX
V
V Day Zepam 2 mg
V Day Zepam 5 mg
V Day Zepam
10 mg/2 mL x 2 mL
V Day Zepam NL
10 mg/2 mL x 2 mL
Valax 2 mg
Valax 5 mg
Valax 10 mg
Valenium 2 mg
Valenium 5 mg
Valium 5 mg
Valium
10 mg/2 mL x 2 mL
Vason 2 mg
Vemed 0.5 mg
Vescopam
10 mg/2 mL x 2 mL
Victan 2 mg
Vispam 2 mg
Vispam 5 mg
Vispam 10 mg
Vomed 2 mg
Vomed 5 mg
Vorapam 2 mg
Vorapam 5 mg
P1A 88/42
P1A 89/42
475
465
P2A 82/43
616
P1A 11/46
-
617
031
132
322
065
150
152
P1A 16/48
-
620
396
316
P1A 7/50
P1A 16/50
P1A 40/50
P1A 41/50
636
182
366
213
323
059
147
064
159
Registration No. Frame No.
Xanax 0.25 mg
Xanax 0.5 mg
Xanax 1 mg
Xanax XR 0.5 mg
Xanax XR 1 mg
Xanax XR 2 mg
Xiemed 0.25 mg
Xiemed 0.5 mg
Xiemed 1 mg
P1C 20/52
P1C 21/52
P1C 22/52
P1C 17/50
P1C 18/50
P1C 19/50
P1A 27/49
P1A 34/50
P1A 28/49
096
240
287
344
069
353
108
249
296
Z
Zeda 0.5 mg
Zeda 1 mg
Zepam 2 mg
Zepam 5 mg
Zepam
10 mg/2 mL x 2 mL
Zepaxid 2 mg
Zepaxid 5 mg
Zepaxid
10 mg/2 mL x 2 mL
†
Zepobrax 5 mg
Zepoxide 5 mg
Zepoxide 10 mg
Zepoxin 5 mg
Zepoxin 10 mg
Zetran 5 mg
Zolam 0.25 mg
Zolam 0.5 mg
Zolam 1 mg
Zolpidem Tartrate:
- Stilnox 10 mg
Zopam 2 mg
Zopam 5 mg
Zopam 10 mg
Zora 0.5 mg
Zora 2 mg
Zorituss 10 mg
P1A 8/52
P1A 9/52
-
014
360
399
354
P1A 20/50
P1A 21/50
614
506
462
P1A 32/50
P1A 3/44
P1A 44/50
P1A 45/50
P1A 46/50
634
384
413
279
205
118
449
093
237
285
P1A 35/49
P1A 36/49
P1A 3/46
P1A 25/50
P1A 26/50
-
110
048
145
331
328
179
197
W
-
063
375
P1A 13/48
P1A 14/48
P1A 15/48
095
239
286
091
236
284
Winopam 2 mg
Winopam 5 mg
X
Xalam 0.25 mg
Xalam 0.5 mg
Xalam 1 mg
Xanacine 0.25 mg
Xanacine 0.5 mg
Xanacine 1 mg
†
Indicates brands that contain more than 1 ingredient
C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:51 AM
¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´
แบบสำ�รวจและแจ้งความต้องการหนังสือและ/หรือแผ่นซีดี
หน่วยงานต้นสังกัด
กระทรวงสาธารณสุข
สำ�นักงานคณะกรรมการป้องกันและปราบปรามยาเสพติด
สำ�นักงานตำ�รวจแห่งชาติ
อื่น ๆ………………………………………………………………
1. ความเห็นของท่านต่อ PNdex ในการพิสูจน์เอกลักษณ์ เพื่อค้นหาชื่อยา
มากที่สุด มาก ปานกลาง
ความสำ�คัญของการพิสูจน์เอกลักษณ์
เม็ดยาต่องานของท่าน
ประโยชน์ของ PNdex ที่ช่วยท่าน
ในการพิสูจน์หรือค้นหาชื่อยา
รูปแบบของหนังสือ ช่วยให้ท่านพิสูจน์
หรือค้นหาได้อย่างรวดเร็ว
รูปแบบของซีดีรอม ช่วยท่านให้พิสูจน์
หรือค้นหาได้อย่างรวดเร็ว
น้อย
ไม่แน่ใจ
2. ข้อผิดพลาดของหนังสือ หรือ /ซีดี-รอม ที่ควรแก้ไข
3. ข้อเสนอแนะในการพัฒนาการจัดทำ�หนังสือเล่มต่อๆ ไป
4. หน่วยงานของท่านมีความต้องการหนังสือเล่มปัจจุบัน (PNdex 2010) เพิ่ม จำ�นวน
และ/หรือแผ่นซีดี-รอม จำ�นวน
แผ่น เหตุผลความจำ�เป็น
5. ผู้ให้ข้อมูลเพศ
6. ผูใ้ ห้ข้อมูลอายุ
ชาย
21-30 ปี
หญิง
31-40 ปี
41-50 ปี
เล่ม
51-60 ปี
7. ชื่อหน่วยงาน
8. ทีอ่ ยู่หน่วยงาน เพื่อส่งของทางไปรษณีย์ และเบอร์โทรเพื่อติดต่อกลับ
กรุณาส่งแบบสำ�รวจนี้กลับมายังที่อยู่ด้านหลัง และขอขอบคุณท่านในการให้ข้อมูลที่เป็นประโยชน์ข้างต้นมา ณ ที่นี้
P87-88 Feed back.indd 1
5/4/2553 13:21:29
ส่ง
แสตมป์
P87-88 Feed back.indd 2
กองควบคุมวัตถุเสพติด
สำ�นักงานคณะกรรมการอาหารและยา
กระทรวงสาธารณสุข
ถ.ติวานนท์ อ.เมือง
จ.นนทบุรี 11000
2/4/2553 12:34:42

Similar documents